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Many polymeric film coats applied onto dosage forms have been reported to 
undergo changes in mechanical properties upon storage. The extent of these changes 
is influenced by several factors, such as the amount of plasticizers added, type of 
plasticizers used, film forming conditions, film storage temperature and humidity. 
Changes in film mechanical properties may ultimately influence the drug release, 
stability and other physicochemical properties of the coated dosage forms. 
Ethylcellulose and acrylates are among the most commonly used polymers in 
the production of coated controlled-release dosage forms. Several researchers have 
studied the effects of different types of plasticizers on the mechanical properties of 
Aquacoat films. Plasticizers, such as dibutyl sebacate, tributyl citrate, acetyl tributyl 
citrate and oleyl alcohol were found to produce ethylcellulose films that showed 
greater elongation upon stretching, after the films had been stored under conditions of 
elevated humidity. However, the actual mechanisms that caused the above change and 
the extent of influence by the different types of plasticizers have not been reported. 
The primary objective of this study was to investigate the effects of different types of 
plasticizers on the stability and other properties of the films exposed to different 
storage conditions. Attempts were made to elucidate the mechanisms responsible for 
the changes observed and correlate these changes in film properties to the release 
profiles of coated pellets. 
This study demonstrated that ethylcellulose film stability is influenced by 
several factors, including type and amount of plasticizers remaining in the film, as 
well as the storage conditions. Plasticizers interact with ethylcellulose and affect its 
film properties primarily in the following three ways. Firstly, plasticizers with low 
permanence, such as glycerin triacetate and diethyl phthalate can cause formation of 
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brittle films as these plasticizers are volatile or degrade on extended storage. 
Secondly, the extent of coalescence or ageing on ethylcellulose films varies with 
different plasticizers. In addition, the stability of ethylcellulose films under different 
storage conditions is also dependent on type of plasticizers used. 
At a commonly applied concentration of 30 percent, the citrate ester 
plasticizers, particularly triethyl citrate, have been shown to interact well with 
Aquacoat, while glycerin triacetate and diethyl phthalate were not able to plasticize 
Aquacoat films as effectively. Exposing the film membrane to low humidity or high 
temperature accelerates loss of bound water, thus enhancing the coalescence or fusion 
of polymer molecules. Storage environments with high moisture content, on the other 
hand could delay and reduce the coalescence of films but not prevent it. With the 
exception of glycerin triacetate, chlorpheniramine release from pellets coated with 
plasticized Aquacoat films were affected to varying degrees by storage conditions. 
Higher storage temperatures tend to cause greater changes for pellets coated with 
Aquacoat containing citric acid class of plasticizers (triethyl citrate and acetyl triethyl 
citrate) compared to other plasticizers. This study demonstrated that the 
physicochemical properties of the plasticizer coupled with the storage conditions have 
an important influence on the stability and performance of the final film coat. Hence it 
is important to exercise caution in the selection of plasticizers for film coating in order 
to ensure good product stability and performance. 
Ethylcellulose is used in controlled released preparations because of its good 
mechanical properties and poor permeability to water vapour. However, these 
properties strongly retard drug release and thereby limit the application of pure 
ethylcellulose coating as controlled release coating. Studies were undertaken to 
modify drug permeability through ethylcellulose coatings by reduction in thickness of 
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the coating layer, formation of pores using organic solvents and hydrophilic additives. 
Polyvinylpyrrolidone is a water - soluble, physiologically inert synthetic polymer 
consisting essentially of linear 1-vinyl-2-pyrrolidinone groups, with varying degree of 
polymerization which results in polyvinylpyrrolidone of different molecular weights. 
Viviprint 540 is a molecular – composite polyvinylpyrrolidone, which is formed by in 
situ incorporation of insoluble crosslinked polyvinylpyrrolidone nanoparticles into 
soluble, film–forming polyvinylpyrrolidone polymer. Hence molecular – composite 
polyvinylpyrrolidone has much larger molecular weight than polyvinylpyrrolidone 
and is less soluble in water. Plasdone S-630 copolyvidonum is a synthetic water-
soluble copolymer consisting of N-vinyl-2-pyrrolidone and vinyl acetate in a random 
60:40 ratio. All the water-soluble polymers discussed above are potential polymeric 
film modifiers for achieving improved drug release. However, to date, their potentials 
have not been explored.  
In this study, the interaction between ethylcellulose and polyvinylpyrrolidone 
was found to be dependent on the molecular weight, concentration and chemical 
nature of the additives. When added to ethylcellulose, low molecular weight 
polyvinylpyrrolidone would be randomly distributed in the ethylcellulose matrix as a 
disperse phase. Increased concentration up to 30 %w/w did not alter the phase 
distribution. In contrast, greater interaction was exhibited between ethylcellulose and 
higher molecular weight polyvinylpyrrolidone, such as polyvinylpyrrolidone K60, 
K90 and molecular – composite polyvinylpyrrolidone. At low concentration, higher 
molecular weight polyvinylpyrrolidone might exist as a disperse phase in the 
ethylcellulose matrix. However, as the concentration increased, the higher molecular 
weight additives tended to aggregate and formed a separate continuous phase. 
Formation of separate continuous layers became more prominent with increasing 
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concentration. Increased molecular weight of additives also accelerated the formation 
of separate layers.  
Addition of polyvinylpyrrolidone increased the glass transition temperature, 
water vapour and drug permeabilities, as well as strengthened the mechanical 
properties of composite ethylcellulose films. However, the magnitude of change was 
not consistent in all cases. For instances, the percent increases in glass transition 
temperature and tensile strength were relatively small (~ 27 percent), while greater 
increments (~ 76 – 80 percent) were observed for the elastic modulus and puncture 
strength of composite ethylcellulose films. Presence of polyvinylpyrrolidone further 
accentuates ethylcellulose film permeability to water vapour (~ 80 - 177 perecent) and 
brought about 1000 times or higher permeability to drugs. Moreover, while a linear 
relationship was found between the molecular weight of polyvinylpyrrolidones and 
permeability to chlorpheniramine, the thermal and mechanical properties of composite 
ethylcellulose films did not showed similar response to increasing molecular weight 
of polyvinylpyrrolidones. 
Though addition of polyvinylpyrrolidones to ethylcellulose resulted in 
increase in glass transition temperature, tensile strength, elastic modulus and puncture 
strength of resultant film, these changes did not correlate with a reduction in 
permeabilities as suggested by other studies. This anomaly could be due to properties 
of additives present. Polyvinylpyrrolidone is a water-soluble and hygroscopic polymer 
which may increase the drug permeability through formation of pores resulting from 
rapid diffusion of polyvinylpyrrolidone into the surrounding diffusion medium. 
Similar trends were observed for changes in physicomechanical and physicochemical 
and release rate from the composite ethylcellulose films regardless of the properties of 
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drugs used. This suggested that influence of properties of adjuvants was the dominant 
factor that affects the permeability of composite ethylcellulose films.  
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A. Film coating 
Film coating is an important technique in the pharmaceutical industry for 
preparation of oral dosage forms (Lachmann et al., 1986). It is a process involving the 
application of a thin (20 to 200 µm) polymer-based coating on an appropriate 
substrate, such as tablets, beads, granules, capsules, drug-powder and crystals (Figure 
1).  
 
1. Reasons for coating 
Over the years, there is increasing popularity for film coating. The reasons for 
film coating are many and varied (Porter et al., 1991). Generally, film coating can be 
categorized as those used for modified released and those used to improve product 
appearance, to mask unpleasant taste, as well as to protect against moisture and light. 
In contrast, functional coating is used to modify the release of drug.  
 
2. Film coating polymers 
Polymers used for general or non release related coating are usually readily 
soluble in the gastrointestinal tract and do not influence drug release significantly. 
They are usually the water soluble cellulose ethers such as methyl cellulose, 
hydroxypropyl methyl cellulose, hydroxyethyl cellulose and hydroxypropyl cellulose 
(Table 1).  
Enteric coating and controlled released coating are examples of modified 
released coating. Enteric coating polymers are usually soluble above a certain pH 
such as pH 5.0. They remain insoluble in the stomach but start to dissolve once the 













Figure 1. Film coating of pellets. (Adapted from Porter, 1991) 
 
are formulated with synthetic polymers that contain ionizable functional groups that 
render the polymer water soluble at specific pH values. Such polymers are often 
referred to as “poly-acids”. Examples of commonly used enteric coating polymers are 
listed in Table 1. 
Polymers used for controlled release coating are usually insoluble or poorly 
soluble in water. Drug release is governed by drug diffusion, polymer dissolution, 
erosion and/or osmosis. For drug diffusion, the dosage form is coated with a water -
insoluble polymer (e.g. ethylcellulose) alone or in combination with a water - soluble 
ingredient (e.g. hydroxypropyl methylcellulose) such that the gastrointestinal fluids 
can permeate through the film and dissolve the drug enabling it to diffuse out at a rate 
dependent on the physicochemical properties of both drug and film coating 
(Sakellariou et al., 1995). For polymer dissolution or erosion, the dosage form is 
coated with either a sparingly soluble or pH dependent soluble film (e.g. cellulose 
acetate phthalate) such that the drug release will be dictated by the dissolution of the 
Spray 
nozzle 










polymer. For osmosis, the dosage form is coated with a semi- permeable membrane 
(e.g. cellulose acetate) through which a small orifice is drilled. The gastrointestinal 
fluids pass across the membrane by osmosis, at a controlled rate determined by the  
Table 1. Polymers commonly used for film coating 
Category Class Polymer Form  Application 
Methylcellulose (MC) Powder 
Hydroxypropyl methyl 
cellulose (HPMC) Powder 
Hydroxypropyl ethyl 




















trimellitate (CAT) Powder 













Vinyl esters Polyvinyl acetate phthalate (PVAP) 
Spray-dried 
powder 
Poly (methacrylic acid -
ethylacrylate)  




Poly (methacrylic acid - 
methylmethylacrylate)  








Poly (methacrylic acid - 
methylmethylacrylate)  




Drug release in 
upper region of 
small intestine 
Cellulose 
derivatives Ethylcellulose (EC) Pseudolatex  
Poly (ethylacrylate - 
methylmethylacrylate)  
EA:MMA = 2:1 
Latex 
Poly (ethylacrylate - 
methylmethylacrylate – 
trimethylammonioethyl 
methacrylate chloride)  





Poly (ethylacrylate - 
methylmethylacrylate – 
trimethylammonioethyl 
methacrylate chloride)  
EA:MMA:TAMCl = 1:2:0.1 
Latex 
Release of drug at 





permeability of the film, to dissolve the drug in the core. Hence, the core formulation 
must include an osmotic agent. The dissolved drug is then released through the 
orifice. 
 
3.  Organic versus aqueous coating systems 
Generally, there are two types of coating systems – organic coating systems, 
which involve the use of organic solvents and the aqueous type which uses water. 
When film coating was first introduced, the polymers employed were only soluble in 
organic solvents (Abbott laboratories 1953). Aqueous coating systems were less 
preferred as the water contents of the coating solution were implicated as the cause of 
stability problems and long processing time (Savage et al., 1995). The principal 
benefits of using organic solvents were the considerable reduction in processing time 
and absence of water from the process, thereby eliminating the loss of active 
ingredient through hydrolysis. In addition, organic solvents can completely dissolve 
the polymeric film formers, thereby allowing formation of smooth and continuous 
coatings which were capable of protecting medicaments from environmental stresses 
and making tablets more distinctive. 
The three most common organo-soluble polymers (cellulose acetate, 
ethylcellulose and methacrylic acid copolymer) used as sustained release membranes 
were introduced to the industry before 1962. To date, there is no other organo-soluble 
coating system that is as widely accepted by the industry. This is largely attributed to 
the risks associated with organic solvent usage and improvement in aqueous coating 
systems. Stricter environmental legislation, in conjunction with the high cost of 
controlling organic solvent emission, has forced researchers to find alternative 
‘environmentally friendly’ coating systems.  
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The current USP lists only three sustained release coatings that function as a 
rate controlling membrane – cellulose acetate, ethylcellulose and methacrylic acid 
copolymer. Aqueous coating system is developed after the organo-soluble coating 
system. Hence, the current aqueous polymeric dispersion systems (e.g. Aquacoat®, 
Surelease®, Eudragit®, Aquateric®) consist of mainly the 3 widely accepted polymers. 
 
4.  Aqueous coating systems 
a. Latex and pseudolatex 
 These coating systems can be classified according to their manufacturing 
processes. Generally, there are four methods of preparation, namely emulsion 
polymerization, emulsion-solvent evaporation, phase inversion and solvent change 
(Chang et al., 1987). Latexes have the disadvantage of being sensitive to several 
stresses, such as electrolytes, pH change, storage temperature and high shear forces. 
 
i. Emulsion polymerization 
Latexes are colloidal polymer dispersions produced by emulsion 
polymerization (Lehmann, 1997). After the monomers have been emulsified in water, 
usually with the aid of anionic or nonionic surfactants, an initiator is added to induce 
polymerization (Woods et al., 1968). The dispersions have a high solid content (up to 
50 percent) but low viscosity. Examples are Eudragit NE 30D, Eudragit L100-55, 
L100 and S 100 (Lehmann, 1997).  
 
ii. Emulsion - solvent evaporation 
Pseudolatex is prepared by dissolving a thermoplastic water-insoluble polymer 
in an organic solvent and emulsifying it with an aqueous solution of surfactant. The 
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organic phase is then removed by vacuum distillation, leaving an aqueous dispersion 
of polymer for coating application. If the polymer is prone to hydrolysis, the aqueous 
dispersion is spray dried (e.g. Aquateric, Aqoat, Sureteric). The spray - dried 
pseudolatex powder is redispersed in water containing surfactant, dye or other 
additives just before coating. Particle size of the emulsified polymer is an important 
factor affecting pseudolatex stability and subsequent film formation. Most 
pseudolatexes consist of spherical solid or semisolid particles less than 1 um in 
diameter, typically less than 0.1 µm (Wheatley and Steuernagel, 1997). 
 
iii. Phase inversion 
Surelease is an example of a pseudolatex prepared by phase inversion. 
Production of this EC pseudolatex involved hot melt extrusion process, where the 
polymer is melted and the molten extrudate is then injected under pressure into 
ammoniated water.  Plasticizers, such as dibutyl sebacate or fractionated coconut oil 
are added to reduce the melting temperature of EC, thereby preventing degradation of 
the polymer at high temperature. Phase inversion occurred when water in the 
ethylcellulose dispersion, formed upon extrusion of the plasticized hot melt mixture 
into water, inverted to EC in water dispersion (Porter, 1997).  
 
iv. Solvent change 
The solid polymers are synthesized by bulk polymerization. The polymer 
powder can be directly emulsified in hot water without further additives (emulsifiers), 
forming a stable aqueous dispersion. Examples of such systems are Eudragit RL 30D 




b.  Suspension 
Another aqueous coating system available is the suspension. It is prepared by 
dispersing a micronized water - insoluble polymer in water containing plasticizer 
(Keshikawa et al., 1994). An example of an aqueous suspension system is micronized 
EC (N-10F, Shin Etsu Chemical Co., Ltd). There is little published literature on the 
use of aqueous suspension systems, suggesting the lack of popularity of these 
systems. Keshikawa et al. (1994) have shown that coating using an aqueous 
ethylcelluose suspension eliminated the need for curing but a large amount of 
plasticizer was usually required (up to 50%). 
 
B.  Mechanism of film formation 
Film formation from aqueous polymeric dispersions requires the coalescence 
of individual submicron-size polymer particles, each containing hundreds of polymer 
chains, to form a continuous layer as the aqueous phase evaporates. Figure 2 shows a 
pseudolatex consisting of polymer particles that are suspended and separated by 
electrostatic repulsion. As water evaporates, interfacial tension between water vapour 
and polymer pushes particles into point contact in a close-packed ordered array. A 
strong driving force is necessary to overcome repulsive forces, to deform the particles, 
and cause the particles to fuse, resulting in complete coalescence. Capillary forces, 
generated by the high interfacial tension produced as water between polymer particles 
evaporates, provide much of the energy required for film formation (Brown, 1956; 
Bindschaedler et al., 1983). As illustrated in Figure 3, the polymer particles are pulled 
closer together as the capillary forces build up with evaporation of water. The surface 
tension of the spherical particle generated by the negative curvature of its surface can 
be described by Frenkel’s equation: 
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        (1) 
 
where θ is one-half the angle of coalescence (contact angle) at time t, γ is the surface 
tension, r is the radius of the particle, driving force (γ) necessary to fuse or coalesce 
the particles and N is the viscosity of the particles (Dillon et al., 1951). For this 
reason, a plasticizer is usually added to aid in the coalescence of the polymer 
particles. A plasticizer is a substantially nonvolatile, high-boiling and nonseparating 
substance that changes the physical and mechanical properties of the polymer to be 
plasticized (Banker et al., 1966). The addition of plasticizers is required for polymer 
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Figure 3. Coalescence of particles during the evaporative phase (Adapted from 
Wheatley and Steuernagel, 1997). 
 
coating temperature. During plasticization, the plasticizer will partition into and soften 
the colloidal polymer particles, thus promoting particle deformation and coalescence 
to form a homogeneous film (Bodmeier et al., 1997). 
 
C.  Substrates for film coating 
Film coating is more commonly applied onto tablets and pellets. Pellets are 
multiparticulates, typically with size ranging between 0.5 - 1.5 mm, produced by an 
agglomeration process which converts fine powders or granules of bulk drugs and 
excipients into small, free-flowing, spherical or semi-spherical units (Ghebre-
Force exerted on three particles wet by 
water film 
Force exerted on two particles 
wet water film 
Water evaporation brings 
particles together 




Sellassie, 1989). Pelletized products offer several advantages over single unit dosage 
forms such as maximizing drug absorption while reducing peak plasma fluctuations 
and potential side effects without compromising drug bioavailability (Bechgaard and 
Nielson, 1978). Use of pellets can reduce intra- and inter-subject variability in gastro 
intestinal transit time, which is commonly observed for single unit dosage forms. 
Pellets are drug delivery systems of choice, particularly when the active ingredients 
are inherently irritative or anesthetic, since they are less susceptible to dose dumping. 
Combination therapy or delivery of two or more drugs in a single unit is also possible 
with pelletized products. Pellets are commonly prepared by depositing successive 
layers of drug from solution, suspension, or dry powder on preformed nuclei by a 
process known as layering (Iyer et al., 1993). Alternatively, they can be manufactured 
by extrusion-spheronisation (Nesbitt, 1994) where a wet mass of powder is extruded 
through a perforated screen to form cylindrical extrudates, which are then spheronised 
into pellets and dried. 
 
D.  Drug release mechanisms of coated pellets 
For general coating, critical factors that may affect its performance include the 
morphology and opacity of the film and permeability of the film to moisture. In the 
case of modified released coating, factors that affect the release mechanism of the 
coated products should be controlled to ensure consistent product quality. Before 
considering what these factors may be, it is necessary to understand the mechanisms 
of release for coated dosage forms. Dosage forms with drug release that is mainly 
controlled by an applied film coat are commonly known as ‘membrane-controlled 
release systems’ or ‘reservoir systems’ (Porter, 1991). In a membrane-controlled 
system, the drug diffuses from the core through the rate-controlling membrane into 
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the surrounding environment. The rate of diffusion may depend on membrane 
porosity, tortuosity, geometry and thickness. In circumstances where film coat is 
insoluble in the dissolution media and in the absence of additives or where the 
influence of additives on drug release is negligible, transport of drug may occur 
through the following pathways: 
• transport of drug through flaws in the membrane (as a result of stress-induced 
cracks in film coat with poor mechanical properties), and 
• transport of drug through pores that result from incomplete coalescence in 
films prepared from aqueous polymeric dispersions. 
Additives are commonly added to the polymer coating dispersions in order to improve 
the film coat quality as well as to modify the release of drugs. Under such conditions, 
drug release may be affected by the following phenomena: 
• a network of capillaries (filled with dissolution media) created by leaching of a 
water-soluble component from the film, and 
• a hydrated, swollen film forms when the film coat contains a hydrophilic 
component that cannot readily leach out.  
Based on mechanisms of drug release, film-coated dosage forms can be broadly 
categorized as diffusion - controlled, swelling - controlled, osmotically - controlled 
and chemically - controlled systems. 
 
1.  Diffusion - controlled systems 
In these systems, drug release is governed by molecular diffusion along a   
concentration gradient across the polymer film coat. The latter may be porous or 
nonporous. Porous controlled release systems contain pores that are large enough for 
diffusion of drug through water-filled pores of the coat (Figure 4a). The size of such 
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pores is usually greater than 200-500 Å. In the nonporous systems, it is assumed that 
the polymer forms a continuous phase (Figure 4b). The diffusion of a solute molecule 
through a polymer phase is an activated process involving the cooperative movements 
of drug and polymer chain segments around it. Thermal fluctuations of chain 
segments allow sufficient local separation of adjacent chains to permit passage of a 
drug. Another mechanism of release is configurational diffusion that involves the 
movement of drug through the polymer chains. The rate of diffusion is therefore 
dependent on polymer parameters such as degree of crystallinity, size of crystallites, 
degree of cross-linking, swelling and molecular weight of the polymer. 
The release rate of a non-porous system can be described by the following 




)C-(CPJ =         (2) 
where J is the flux (release rate per unit surface area of coating), Cs and Cb are the 
concentrations of drug at drug-coating interface and in the bulk, respectively, and δc is 
the coating thickness. The permeability coefficient, Pm, of the coating polymer 
membrane can be expressed as  
       (3) 
 
where D is the molecular diffusitivity of the drug, K is the distribution coefficient of 
the drug between the polymer membrane and fluid in the core, ε the volume fraction 
of the chain openings, β the chain immobilization factor, and τ the tortuosity factor. 
The frequency with which a diffusion step occurs depends on (a) the size and shape of 








































Figure 4. Drug release from coated pellets, (a) diffusion - controlled through porous 
coat, (b) diffusion – controlled through non – porous coat, (c) swelling – controlled, 




























polymer chains, and (c) stiffness of polymer chains. The overall permeability of 
polymer membrane to drug will depend on the ability of the drug to partition into the 
polymer as well as its ability to diffuse through the polymer. This can be estimated 
from the solubility parameters of the drug and polymer. In general, the 
solution/diffusion mechanism is dominant in cases where the film coat is continuous 
(lacks pores) and flexible, and where the drug has a high affinity for the polymer 
relative to water. 
In the case of a porous system, the diffusion coefficient is often expressed as 
an effective diffusion coefficient, Deff, which is related to the diffusion coefficient of 
the drug through the pores filled with drug solution, Diw, as follows: 
        (4) 
 
As release occurs, more drug is lost, and the solution becomes more and more diluted. 
Porosity is the fraction of pores in the system that is open (0 < ε < 1). The turtuosity, 
τ, indicates the complexity of the pathways that constituent the pores. Diffusion in a 
porous system is dependent on the size of the drug and size of the pore. 
 
2.  Swelling - controlled systems 
These systems consist of water-soluble drugs that are initially dispersed in 
solvent-free glassy polymers. When in contact with water, dynamic swelling of film 
coat leads to considerable volume expansion (Figure 4c). The swelling behaviour is 
characterized by two fronts: 
• swelling interface that separates rubbery (swollen) state from glassy state and 
moves inward with velocity, v 





Swelling of glassy polymers is accompanied by macromolecular relaxation 
which affects drug diffusion through the polymer. The transport of drug through the 
polymer can be controlled by either the rate at which the macromolecular chains relax 
during transition from a glassy to rubbery state or by the diffusion of drug through the 
rubbery polymer. A dimensionless number known as Deborah, De, was employed by 
Vrentas et al., (1984) to characterize this mode of drug transport 
         (5) 
 
where λ is the relaxation time, and θ d is the diffusion time. When De >> 1 (i.e. when 
the transport is completely relaxed) or when De << 1 (i.e. when the transport is 
completely controlled by diffusion), Fickian behaviour is observed. When De ~ 1 (i.e. 
when the relaxation time is of the order of the diffusion time), anomalous diffusion 
behaviour is observed. 
Water enters the film coat gradually, bringing about swelling in ‘layers’. The 
layers on the surface will swell first while the center is dry. The diffusional behaviour 
of water into the dosage form coated by a swelling film is described by Fujita 
equation: 
Ddrug = Ddo exp{- α (β - cw)}        (6) 
 
where α and β are two characteristic constants of the polymeric system and cw is the 
water concentration in the system. 
 
3.  Chemically - controlled systems 
Drug diffusion is controlled by the erosion of the polymer matrix (Figure 4d). 






the breaking down of polymer due to chemical reaction. Bioerosion is a process 
whereby a phase of the carrier is lost, not by chemical reaction but by dissolution. 
 
4.  Osmotically - driven release systems 
There is a possibility of release being driven by an osmotic pressure difference 
between core materials and release environment, when the coating is porous (Figure 
4e). Sources of osmotic pressure in the core formulation include low molecular 
weight exicipients and the drug. However, for the drug to contribute significantly to 
osmotic pressure, it should be highly water soluble, of low molecular weight and 
present in a substantial dose (capable of achieving saturation concentration in the 
core). When the dosage form comes into contact with an aqueous environment, water 
is imbibed through the coating, creating a solution in the core. The osmoactive 
substances dissolve in the imbibed water and generate an interior osmotic pressure. 
The osmotic pressure difference between core and external medium then provides a 
driving force for efflux, J, through pores in the coating. This transport phenomenon 
can be quantified by the following equation: 
J = Kf σ ∆π (Ci - Cm)         (7) 
 
where Kf is the filtration coefficient, σ is the reflection coefficient of the coating, ∆π 
is the osmotic pressure difference across the coating, and Ci and Cm are the interior 
and media drug concentrations respectively.  
Assuming that drug is released under sink conditions in the intestine, zero-
order release is achieved only when (a) the materials responsible for maintaining the 
osmotic pressure difference are present in the core at concentrations above their 
solubilities (hence constant ∆π is maintained), and (b) the drug is present at a 
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concentration greater than its solubility. A semipermeable coating consists of 
presence of aqueous pores within the coating and core materials that are capable of 
generating sufficient osmotic pressure are necessary for attaining osmotically - driven 
release. 
 
E.  Performance of film-coated products 
For ease of understanding, the factors that could influence the performance of 
film coatings, in particular the release properties of coated dosage forms. They are 
broadly classified into 3 areas: substrate, coating formulation, and coating process. 
 
1.  Substrate 
In practice, while the release of drug from dosage forms may be membrane-
controlled, the substrate is also critical in determining the behaviour of the final 
coated dosage form. Some of the substrate variables that need to be considered 
include the surface area, friability, porosity and chemical properties of the substrate. 
The total surface area of the substrate cores largely determines the amount of coating 
material needed to produce coats with the required thickness. The total surface area is 
dependent on the size and size distribution, shape and surface roughness of the 
substrate cores (Porter, 1991; Ragnarsson and Johanson, 1988; Chen and Lee, 2002). 
Smaller substrate cores, such as pellets, have higher surface area to volume ratios and 
hence would require more coating material to achieve similar coat thickness as 
compared to larger substrate cores, like tablets. Substrates, which are spherical in 
shape, have been found to be more evenly coated compared to needle-like substrates 
(Chopra et al., 2002). The roughness of the substrate cores may affect the evenness of 
the film coat (Johansson and Alderborn, 1996). Great variation in thickness may result 
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in films with non-uniform mechanical strength and lower ability to withstand internal 
stress.  
Coating processes are usually carried out in a highly stressed environment 
where there may be abrasion of the substrate. Consequently, some of the drug powder 
generated may be distributed in the coating and affect the release profiles of the final 
dosage form. The substrate porosity may affect drug release in two ways. Firstly, a 
highly porous substrate may permit water from the film coat to penetrate into the 
substrate, causing drug to be leached out. In addition, porous substrates tend to retain 
liquid by capillary forces and this may affect the coalescence of pseudolatex particles 
to form a coherent film (Tunon et al., 2003).  
Besides the physical properties of substrates, the chemical nature of the drugs 
also plays a significant role in determining the release profiles of the final dosage 
form. These include drug solubility in the dissolution fluid and coating membrane, 
diffusivity in the film coat, molecular size and osmolarity, and the presence of 
osmoactive substances. Drugs of higher water soubilities show faster release rates 
(Ragnarsson et al., 1992; Nesbitt et al., 1994). However, if chemical interaction 
occurs between the drug and coating, less soluble complexes may form and drug 
release will be reduced. Hydrophilic substrates have also been reported to aid in drug 
release by attracting water to the core, thereby facilitating dissolution of the drug 
(Sousa et al., 2002). Drugs or excipients with high osmolarity can also result in a 
build up of osmotic pressure once the substrate core is wetted. The build up of 
osmotic pressure can increase drug release by aiding the transportation of drug 




2.  Coating formulation 
Film-coating formulations usually contain the following components, film 
forming polymers and additives such as plasticizers, colorants, surfactants, anti-tack 
agents and secondary polymers. 
 
a.  Nature of the polymer 
 The choice of polymer depends largely on its suitability for the intended 
functions as discussed previously. A good knowledge of the polymer chemistry would 
greatly help to understand the behaviour and interaction of the polymer with other 
substances. This includes the polymer chemistry, physical properties of the polymers 
such as the molecular weight, solubility, viscosity, permeability, mechanical and 
thermal properties (e.g. glass transition temperature and softening temperature). The 
molecular weight of the polymer has been reported to affect the mechanical properties 
of the film directly. For the film coat to perform its intended function, it must have 
sufficient mechanical strength so that it will not lose its intergrity when used. 
Increasing the molecular weight of polymer will result in films of higher mechanical 
strength as well as elastic modulus. Rowe (1980) suggested a molecular value of 7 to 
8 x 104 as the limiting value for tablet-coating polymers. The solubility of a polymer 
in the dissolution fluid will determine its suitability for various applications as 
discussed earlier. Hydroxypropyl methylcellulose and EC are usually available in a 
number of viscosity grades. Polymers of lower viscosity can be employed at higher 
concentrations, thus enabling reduction in solvent content of the polymer solution. 
This also reduces the processing time as the amount of solvent needed to be removed 
during coating is less. However, very low viscosity polymers have low MW and tend 
to have poor film strength.  
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 Permeability of the polymer film to water vapour or other atmospheric gases, 
such as oxygen, is an important property of film coats that function as protective 
barriers to moisture or oxidation. The thermal properties of the polymer film are also 
important. The softening temperature, which is the temperature at which a film strip 
laid on a heated metal bar begins to soften corresponds to the degree of tackiness that 
may occur during high-temperature drying or during heat sealing process for strip or 
blister packing. Knowledge of the surface activity of the polymer solution is 
necessary for determining the degree of wetting of the substrate and spreading of the 
polymer spray droplet during film coating.  
 The more common polymers used for coating can be boardly classified as the 
cellulose derivatives, acrylic polymers and others.  
i. Cellulose derivatives 
 These include polymers, such as methylcellulose (MC), hydroxypropyl 
methylcellulose (HPMC), hydroxypropyl cellulose (HPC), ethylcellulose (EC), 
cellulose acetate phthalate (CAP), and hydroxypropyl methylcellulose phthalate 
(HPMCP). These polymers possess the cellulose backbone made up of repeating units 
of anhydroglucose, with hydroxyl groups that can be substituted with other functional 
groups (Figure 5). The degree of substitution (DS) is expressed as the number or 
weight percentage of substituent groups. The term molar substitution (MS) takes into 
account the total number of moles of substituents. Both DS and MS affect the 
solubility and thermal gel point of the polymer. The polymer chain length, molecular 
size and extent of branching will determine the viscosity of the polymer in solution.  
 The cellulose derivatives can be further divided into water-soluble, water-
insoluble and pH-dependent soluble polymers. The most commonly used water-
soluble cellulose polymers include methylcellulose, hydroxypropyl cellulose and 
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hydroxypropyl methylcellulose. All these polymers are freely soluble in cold water 
but insoluble in hot water. Hydroxypropyl methylcellulose is popular because of its 
compatibility with organic solvents and water. Gelation temperature is the 
temperature at which the polymers separate from their aqueous solution. When this 
occurs, the viscosity of the solution will increase correspondingly. The approximate  
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‘gelation’ temperature for methylcellulose, hydroxypropyl methylcellulose and 
hydroxypropyl cellulose are 50 °C, 60 °C and 45 °C respectively.   
 The most widely used water-insoluble cellulose derivative in film coating is  
ethylcellulose. It has a DS of between 2.27 and 2.62 corresponding to an ethoxyl 
content of between 44 and 51 %w/w. The ethoxyl groups are quite uniformly 
distributed on both the primary and secondary hydroxyl group of the anhydroglucose 
units. ethylcelullose is usually soluble in solvents that have nearly the same cohesive 
energy density or solubility parameter as itself. The amount of alcohol that is required 
to obtain minimum viscosity at a given concentration is proportional to the number of 
hydroxyl groups that remain unsubstituted.  
 The pH-dependent soluble cellulose polymers are usually the phthalyl (σ 
carboxybenzoyl) derivatives of cellulose or hydroxypropyl methylcellulose. They are 
insoluble at low pH but soluble at high pH. The pH at which they dissolve depends on 
the degree of acetyl and phthalyl substitution. The solubility of the polymers in 
organic solvents also depends on the degree and type of substitution.  
 
ii. Acrylic polymer 
Two main groups of acrylic polymers more commonly used in coating are 
methacrylate ester copolymers, and methacrylic acid copolymers (Figure 6) 
(Lehmann, 1997). Methacrylate ester copolymers and methacrylic acid copolymers 
are structurally similar except that the former is totally esterified with no free 
carboxylic acid groups. Methacrylate ester copolymers are neutral in character and are 
insoluble over the entire physiological pH range. They can swell and become 
permeable to water and dissolved substances. Due to the presence of free carboxylic 
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acid groups, methacrylic acid copolymers are useful as enteric coating materials. They 
are capable of forming salts with alkalis and are relatively soluble at pH above 5.5. 
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Methacrylic acid copolymers, where R1 = H or CH3 and R2 = C2H5 or CH3 
 
Figure 6. Chemical structures of acrylic polymer 
 
b.  Additives 
i. Plasticizers 
Plasticizers are low molecular weight materials which have the capacity to 
alter the physical properties of a polymer to render it more able to form a coherent 
film (Banker et al., 1966). The plasiticizer molecules interpose themselves between 
individual polymer strands, thus reducing polymer-polymer interactions and enabling 
the polymer strands to move past each other with greater ease. Plasticizers affect 
polymers which are either amorphous or have low crystallinity. Strongly crystalline 
polymers are difficult to plasticize as it is not easy to disrupt the intermolecular 
crystalline structure of the polymer.  
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Plasticizers can be classified as polyols, organic esters or oils/glycerides 
(Table 2). The polyols include glycerol, propylene glycol, polyethylene glycol (PEG) 
of molecular weights 200 - 6000. They are freely souble in water and hygroscopic in 
nature, except for higher molecular weight polyethylene glycol. The polyols are 
suitable for plasticizing water-soluble cellulose ethers containing a large proportion of 
hydroxyl groups. The organic esters include phthalate esters, dibutyl sebacate, citrate 
esters and triacetin (glycerol triacetate). This group of plasticizers is suitable for 
plasticizing the less polar cellulose esters, cellulose acetate phthalate and 
hydroxypropyl methylcellulose phthalate polymers. Most of the organic esters are 
miscible with organic solvents but have limited solubility in water. The commonly 
utilized vegetable oils or glycerides plasticizers include caster oil and acetylated 
monoglycerides. The vegetable oils themselves also contain a high proportion of 
glycerides. The distilled acetylated monoglycerides are modified fats of high purity 
and are available in various grades with degree of acetylation ranging from 50 to 98 
percent. They are often used as plasticizers for ethylcellulose and polymers for the 
enteric coating. The choice of plasticizer depends on its compatibility with the 
polymer, plasticizer efficiency and permanence. Compatibility is demonstrated by the 
ability of the plasticizer to act as a solvent for the polymer to be plasticized. 
Thermodynamically, in order for the polymer to dissolve in a solvent (plasticizer), the 
Gibbs free energy of mixing, ∆G, must be negative, 
∆G = ∆H - T∆S         (8) 
 
where ∆H is the heat of mixing, T is the absolute temperature and ∆S is the entropy of 
mixing. Okhamafe and York (1987) showed that ∆H could be calculated using the 



























⎛=∆        (9) 
 
where Vm is the total volume of the mixture, ∆E1 and ∆E2 are the energies of 
components 1 and 2 respectively, V1 and V2 are the molar volumes of component 1 
and 2 respectively and φ1 and φ2 are the volume fractions of components 1 and 2 
respectively. The term ∆E/V is generally referred to as the cohesive energy density 
Table 2. Physical properties of plasticizers used in film coating. (Adapted from Wick 
et al., 1999; Hoechst, 1997; Union Carbide, 1981; Chas. Ffizer, 1961; Scheflan and 


















Glycerol 92 1.260 1.473 290 177 
Propylenel glycol 76 1.035 1.431 188 99 
Polyethylene glycol 400 400 1.128 1.452 > 300 245 
Polyethylene glycol 4000 4000 1.20 
(solid) 





Dimethyl phthalate 194 1.189 1.517 282 163 
Diethyl phthalate 222 1.123 1.501 296 168 
Dibutyl phthalate 278 1.051 1.490 340 171 
Dibutyl sebecate 314 0.932 1.443 345 185 
Triethyl citrate 276 1.136 1.440 127 155 
Tributyl citrate 360 1.045 1.446 170 185 
Triethyl acetyl citrate 318 1.135 1.438 132 188 
Triethyl butyl citrate 402 1.048 1.441 173 204 
Triacetin 218 1.156 1.431 258 132 
Vegetable oils and glycerides 
Castor oil - 0.960 1.480 - - 
50% acetylated 
monoglyceride 
- 0.94c - > 150 239 
Fully acetylated 
monoglyceride 
- 0.98 - > 500 242 
a Measured using Cleveland open cup; b Measured at 70 °C; a Measured at 50 °C. 
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(CED) and its square root as the solubility parameter, δ.  
Hence, equation 9 can also be expressed as,  
( ) 2121 2 φφδδ −=∆ mVH        (10) 
 
If δ1 and δ2 are the same, the heat of mixing will be zero, indicating a state of 
maximum compatibility between polymer and plasticizer. Hence, solubility parameter 
measurements can be used as a measure of platicizer compatibility. It has been shown 
from the solubility parameters of EC in several plasticizers that EC is most 
compatible with the phthalic acid esters and dibutyl sebacate, but incompatible with 
glycerol or propylene glycol (Burrell, 1975). However, the above approach for 
predicting compatibility between polymers and plasticizers is not widely adopted and 
hence many solubility parameters of polymers and plasticizers are unknown. The 
limitations of solubility parameter measurement can be overcome by using intrinsic 
viscosity measurement. The intrinsic viscosity of the polymer in the plasticizer will be 
high when there is a good interaction between the plasticizer and polymer.  
Entwistle and Rowe (1979) had reported a correlation between the intrinsic 
viscosities of the polymer/plasticizer mixtures and the mechanical attributes of the 
resultant films formed. The mechanical strength of the film was found to be the 
lowest when the intrinsic viscosity of the polymer/plasticizer mixture was the highest. 
This is attributed to the interaction between the plasticizer and polymer, giving rise to 
increased segmental movements. Thus, the resultant plasticized polymer film has a 
more porous, more flexible but less cohesive structure, as indicated by increased 
strain or film elongation and decreased elastic modulus and tensile strength. Changes 
in the mechanical properties of plasticized films have been widely used as a 
convenient means to evualate the efficiency of plasticizers (Aulton et al., 1981; 
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Bodmeier and Paeratakul, 1994; Sinko and Amidon, 1989). Sinko and Amidon (1989) 
had further proposed a term to describe the efficiency of plasticizers based on their 
ability to induce changes on the rate of mechanical response as the solvent leaves the 
film and the polymer passes through a rubbery to glassy transition. In addition to the 
above mechanical methods, a thermal method that involves the measurement of glass 
transition temperature has also been used to evaluate the compatibility and 
effectiveness of plasticizers. Glass transition temperature is the temperature at which a 
polymer changes from a glassy rigid material to a viscous rubbery material. The glass-
transition temperature of a plasticized polymer can be determined by studying the 
temperature dependence of properties such as specific heat, refractive index, elastic 
moduls, film hardness or mechanical damping. The most effective plasticizer is one 
that gives the greatest decrease in glass transition temperature per unit amount 
incorporated. 
Permanence of the plasticizer is an important factor to consider when more 
volatile plasticizers, such as DEP and PG are used. Loss of such plasticizers may 
occur after coating, curing (Bindschaedler et al., 1987; Bodmeier and Paeratakul, 
1994) and storage under stress conditions (Gutiérrez-Rocca and Mcginity, 1994; 
Hutchings et al., 1994). The volatility of the plasticizer depends on the effective 
vapour pressure of the plasticizer and its rate of diffusion through the polymer matrix. 
The effective vapour pressure is dependent on its relative proportion, interaction and 
compatibility with respect to the polymer and the molecular weight of the polymer. 
Migration of plasticizer into the cores or into packaging materials can occur, resulting 
in brittle film coats and hence faster drug release (Hogan, 1995). Leaching of 
plasticizers from polymer film coat may also occur depending on the chemical and 
physical properties of the plasticizers (Lippold et al., 1990; Bodmeier and Paeratakul,  
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1992, 1993, 1994). 
It was mentioned earlier that one of the important endpoint requirements of a 
film coat is its ability to retard the entry of water vapour or other gases into the dosage 
form. The transport of a permeant across a barrier is defined by Crank’s equation 
(Okhamafe and York, 1983): 
P = D S         (11) 
 
where P, D and S are the permeability, diffusion and solubility coefficients of the film 
coat respectively. Transport of a permeant across a film involves dissolution of the 
permeant in the film material and diffusion of the permeant across of the film. 
Diffusion of permeant across a film may occur through the polymer matrix 
itself and/or through the voids present. Since addition of plasticizers often results in 
alteration to the polymer structure, it may also change the permeability of the film 
coats. For instance, it was found that hydroxypropyl methylcellulose films plasticized 
with polyethylene glycol 400 and 1000 had higher diffusion coefficients for water 
than the non - plasticized film (Okhamafe and York, 1983).  
Special considerations have to be taken when mixing water – insoluble 
plasticizers with aqueous polymeric dispersions. These plasticizers have to be 
dispersed efficiently in the aqueous medium and sufficient time should be allowed for 
plasticizer uptake by the colloidal polymer particles (Bodmeier et al., 1997). 
Unabsorbed plasticizer will coalesce resulting in an inhomogeneous distribution of the 




ii. Colorants and opacifiers 
Colorants and opacifiers can be boardly classfied as synthetic or natural. 
Synthetic organic colorants include dyes which are usually water soluble and have 
restricted use. However, they can be complexed with hydrated alumina to form more 
useful water - insoluble complexes, known as pigments. Synthetic inorganic 
colorants, such as titanium dioxide have good opacifying capacity and provide good 
protection against light. The natural colorants are chemically and physically most 
diverse. They are not widely used because of their relatively poor stability to light and 
high price. 
Pigments are generally considered superior to water - soluble dyes for several 
reasons. There has been concern with migration of water - soluble colorant over tablet 
surfaces during the drying process. This undesirable phenomenon is less likely to take 
place for water – insoluble pigments. The latter is also more opaque than dyes, thus 
offering better protection against light. In addition, low amount of pigments had been 
shown to decrease the permeability of films to water vapour and oxygen (Hogan, 
1995). Pigments can contribute to the total solids of a coating suspension without 
increasing the viscosity significantly. However, increasing concentration of pigments 
would require more polymer particles to fill interparticle voids. The critical pigment 
concentration in a film is determined by the concentration beyond which marked 
changes in the film mechanical properties, appearance and permeability occur 
(Gibson et al., 1988). The presence of pigments has been reported to reduce the 
tensile strength, decrease the percent elongation and increase the elastic modulus of a 
film (Aulton et al., 1984). Okhamafe and York (1985) found that polymer - pigment 
interactions also affected the mechanical properties of films. High pigment - polymer 
interaction decreased film elongation. Moreover, it was found that pigments used in 
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film coating of tablets can exert opposing effects on adhesion. In a study, the adhesion 
of hyrdoxypropyl methylcellulose film to tablet surface was increased when a small 
amount of talc was incorporated. However, when the talc concentration was increased 
to more than 10 percent, the internal stress of the film became more dominant and 
film – tablet adhesion strength decreased. 
 
iii. Surfactants 
Presence of surfactants in film coat has been known to cause variation in drug 
release (Lippold et al., 1989; Paeratakul and Bodmeier, 1989; Hutchings and Sakr, 
1994; Gunder, et al., 1995; Dressman, et al., 1995; Goodhart et al., 1984). Cationic 
drugs, such as chlorpheniramine maleate, propranolol HCl, diltiazem HCl and 
quinidine sulphate, have also been reported to interact with the anionic surfactant, 
sodium lauryl sulphate and form water-insoluble ion-pair complexes (Wheatley and 
Steuernagel, 1997).  
 
iv. Anti-tack agents 
Magnesium stearate, talc or kaolin as antitack or separating agents help to 
reduce agglomeration or sticking of particles during the coating process. Some soluble 
salts (Yuasa et al., 1997; Nakano and Yausa, 2000), plasticizers and film formers 
(Heng et al., 1996; Wong et al., 2002) were also found to have antitack properties. 
The lag time was also found to increase when talc was employed in the coating 
formula. Schultz (1997) suggested that increased diffusional resistance and hence 
reduced water permability of the film coat was responsible for the longer lag time. On 
the other hand, anti-tack agents such as magnesium stearate, stearic acid and silicon 
INTRODUCTION  
 31
dioxide were reported to increase the rate of drug release when their concentrations 
were higher than the critical pigment volume concentration (Wan and Lai, 1992).   
 
v. Hydrophilic additives 
Hydrophilic additives are often added to modify the barrier properties of film 
coats and membranes. These additives can be boarded divided into water – soluble, 
low molecular weight and water – soluble, high molecular weight. Low molecular 
weight additives are usually dispersed as discrete particles in the polymer matrix and 
dissolve readily in the dissolution media, resulting in formation of pores in the 
polymer matrix. Examples of such ‘pore-forming’ additives include micronised 
sucrose, lactose, sorbitol, sodium chloride and calcium phosphate (Lindholm et al., 
1987; Hennig and Kala, 1987; Kallstrand and Ekman, 1983; Bodmeier et al., 1997) 
Water – soluble polymers such as hydroxypropyl methylcellulose and hydroxypropyl 
cellulose had also been added to EC to modify drug release properties (McAinsh and 
Rowe, 1979; Rowe, 1986). These hydrophilic polymeric additives increase the 
permeability of hydrophobic films by several mechanisms. For example, polyethylene 
glycol dissolves or erodes in the dissolution medium to create pores in EC films 
(Donbrow et al., 1975).  In contrast, hydroxypropyl cellulose which dissolves partially 
forms a matrix with EC (Donbrow et al., 1980). Some additives modify drug release 
through EC films by acting as carriers for drugs, such as Span 20 and 
tetrabutylammonium bromide for salicylic acid (Lindholm et al., 1982). 
 
3.  Coating process variables 
Coating process itself is an important factor that can affect the quality of film 
coat and uniformity of distribution of coat across all surfaces of the substrate 
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(Eastman Chemical Products, 1981). For example, porosity of the coat may be 
affected by excessive ‘spray drying’ of the coat or incomplete coalescence of coat 
deposited. Vigorous drying conditions during the coating process may result in stress 
cracks on the coatings. Excessive spray rates with organosols or excessively high 
temperature with aqueous polymer dispersions can cause tackiness, thus giving rise to 
‘picking’ of the coat. 
A wide variety of coating equipment with different coating efficiencies is 
available (Yang et al., 1992; Wesdyk et al., 1993; Bertelsen et al., 1994). The first 
coating equipment consistent of conventional coating pans that have poor mixing and 
drying efficiencies. The design of the coating pans was subsequently improved with 
the addition of side or perforated vent, immersion swords and better exhaust systems 
(Cole, 1995). The fluidized bed coater is recommended for smaller sized substrates 
which cannot be easily coated in coating pans. In the fluidized bed coating process, 
the coating materials are applied to a fluidized substrate bed using nozzles located 
either at the top, bottom or side of the coating chamber. Mehta (1997), Jones and 
Percel (1994) studied the quality of film coatings produced by fluidized bed coater 
and coating pan. They found that the quality of coatings decreased in the following 
order: wruster = tangential spray > side-vented pan >> conventional pan 
In the coating process, there are various processing parameters that can affect 
the quality of the coat. These parameters depend on the type of coating equipment 
employed and they include: 
• product batch size, 
• pellet size and size distribution, 
• pellet density (and variability within the batch), 
• coating liquid: organosol or aqueous polymer dispersion, 
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• rheological characteristics of the coating liquid, 
• solid content of coating liquid, 
• quantity of coating liquid to be applied, 
• spray application rate, 
• drying air temperature, volume, and humidity, 
• product temperature,  
• atomizing air pressure/volume, 
• partition height, 
• pan speed, 
• baffle design, 
• spray nozzle design (fluid orifice size, fluid orifice design, air cap design), 
• disk speed (tangential spray process), and/or 
• split opening (tangential spray process). 
 
The influence of various processing parameters in pellet coating listed in 
Table 3. In practice, each processing parameter tends to be affected by the other. For 
instance, when determining the drying conditions (drying air volume, temperature and 
humidity), one has to consider them in the context of the spray application rate and 
solid content of the coating liquid. In addition, the impact of drying conditions on 
properties of the resultant film coat defers between organosols and aqueous polymer 
dispersion. Where organosols are used, inappropriate drying conditions may result in 
creation of unacceptable porous coatings, increased tackiness and ‘picking’ of film 
coat. In contrast, the inappropriate drying conditions may affect the coating applied 
from aqueous polymeric dispersions by incomplete coalescence of the coat, tackiness 
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due to exposure of the coating to temperature in excess of its glass transition 
temperature and leaching of drug from pellets (Yang and Ghebre-Sellassie, 1990). 
After completion of the coating procees, additional time may be required for 
further drying and coalescence of the polymer coat (Gilligan and Wan Po, 1991). In 
order for complete coalescence of the film, the coated product should be stored at 
temperature above the glass transition temperature of the polymer film (Lippold et al., 
1989; Bodmeier and Paeratakul, 1994; Hutchings et al., 1994; Keshikawa and 
Nakagami, 1994). It was found that curing of EC coated pellets at 60 °C for at least 1 
h was necessary to prevent aging effects in drug release (Gilligan and Wan Po, 1991). 
Curing beyond a particular duration did not contribute to further coalescence. Increase 
in drug release rate for curing periods in excess of 4 h was reported. This was  
Table 3. Influence of various processing parameters in pellet coating (Adapted from 
Porter and Ghebre-Sellassie, 1994) 
Effects Contributing processing parameters  
Film formation (structural 
quality of coat) 
Drying conditions (processing temperature,  
air volume and humidity) 
Spray application rate 
Atomizing air pressure/volume 
Tackiness of coat Drying conditions 
Spray application rate 
Solid content of coating liquid 
Uniform distribution of coat Mixing of pellets in process 
Number of spray nozzles used 
Design of spray nozzles 
Atomizing air pressure/volume 
Spray application rate 
Solid content of coating liquid 
Quantity of coating applied 
Leaching of drug from core Nature of coating liquid (organosol or  
aqueous polymer dispersion) 
Drying conditions 
Spray application rate 
Atomizing air pressure/volume 
Solid content of coating liquid 
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attributed to migration of drug from the interior to the surface of the pellets during 
curing. Curing at high temperature could cause excessive tackiness and agglomeration 
of the solid pellets.  
 
F.  Analysis and comparison of dissolution data 
Drug release profiles of coated dosage forms are usually obtained by 
dissolution studies. The dissolution data are analyzed by various methods that provide 
different perspectives of the release profiles. These methods can be broadly classified 
as: 
• explanatory data analysis (O’Hara et al., 1998), 
• analysis of variance (ANOVA)-based method (Mauger et al., 1986; Polli et 
al., 1997), 
• model-dependent method (Sathe et al., 1996; Polli et al., 1997; Shah et al., 
1997), and 
• model-independent method (Podczeck, 1993; Moore and Flanner, 1996; Polli 
et al., 1997; Shah et al., 1997, 1998). 
In the explanatory data analysis method, the dissolution profile is illustrated 
graphically by plotting each dissolution time point with error bars that usually extend 
to two standard errors. The dissolution profiles of two formulations may be 
considered significantly different from each other if the error bars of corresponding 
dissolution time points do not overlap. This method is usually performed as a first 
step to compare dissolution profiles. However, explanatory data analysis is not 
comprehensive and may be difficult to perform when there are too many formulations 
to be compared (O’Hara et al., 1998).  
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The ANOVA - based method does not involve curve fitting. The dissolution 
data are used in their native form or as a simple transform. Information on the 
differences between profiles in level and shape can be obtained.  However, while this 
method takes the variability in dissolution profiles into account in the comparison at 
each point, it ignores the correlation between the dissolution profiles, treating each 
point as if it were independent of the others (O’Hara et al., 1998). Hence, this method 
is deemed overly discriminating and not very useful (Polli et al., 1997).  
The model - dependent and model - independent methods are the two most 
widely used analytical methods to compare dissolution profiles. Quantitative 
difference is then compared using both method dependent and independent methods 
in order to obtain a more accurate and complete understanding of the dissolution data.  
 In the model dependent method, the dissolution data are fitted into relevant 
selected mathematical models, characterized by suitable mathematical functions. The 
dissolution profiles are then evaluated in terms of the derived model parameters. 
Mathematical models used in dissolution data analysis include zero-order, first-order 
exponential function (Gibaldi and Feldman, 1967), cubic root law (Hixson and 
Crowell, 1931), square root of time (Higuchi, 1963), Baker and Lonsdale (Baker and 
Lonsdale, 1974) and Hopfenberg equation (Hopfenberg, 1976; Katzhendler et al., 
1997).  
 
1.  Zero order equation 
Drug release that occurs slowly from dosage forms that do not disintegrate 
(assuming that area does not change) can be represented by: 




where W0 is the initial amount of drug in the dosage form, Wt is the remaining 
amount of drug in the dosage form at time t and K is a proportionality constant. The 
equation can also be expressed as: 
Qt = Q0 + K0 t         (13) 
 
where Qt is the amount of drug dissolved in time t, Q0 is the initial amount of drug in 
the dissolution medium and K0 is the zero order release constant. Q0 is usually zero. 
 
2. First order equation 
This model was first proposed by Gibaldi and Feldman (1967) and can be 
expressed as: 
Qt = Q0 e-k1 t         (14) 
 
where K1 is the first order release rate constant. If drug release follows first order 
equation, the release is proportional to the amount of drug remaining in the dosage 
form. 
 
3. Hixson – Crowell equation 
Hixson and Crowell (1931) derived an equation that could be applied to 
pharmaceutical dosage forms, whose dimensions diminish proportionally as 
dissolution occurs:  




where W0 is the initial amount of drug in the dosage form, Wt is the remaining 
amount of drug in the dosage form at time t and Ks is a constant incorporating the 
surface – volume relationship. This equation can be rewritten as, 
W01/3 − Wt1/3 = K′ N1/3 D Ce t / δd      (16) 
 
where K′ is a constant related to the surface, shape and density of the particle, N is the 
number of particles, D is the diffusion coefficient, Ce is the solubility in dissolution 
medium and δd is the thickness of the diffusion layer. The shape factor for cubic or 
spherical particles is constant if the particles dissolve in an equal manner from all 
sides. Equation 16 can be simplified as: 
(1 − ft)1/3 = 1 − Kβ t         (17) 
 
where ft = 1 − (Wt/W0), respresenting the fraction of dissolved drug at time t and Kβ is 
a release constant. Hence, a plot of the cubic root of the unreleased fraction of drug 
versus time will be linear if the equilibrium conditions are not reached and if the 
geometrical shape of the dosage form diminishes proportionally over time. When this 
model is used, it is assumed that the release rate is limited by dissolution and not 
diffusion of drug that might occur through the polymeric matrix.  
 
4.  Higuchi equation 
This model, which is also known as the Higuchi square root time equation, can 
be expressed as: 




where Q is the amount of drug released per unit area in time t, D is the diffusivity of 
the drug molecules (diffusion constant) in the matrix substance, W is the total amount 
of the drug per unit volume of the matrix, and Cs is the solubility of the drug in the 
matrix. When W >> Cs the above equation can be simplified to, 
t2WDCQ s=         (19) 
 
This equation indicates that the amount of drug released is proportional to the square 
root of time, which is typical of a matrix-type system. Diffusion of drug can occur 
through insoluble matrices or film coats (Rao and Murthy, 2002). In the case of 
coated pellets, drug release involves penetration of dissolution fluid, dissolution of 
drug in the dissolution fluid and leaching of drug through interstitial channels or 
pores. The overall release rate is usually by the rate at which dissolved drug leaches 
out when the drug concentration in the matrix is lower than its solubility. The 
following equation can be used: 
2/1
1/2
ss  t))CC -(2A 
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ε       (20) 
 
where Q is the amount of drug released per unit surface area in time t, D denotes the 
drug diffusion coefficient in the matrix phase, Cs is the drug solubility in the 
matrix/dissolution medium, A represents the drug concentration in the matrix, ε is the 
porosity, τ denotes the tortuosity of the matrix and k is the dissolution rate constant of 
the drug. If the matrix is not coated and does not undergo significant alteration in the 
presence of water, the Higuchi model can be further simplified as: 




where KH is the Higuchi dissolution constant. 
 
5. Baker and Lonsdale equation (Higuchi's model for spherical matrices) 
The Baker and Lonsdale equation (Baker and Lonsdale, 1974), which was 
derived from Higuchi's model (Higuchi, 1963), describes drug release from sustained 
release microspheres (Lu et al., 1996): 
( )[ ] ktff tt =−−− 3/21123        (22) 
 
where ft is the fraction of drug released at time t. For controlled release of drug from a 
spherical matrix, the constant k is equal to 3D Cs /ro2 C0, where, D is the diffusion 
coefficient, Cs is the drug solubility in the matrix, ro is the radius of the device and Co 
is the initial concentration of the drug in the polymer matrix. 
If the matrix is not homogeneous and presents fractures or capillaries that may 
contribute to the drug release, k is equal to 3DfCfsε/ro2C0τ 
where Df is the diffusion coefficient, Cfs is the drug solubility in the liquid 
surrounding the matrix, τ is the tortuosity of the matrix and ε is the porosity of the 
matrix.  
 
6.  Hopfenberg equation 
Hopfenberg proposed a general mathematical equation to describe drug 
release from slabs, spheres and infinite cylinders that display heterogeneous erosion 
(Hopfenberg, 1976; Katzhendler et al., 1997): 




where K = Ke/C0 a0, Ke is the erosion rate constant, C0 is the initial concentration of 
drug in the matrix and a0 is the initial radius for a sphere or cylinder or the half-
thickness for a slab. The value of n1 is 1, 2 and 3 for a slab, cylinder and sphere, 
respectively. This model assumes that the rate-limiting step of drug release is the 
erosion of the matrix itself and that time dependent diffusional resistance internal or 
external to the eroding matrix has no influence.  
A number of mathematical models may be employed for characterizing drug 
release profiles and elucidating drug release mechanisms. The suitability of the model 
is indicated by the correlation coefficient (r2) and Akaike information criterion (AIC) 
values. The r2 value is a convenient and common metric used to measure model fit 
(Costa and Lobo, 2001). The AIC value is a measure of goodness of fit based on 
maximum likelihood. When comparing several models for a given set of data, the 
model associated with the smallest value of AIC is regarded as giving the best fit. AIC 
is only appropriate for comparing models using the same weighting scheme. 
AIC = n ln (WSSR) + 2p       (24) 
 
where n is the number of dissolution data points, p is the number of parameters in the 






[wi(yi-ŷi)2]       (25) 
 
where wi is an optional weighing factor and ŷi  denotes the predicted value of yi. 
 
The model - independent method compares dissolution data directly, and does 
not rely on the choice of mathematical model which may be unrealistic at times. In 
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this method, graphical representation of the dissolution profiles is performed as a 
preliminary step to illustrate non-quantitative differences and their evolution along the 
profile. The dissolution data are subjected to further analysis, using time-point or 
pairwise approaches to determine similarity or dissimilarity between dissolution 
curves (Pillay and Fassihi, 1998). Dissolution studies are usually carried out in 
triplicate. The tx% parameter corresponds to the time taken for the release of a specific 
percentage of drug. In the time point approach, the t50% values as well as their mean 
(MDT) were calculated for each formulation in each of the triplicate dissolution 













MDT         (26) 
 
where j is the sample number, n is the number of dissolution sample times, jtˆ  is the 
time at midpoint between tj and tj-1 and j∆M  is the additional amount of drug 
dissolved between tj and tj-1.  
In the pairwise approach, fit factors are employed. The "difference factor, f1" 
and "similarity factor, f2" are determined using equations 27 and 28 (Costa and Lobo, 
2001). The difference factor (f1) calculates the percent difference between two 
dissolution curves at each time point and is a measure of the relative error between the 





















where n is the sampling number, jR and jT are the percent drug dissolved from 
reference and test products at each time point j. The percent error is zero when the 
dissolution profiles of the reference and test products are identical and increases 
proportionally with the dissimilarity between the two dissolution profiles. For curves 
to be considered similar, f1 values should be close to 0. Generally, f1 values up to 15 
indicate an average difference of no more than 10 % and the two curves are deemed to 
be equivalent.  
The similarity factor (f2) is a logarithmic transformation of the sum-squared 



















jjjwnf     (28) 
 
where jw is an optional weight factor.  
When the two dissolution profiles are identical, f2 = 50 x log (100) = 100, and when 



















nf   = -0.001 which can be rounded to 0.  
Hence the values of f2 range between 0 to 100 with a higher f2 value indicating greater 
similarity between the two profiles. In practice, a test batch is accepted as ‘similar’ to 
a reference batch if the dissolution profile difference between the two batches is no 
more than the dissolution profile difference between two reference batches. By 




















f      (29) 
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f2 = 50 x log {[101]-0.5 x 100} = 49.89 ~ 50     (30) 
A test batch dissolution is considered similar to that of the reference batch if the f2 
value of the two profiles is not less than 50.  
Fit factors are adopted by the FDA Center for Drug Evaluation and Research 
(CDER) and the European Medicines Evaluation Agency (EMEA) Committee for 
Proprietary Medicinal Products (CPMP) in the assessment of similarity between two 
in-vitro dissolution profiles (Yuksel et al., 2000). However, it is noted that fit factors 
are incapable of indicating the sense of the deviation (Moore and Flanner, 1996). 
They also do not directly take into consideration the shape of the curve nor allow for a 
variation in the spacing between sampling times (Costa, 2001; Costa and Lobo, 2001). 
Moreover, they are sensitive to measurements obtained after either test or reference 
has released more than 85 percent of its drug content (Shah et al., 1998). The 
selection and determination of the dissolution end points therefore play a critical role 
in the calculation of fit factors and the subsequent decision as to whether the test and 
reference profiles resemble each other or not (Yuksel et al., 2000 and Pillay and 
Fassihi, 1998). In spite of these limitations, fit factors are very useful for comparing 
dissolution curves by providing a single number to describe two curves that consist of 




Ethylcellulose (Porter, 1989; Iyer et al., 1990) is one of the most commonly 
used polymers in the production of coated controlled-release dosage forms. Its 
popularity is largely owed to its good film forming ability and low permeability to 
moisture (Rekhi and Jambhekar, 1995). As a result of its being practically insoluble in 
water, coating preparations of ethylcellulose in the past were only possible when 
dissolved in organic solvents (Porter, 1989). However, over the past decade, water-
based coating has gradually gained popularity and become the preferred coating 
system for new product development (Savage et al., 1995). Though both organic 
solutions and aqueous polymeric dispersions produce chemically similar polymeric 
film, the physical properties of the film produced by each system can be very 
different. This is essentially due to differences in film formation mechanism caused 
by differences in the molecular states of ethylcellulose in different types of solvents 
(Savage et al., 1995; Wheatley et al., 1997). The existence of ethylcellulose as 
dispersed particles in water, in contrast to solvated molecules by organic solvent, can 
affect ethylcellulose film formation as well as interaction with other additives present 
in the coating formula. While the use of organic ethylcellulose coating system is 
better described in literature, there is still limited information on the newer aqueous 
ethylcellulose coating systems. In particular, knowledge pertaining to the type of 
interaction between ethylcellulose dispersed particles in water as well as in the 
presence of additives is still being sought (Porter and Ghebre-Sellassie 1994). Hence, 
it is the aim of this study to explore further the effects of interaction between 
ethylcellulose and additives that are commonly employed in aqueous coating systems, 
on the film coat properties. Two additives, plasticizers and hydrophilic polymeric 
additives, were specifically chosen for this study, as they are most likely to interfere 
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the film formation mechanism and consequently affect the film quality, product 
performance and stability. 
 
Part 1. 
A number of researchers have reported that polymeric film coats applied on 
dosage forms undergo changes on storage. The extent of these changes is influenced 
by several factors such as the amount of plasticizers added, type of plasticizers used, 
film forming conditions and storage temperature and humidity. It was found that films 
formed from aqueous ethylcellulose dispersions showed significant changes in their 
mechanical properties when they were dried at a higher temperature (Hutchings et al., 
1994). Exposure to a high relative humidity may cause a polymeric film coat to 
absorb moisture from the atmosphere. Findings of several researchers suggested that 
changes in mechanical properties of some polymeric films stored at high humidity are 
correlated with the plasticizing effect of the moisture present in the films (Aulton et 
al., 1981; Wu and McGinity, 2000). Changes in film’s mechanical properties may 
ultimately influence drug release, stability and other physicochemical properties of 
the coated dosage forms (Chowhan, 1982). 
It has been reported that plasticizers such as dibutyl sebacate, tributyl citrate, 
acetyl tributyl citrate and oleyl alcohol produced ethylcellulose films that showed 
greater elongation upon stretching, after the films had been stored under conditions of 
elevated humidity (Hutchings et al., 1994). However, the actual mechanisms that 
caused the above change and the extent of influence by the different types of 
plasticizers have not been reported. 
The objective of this study was to investigate the effects of different types of 
plasticizers on the properties and stability of ethylcellulose films exposed to different 
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storage conditions. Attempt were made to elucidate the mechanisms responsible for 
the changes observed and to correlate the micro and macro changes in the film 
structure with the release profiles of coated pellets. 
 
Part 2 
In the recent years, great interests in the modification of drug release from 
reservoir and matrix delivery systems is seen from the increased amount of research 
(Verma and Garg 2004; Sangalli et al., 2001; Kim et al., 2000; Frohoff-Hulsmann et 
al., 1999; Bussemer et al., 2003). The goals of such innovations include developing 
systems capable of enhancing the release for poorly water-soluble drugs, providing 
precise control of drug release, as well as broad ranges of drug release patterns 
(Lecomte et al., 2003, 2004). Due to its lack of permeability to water, ethylcellulose is 
one such polymer which has great practical impetus for seeking solution to overcome 
the undesirable slow release obtained for poorly soluble drugs (Frohoff-Hulsmann et 
al., 1999).  
Methods employed to improve drug permeability through ethylcellulose 
coatings included reduction in coat thickness (Osterwald et al., 1985), as well as 
formation of pores in ethylcellulose films using organic solvents (Narisawa et al., 
1993; Narisawa et al., 1994) and hydrophilic additives (Frohoff-Hulsmann et al., 
1999a; Frohoff-Hulsmann et al., 1999b). A number of studies were directed at 
employing additives to modify the permeability of ethylcellulose films: 
hydroxypropyl methylcellulose (Gilligan et al., 1991 and Hjärtstam et al., 1998), 
hydroxypropyl cellulose (Umprayn, et al., 1999), carboxy methylcellulose (Yamada 
et al., 2001), acrylates (Sánchez-Lafuente et al., 2002, Fan et al., 2001, Phuapradit et. 
al., 1995), pectin (Macleod et al., 1997), maltodextrins (Rohera et al., 2002), xylitol 
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(Rohera et al., 2002) and poly ethylene glycol (Sakellariou et al., 1986 and Rohera et 
al., 2002). Hydroxypropyl methylcellulose is the most popular secondary polymer 
used to for pore formation of ethylcellulose films. However, it was found to have 
limited degree of miscibility in an organic mixture of ethylcellulose and 
hydroxypropyl methylcellulose (Sakellariou et al., 1986), with occurrence of phase 
separation, especially at high concentration (Sakellariou and Rowe, 1995). 
Complicated release phenomenon has also been reported for theophylline pellets 
coated with ethylcellulose containing hydroxypropyl methylcellulose (Gunder et al., 
1995). It was believed that the two-phase release profiles portrayed was partly 
attributed to the closure of pores which were initially created by dissolution of 
hydroxypropyl methylcellulose in the films. Consequently, the subsequent release was 
controlled by the distribution and diffusion of dissociated drug through the coating 
membrane.  
Polyvinylpyrrolidone (PVP) is a water-soluble, physiologically inert synthetic 
polymer consisting essentially of linear 1-vinyl-2-pyrrolidinone groups, with varying 
degree of polymerization which results in polymers of different molecular weights 
(Wade and Weller, 1994; Blecher et al, 1990; BASF, 1986; Aldeyeye and Barabas, 
1993; Kumar et al., 1999). Polyvinylpyrrolidone has been reported to increase the 
solubility of active substances by forming water-soluble complexes. Viviprint 540 is a 
molecular – composite polyvinylpyrrolidone (MCPVP) which is formed in situ by 
incorporation of insoluble crosslinked poly(Polyvinylpyrrolidone) nano particles into 
soluble, film–forming polyvinylpyrrolidone (Hood et al., 2003). It is therefore of 
much higher molecular weight than polyvinylpyrrolidone and less soluble in water. It 
can be used as a binder, as well as a top coat in multi-layer coating systems. The 
swelling property of cross-linked polyvinylpyrrolidone was employed to enhance 
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drug release (Fan et al., 2001). Plasdone S-630 copolyvidonum (PV/VA) is a 
synthetic water-soluble copolymer consisting of N-vinyl-2-pyrrolidone and vinyl 
acetate in a random 60:40 ratio. It can be used as a binder in dry and wet granulation 
methods. Zingone et al. (1994) reported that the solubility and dissolution rate of 
carbamazepine were enhanced by mixing with PV/VA copolymer, possibly due to 
decrease in crystallinity and increase in wettability of the drug.  
All the water-soluble polymers discussed above are potential polymeric film 
modifiers for enhancing drug release. Their good solubility in water also has the 
added advantage of convenient mixing with ethylcellulose aqueous dispersion. To 
date, studies on composite ethylcellulose films containing polyvinylpyrrolidone and 
its derivatives for controlled release have not been reported. Hence, one of the aims of 
this study was to explore the potential of polyvinylpyrrolidone and its derivatives as 
ethylcellulose film modifier, through systematic investigations of their compatibility 







A.  Materials 
1.  Drugs, polymers and additives 
The model drugs used were propranolol USP, sulphanilamide BP, 
sulphaguanidine BP (Luen Wah Med Co., Singapore), metformin hydrochloride BP 
(Auro Lab, India), theophylline USP (Fluka Buchs, Switzerland), chlorpheniramine 
maleate BP (Merck, Singapore), verapamil hydrochloride USP (Nicholas Piramal, 
India), and paracetamol B.P. (China). Their properties are shown in Table 4.  
Lactose monohydrate (Pharmatose, 200 Mesh, De Melkindustrie Veghel, The 
Netherlands) and microcrystalline cellulose (MCC; Avicel PH-102, Asahi Chemical, 
Japan) were used to prepare core spheroids. 
The main film formers and coating polymers were methacrylic acid-ethyl 
acrylate copolymer (MA; Eudragit® L 30D, Röhm Pharma, Darmstadt, Germany) and 
ethyl cellulose (EC; Aquacoat®, type ECD-30, FMC Corp., Newark, US and 
Surelease®, Colorcon, West Point, US).  
The additives consist of plasticizers: dibutyl phthalate (DBP), triethyl citrate 
(TEC), glycerin triacetate (GTA) from Merck-Schuchardt (Darmstadt, Germany), 
diethyl phthalate (DEP) from The British Drug House (Poole, UK), acetyltriethyl 
citrate (ATEC) and acetyltributyl citrate (ATBC) were donated by Morflex 
(Greensboro, US); and soluble polymers: Plasdone® K-17 (PVP K17), Plasdone® K-
29/32 (PVP K29), Plasdone® K-60 (PVP K60), Plasdone® K-90/D (PVP K90), 
Plasdone® S-630 (PV/VA) and Viviprint® 540 (MCPVP) from ISP (New Jersey, US). 
The properties of the polymeric additives are shown in Table 5. 
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Table 4. Chemical structures, molecular weights, solubility in water and 
acidity/basicity of drugs used. 











1 in 120 parts 
Propranolol 
hydrochloride 
295.8 Basic 1 in 20 parts 
Sulphaguanidine 232.3 Basic 














390.9 Basic 1 in 4 parts 
Paracetamol 
 





Table 5. Chemical structures, typical molecular weights and viscosity of polymeric additives. 











25.4-34.2 58,000a 2.5b 
Polyvinylpyrrolidone 
PVP K17 
16-18 8,000a 1.5b 
PVP K29 29-32 58,000a 2.5b 
PVP K60 50-62 400,000 147 





- 1,500, 000 – 
2,000, 000d 
5, 000 - 
20,000c 
a Weight average, determined by light scattering; b 5% solution in deionized water. Brookfield LVT viscometer (60rpm at 25°C); c Brookfield 
LV, Spindle 4, 12 rpm at 25°C; d weight range determined by GPC/MALLS; e K-value represents a viscosity index which is calculated by the 
Fikentscher’s formula: K= (1.5 logηrel -1)/ (0.15 + 0.003c) + (300c logηrel + (c + 1.5clogηrel )2)1/2/ (0.15c + 0.003c2), where ηrel is relative 
viscosity of aqueous PVP solution to water and c is the concentration of PVP in the aqueous polymer solution.
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B.  Methodology 
1.  Preparation of film forming dispersions  
a. EC and acrylic dispersions containing plasticizers 
Three types of aqueous polymeric dispersions were studied: Surelease, 
Aquacoat and Eudragit L 30D. Except for Surelease which already contained medium 
chain triglycerides as a plasticizer, 30 %w/w (based on polymer weight) of 
plasticizers were added to the polymeric dispersions which were then diluted with 
water to obtain final polymer concentration of 10 %w/w. The plasticizers were used at 
level suggested by the manufacturer where appropriate. The water-soluble plasticizers 
(TEC and GTA) were stirred in the polymeric dispersions for 5 h using magnetic 
stirrers while the water-insoluble plasticizers (DEP, DBP, ATEC and ATBC) were 
stirred for 24 h. 
 
b.  EC dispersions containing polymeric additives 
10 to 30 %w/w of polymeric additives (based on total solid content of film) 
were added to an appropriate amount of EC dispersion. The mixture was then diluted 
with distilled water to 10 %w/w of EC and was stirred for 5 h using a magnetic stirrer 
before it was used to cast films. 10 %w/w EC dispersion without any polymeric 
additives was used as a control. This was prepared by diluting an appropriate amount 
of EC dispersion with distilled water and the mixture was stirred for 1 h before use.  
 
2.  Preparation of films 
Films of 200 µm thick were prepared by casting pre-determined amounts of 
film forming dispersions on leveled polytetrafluoroethylene (PTFE)-coated glass 
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plates (casting area = 17 cm × 17 cm). Films prepared from Eudragit L 30D were 
dried at 40 °C and the rest at 55 °C. After 48 h of drying, the films were removed 
from the glass plates using a sharp knife. Only films that were free from 
imperfections, such as cracks and presence of air cavities, were used for subsequent 
tests. 
 
3.  Evaluation of film properties 
Films were aged at room temperature in desiccators containing silica gel for at 
least 5 days prior to testing, unless otherwise stated. They were cut into strips of 
specific sizes for determination of various properties. For evaluation of mechanical 
properties and puncture strength, the thickness of each piece of cut film was 
determined at five locations on the film using a digital micrometer (Mitutoyo, Japan). 
Only films with thickness deviation less than 10 % of the mean thickness were used 
for the respective tests.  
In part I of the study, film samples used for mechanical testing, assay of 
plasticizer and moisture content and determination of percent weight change when 
stored in controlled environment chambers of 30 °C and 50 or 75 %RH. Samples 
were removed after 0, 3, 7, 14, 28 days of storage for evaluation.  
 
a. Surface morphology 
Surface morphology of the films was examined using a light microscope (BX 
61, Olympus, Japan). Film surface roughness was evaluated using a scanning probe 
microscope (SPM – 9500J, Shimadzu, Japan) over an area of 25 µm by 25 µm in the 




b.  Film transparency 
The film sample (40 mm x 25 mm, n = 3) was mounted on the cell holder of a 
spectrophotometer (UV-1201, Shimadzu, Japan) and light transmittance at 600 nm 
through the film was determined. The mean percent transmittance for each film 
formulation was calculated. 
 
c.  Mechanical properties  
The mechanical properties of the films (70 mm x 10 mm) were evaluated 
using a tensile testing instrument (EZ Test-100N, Shimadzu, Japan) mounted with a 
100 N capacity load cell. The test procedure was based on the ASTM D 882 - 75d 
method using flat-faced metal grips with surfaces laminated with sand paper for better 
hold.  The initial gauge length was set at 50 mm and the extension speed was 5 
mm/min. The films were equilibrated for 1 h ambient conditions of prior to test. The 
ambient conditions for Part I and Part II of the study were 55  ± 2 %RH, 22  ± 2 °C 
and 47 ± 2 %RH, 25 ± 2°C respectively. 
Four mechanical properties, namely tensile strength, percentage elongation at 
break, elastic modulus and work of failure were computed from the load - strain 




















sδω =         (34) 
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where, Ts is the tensile strength, Lmax, the maximum load, Ai, the initial cross-
sectional area of the sample, EL, the percent elongation at break, ∆lb, the increase in 
length at break point, li, the initial gauge length, EM, the elastic modulus, dL/dm, the 
slope of the linear potion of the elastic deformation, ω, the work of failure, AUC, the 
area under the curve and δs, the cross-head speed. Five measurements were taken and 















Figure 7. A typical load - strain profile of film undergoing tensile test.  
 
d. Puncture test 
The puncture test (n = 4) was carried out on both dry and wet circular films of 
diameter 25.2 mm, using a tensile testing instrument (EZ Test-500N, Shimadzu, 




















Area Under the Curve 
(≅ Work done) 
(≅ Toughness)
Load at Failure (≅ Tensile strength)
Slope (≅ Elastic modulus)
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angle of 60° and lateral area of 5 cm2 was attached to the load cell. The film, 
sandwiched between rubber and polytetrafluoroethylene gaskets, was placed over the 
mouth of a stainless steel cup and secured by an open screw cap. The wet film, 
immersed in distilled water for 24 h, was blotted dry prior to mounting. The puncture 
probe was driven downward through the center of the mounted film at a crosshead 
speed of 5 mm/min, with the load-displacement data recorded from the point of 
contact of the probe with the film until the film was pierced. Puncture strength and 
percentage elongation were derived from the load-displacement profile based on the 











2 +=∂       (36) 
 
where γp is the puncture strength (N/mm2), F, the load required for puncture, Acs, the 
cross-sectional area of the film,  ∂ , the % elongation, R, radius of the film exposed 
across the open screw cap and Dp, the displacement of the probe from point of contact 
to point of puncture. 
 
e.  Plasticizer content 
The amount of plasticizer in the Aquacoat film was determined using gas 
chromatography (Model 5890 series II, Hewlett Packard, US) with a a 23.5 m by 0.32 
mm fused silica-polyethylene glycol capillary column (HP-FFAP X-linked 
polyethylene glycol) and a flame ionization detector. About 200 mg of film sample 
were accurately weighed and dissolved in methanol. An internal standard of 1 ml was 
then added to the mixture. TEC (5 mM) was employed as the internal standard for 
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GTA while GTA (10 mM) was the internal standard for the rest of the plasticizers. 
Using methanol, the mixture was made up to a final volume of 20 ml for DBP and 10 
ml for the rest. Nitrogen was used as the carrier gas at a flow rate of 28.5 ml/min, with 
injector temperature at 240 °C and detector temperature at 270 °C. For the assay of 
DEP, TEC, ATEC and GTA, the column temperature was increased from 150 °C to 
230 °C at a rate of 10 °C/min and held at 230 °C for 3 min. For the assay of DBP and 
ATBC, the column was heated up from 150 °C to 240 °C at a rate of 10 °C/min and 
held at 240 °C for 5 min. 
 
f. Percent weight change of film 
Film samples of 2.5 cm by 4.5 cm were accurately weighed and stored in the 
controlled environment chambers at 30°C and 50 or 75 %RH. At specified time 
intervals, the films were removed and weighed immediately. The percent change in 
weight was computed from the difference between the final and initial weights, with 
respect to the initial weight of the film. 
 
g. Moisture content  
The moisture content of the film was determined by Karl Fischer analysis (701 
KF Titrino, Metrohm, Switzerland). About 0.2 g of film sample, were accurately 
weighed and dissolved in methanol before titration. Four sets of measurements were 
obtained for each film formulation. The moisture content of film was expressed as 
percent weight of film moisture with respect to weight of film. The percent change in 
moisture was represented by the difference between the final and initial moisture 




h. Water vapour permeability  
For Part I of the study 
Water vapour permeability of the films was determined using the ASTM water 
vapour transmission test method (Dry cup method, ASTM E 96 - 95). The film 
samples (circular pieces with diameter of 7.46 cm) were conditioned by storing at 
ambient conditions of 22 ± 2°C and 55 ± 2 %RH for at least 5 days. The drying agent, 
silica gel beads, was activated by heating at 200°C. A sample of 15 g of activated 
silica gel beads was placed in each aluminium permeability cup (Paul Garner, US), 
which was sealed with film sample sandwiched between rubber and 
polytetrafluoroethylene gaskets. The cup was then tightly closed with a screw cap 
with an opening exposing an effective film area of 24.5 cm2 for water vapour 
permeation. The whole assembly was weighed and placed in a controlled environment 
chamber set at 30°C, 50 % RH or 30°C, 75 % RH for 30 h. At specified time 
intervals, the cup was briefly removed and weighed. At least 3 sets of measurements 
were obtained for each film formulation. Plots of weight gain against time were 
constructed. 
The water permeation rate was calculated using the following formula: 
 pA
W R ∆×
∆=wvp         (37) 
 
where Rwvp is the water vapour permeation rate, ∆W, the amount of water vapour 
permeated through the film, A, the area of exposed film, and ∆p, the vapour pressure 
difference. 
Assuming that the air on the desiccant side was dry (i.e. 0 mmHg of water), 
the water vapour pressure difference across the film at 30 °C would be 15.5 mmHg 
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and 23.8 mmHg for cups stored at 50 % RH and 75 % RH respectively (Wiederhold, 
1997). The permeability, P was calculated as follows, 
P = R wvp x t          (38) 
where t is the thickness of the film. 
 
For Part II of the study  
The same ASTM water vapour transmission test method was employed, with 
different film size, permeability cup and test conditions. The circular film sample 
(diameter of 25.2 mm) was placed over the mouth of a stainless steel cup containing 
10 g of activated silica gel and held in place with a screw lid with an opening of 5 
cm2. The cup was then placed in a controlled environment chamber set at 38 °C and 
90 %RH. The amount of moisture transmitted through the film was determined by 
weighing the cups at specific time intervals of 0, 2, 4, 6, 8, 10, 12, 24, 48, 72 h. A plot 
of weight gain against time was constructed. The permeability of the film was 
determined using equations 37 and 38. 
 
i. Thermal properties 
Glass transition temperature 
The thermal properties of EC and the additives were determined using 
differential scanning calorimeter (DSC-50, Shimadzu, Japan) which was coupled with 
a thermal analyzer (TA-60W, Shimadzu, Japan) to the computer. Films of pure EC, 
PVP, PV/VA, MCPVP and polymer blends were prepared by casting 5 %w/w of 
polymer(s) in solvent mixture of methylene chloride and acetone in the ratio of 5:1 
onto a polytetrafluoroethylene dish. The film forming solutions were dried by 
evaporation at about 30 °C for 24 h and the films were then kept in a dessiccator 
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containing silica gel for 5 days before analysis. About 5 mg of film samples were 
accurately weighed for determination of thermal properties of the polymers and 
polymer blends under nitrogen. The samples were first heated to 200 °C at a rate of 20 
°C/min to erase the previous thermal history and remove any residual moisture. After 
cooling, a second scan was carried out at a heating rate of 10 °C/min to 250 °C. The 
glass transition temperature (Tg) was taken as the temperature corresponding to 50 % 
of the transition, i.e. the midpoint of the discontinuity in heat flow in the second 
heating cycle.  
 
Thermal mechanical spectra 
The thermal mechanical spectra of the films were obtained using a dynamic 
mechanical analyzer (DMA 2980, TA Instruments, USA). This technique involves 
measurement of a sinusoidal strain induced by application of a sinusoidal mechanical 
force on the film. The response of the film consists of 2 components: one in phase 
with the applied stress (elastic response) and the other out of phase with the applied 
stress (viscous response) (Lafferty et al., 2002). Changes in these responses are 
studied as a function of temperature and frequency. For a viscoelastic material, the 
elastic response (recoverable energy) is represented by the storage modulus E’ while 
the viscous response (lost energy) is represented by the loss modulus E”. The tangent 
of the loss angle, tan δ, is equal to the ratio of the energy lost (dissipated as heat) to 








Plots of elastic response (E’) and mechanical loss (tan δ) with respect to temperature 
at fixed frequency are constructed. The glass transition temperature corresponds to a 
sharp drop in E’ and a peak for tan δ.  
The instrument employed consisted of a clamp assembly with a plate affixed 
to the drive clamp. The film sample (10 mm by 5 mm) with thickness varying from 
0.225 to 0.348 mm was sandwiched between the plate and stud mounted on the fixed 
clamps. The clamp assembly was surrounded by a furnace which was used to heat and 
cool the sample. The samples were tested in tension mode and heated from 20°C to 
120°C at 3 °C/min with a frequency of 1 Hz. The maximum tan δ or a sharp drop in 
modulus was taken as the glass transition temperature. The upper temperature was 
limited due to the rapidly decreasing mechanical stability of the plasticized sample 
above its glass transition temperature. All experiments were performed under a dry 
nitrogen atmosphere. 
 
j. Drug permeability  
Drug permeability tests were conducted using acrylate diffusion cells. The 
film sample (circular piece with diameter of 32.2 mm) was mounted between two 
compartments, which were then filled with saturated chlorpheniramine maleate 
solution (20 g/250 ml) and distilled water respectively. The diffusion cells were 
placed in a water bath at 37 ± 1°C and shaken at a rate of 35 shakes/min. Five ml 
samples were collected at specified time intervals from the distilled water 
compartment and assayed for the drug spectrophotometrically (UV-1201, Shimadzu, 
Japan).  
 
Calculation of permeability coefficient  
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a. Simple steady state model 
Several mathematical models have been used to determine permeability 
coefficient (Grassi et al., 1999). Among them, the steady state model is most 
commonly used. Generally, diffusion in an isotropic medium can be characterized by 
Fick’s second law which states that the rate of change in concentration in a volume 
element within the diffusional field is proportional to the rate of change in 
concentration gradient at that point on the field. The proportionality “constant” is 
referred as the diffusivity, D.  
The steady state model represents the analytical solution of Fick’s second law 
assuming sink condition in the receiver volume, a constant drug concentration in the 
donor volume and neglecting the presence of the stagnant layers. It also assumes that 
the solute is neither irreversibly bound within the film nor degraded during transport. 









∂         (40) 
 
where Dm is the diffusion coefficient across the membrane and C is the concentration 
of drug within the membrane, t is time, and x is the space coefficient normal to the 
surface of the membrane (Shah, 1993). The membrane concentrations at the surfaces 
can be related to the solution concentrations by the partition coefficient provided that 
equilibrium exists at the interface of the membrane and solution. The flux can be 











where K is the partition coefficient, Cr and Cd are the concentrations of the drug in the 
receptor and donor fluids respectively, and h is the thickness of the membrane. 
From equation 41, transport in side-by-side membrane cells can be described 





 dC VP 
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r=       (42) 
 
where V is the volume of the receptor fluid (cm3), A is the effective area for mass 
transfer (cm2) and P is the permeability coefficient (cm2/s). The rate of drug diffusion 
can obtained from the slope of cumulative amount of drug diffused versus time plot 
after 3 lag times. 
 
b. Solutions involving quasi-steady state 
Equation (42) is based on the assumption that sink condition prevails, and the 
drug concentration gradient is kept constant during the experiment. However in some 
cases the donor and receptor concentrations may continue to change even after a long 
time. In such cases mathematical analysis becomes more complicated. After some 
finite time, an instantaneous or quasi-steady state will develop and the time course for 
the diffusional process is initiated and followed after the onset of the quasi-steady 
state. Assumptions are made that the gradient within the membrane must 
instantaneously adjust to the external conditions (continuous phase concentrations) 
and the amount of diffusant in the membrane must be negligible. When the conditions 
are such that there is a linear fall of concentration within the barrier, the instantaneous 
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where Co and Ch are the respective surface concentrations of the membrane. Co and Ch 
can be related to the concentrations in the donor and acceptor compartments by 
incorporation of the partition coefficient, K. A concise mathematical derivation is 
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where Ca denotes the solute concentration in the receptor P can be calculated from the 
plot of – In [(Co - 2Ca)/Co] vs time. In this study, the drug permeability coefficients of 
composite EC films were determined from both simple steady state and quasi-steady 
models using equations (42) and (44). 
 
k. Swelling and leeaching of film  
The initial weight of the completely dried film sample (40 mm × 25 mm) was 
measured before it was introduced into a bottle containing 50 ml of distilled water. 
The bottle was placed in a water bath at 37 ± 1 ºC and shaken at a rate of 35 
shakes/min. The film was removed at predetermined time intervals, blotted gently to 
remove excess water and weighed immediately. The hydrated films were then oven 
dried for 2 days and weighed. Swelling index was calculated according to the 









where Is is the swelling index at specific time, Ws, the weight of the swollen film and 
Wd, the initial weight of the film. The amount of extracted components, EXC, was 




ed=        (46) 
 
where EXC is the amount of extracted components and We, the final weight of the 
film dried to constant weight. Three measurements were taken for each film formation 
and the average reported. 
 
4.  Preparation of pellets 
A blend of 1 kg, consisting of 2 %w/w drug, 25 %w/w MCC and 73 %w/w 
lactose was mixed using a double cone tumbler mixer (Erweka AR 401, Germany) for 
30 min at 6 rpm. The dry powder mixture was transferred to a planetary mixer 
(Kenwood Major, UK) and an appropriate amount of water (37.5 to 41 %w/w) was 
gradually added and mixed over a period of 5 min. The resultant wet powder mass 
was extruded using a radial screw extruder (Niro E 140, UK) fitted with a screen of 1 
mm thickness with 1 mm circular dies. One kg of the extrudate formed was 
transferred to a spheronizer (Niro S320, UK) with a 300 mm diameter friction plate 
and rotated for 10 min at 600 rpm. The pellets produced were dried first in a fluid bed 
(Niro-Aeromatic, Strea-1, Switzerland) for 30 min at 60 °C inlet temperature and then 
further dried in an oven at 40 °C overnight. The dried pellets were sieved to obtain 




5.  Coating of pellets 
a. Coating with Aquacoat 
The drug-loaded pellets were coated with Aquacoat dispersions plasticized 
with 30 %w/w (based on polymer weight) of TEC, ATEC, DEP or GTA. The 
plasticizers were added to the polymer dispersions which were then diluted with water 
to 15 %w/w polymer. The water-soluble plasticizers (TEC and GTA) were stirred in 
the polymer dispersions for 5 h using magnetic stirrers while the water-insoluble 
plasticizers (DEP, and ATEC) were stirred for 24 h. The coating dispersions thus 
prepared were also stirred throughout the coating process.  
The drug-loaded pellets (250 g) were transferred into a fluid bed coater (Strea 
I Aeromatic, Muttenz, Switzerland), equipped with a bottom-spray nozzle and 
operating with an air inlet temperature of 50 ± 5 °C. The pellets were preheated for 10 
min before coating. A slow spray rate of 2 g/min was employed for the first 10 min to 
avoid overwetting of the pellets and drug migration into the film coat. The spray rate 
was gradually increased to 3 - 5 g/min with atomizing pressure ranging from 1 - 1.2 
bar and air volume 70 - 80 m3/h. The total spraying time was 1 to 2 h. The amount of 
EC employed was about 10 % of the weight of drug-loaded pellets. On completion of 
coating, the pellets were fluidized in the coating chamber for a further 15 min to 
evaporate residual solvent in the film coatings. The coated pellets dried were further 
at room temperature of 22  ± 2 °C for 24 h before transferring them to controlled 




b. Coating with Surelease 
The drug-loaded pellets were coated with Surelease dispersion with and 
without additives (PVP K17, K29, K60, K90, PV/VA and MCPVP). The amount of 
additives employed varied from 10 to 30 %w/w, based on total solid content of 
Surelease dispersion. The required amount of additive was first dissolved in distilled 
water before adding to Surelease dispersion. The mixture was then diluted with 
distilled water to obtain 15 %w/w of Surelease solid content. The mixtures containing 
additives were mechanically stirred for 5 h while those without additives were stirred 
for 1 h. The coating dispersions thus prepared were also stirred throughout the coating 
process.  
Known weights of drug-loaded pellets (250 g) were transferred into a fluid bed 
coating apparatus (Strea I Aeromatic, Muttenz, Switzerland), equipped with a bottom-
spray nozzle. The inlet temperature of drying air was 50 ± 5 °C. The pellets were 
preheated for 5 min before coating. Initially, the pellets were coated at a slow spray 
rate (2 g/min for the first 10 min) in order to avoid overwetting of the pellets and 
avoid drug migration into the film coat. Subsequently, the coating dispersions was 
delivered at a flow rate of 3 - 5 g/min and an atomizing pressure ranging from 1 - 1.2 
bar was used. Air volume used ranged from 50 - 70 m3/h and the total spraying time 
was 1 to 2 h. After coating, the beads were dried for a further 15 min in order to 
evaporate residual solvent in the coating prior to the curing step. A portion of the 
pellets was cured at 60 °C for 24 h while the rest was stored at room temperature. The 
film coating consisting of EC with or without additives amounted to about 12 percent 
of the weight of the drug-loaded pellets. For pellets coated with EC and EC-PV/VA 
(7:3), samples of 120 g of pellets were removed from the coating pan when the 
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coating had reached 4 %, 6 %, 8 %, 10 % 12 % w/w. The coating level was calculated 
by weight of the sprayed dispersion without additives. 
 
6.  In vitro dissolution studies  
Drug release from coated pellets was investigated by dissolution study (USP 
XXII, method II, Optimal DT-1 dissolution tester, Optimal Instruments, USA). 900 
ml of 0.1 M pH 7.4 phosphate buffer or 0.1 M HCl, as dissolution medium, was 
maintained at 37 ± 1 °C with paddle speed 50 rpm. At predetermined time intervals, 5 
ml samples were collected through Pyrex- G3 filter stick (Pyrex, UK) and assayed 
spectrophotometrically (UV-1201, Shimadzu, Japan) for the drug: 261.6 nm and 
264.2 nm for chlorpheniramine maleate in phosphate buffer and 0.1 M HCl 
respectively; 272.4 nm and 268.6 nm for theophylline in phosphate buffer and 0.1 M 
HCl respectively; and 244.6 nm for paracetamol in both media. The dissolution data 
was obtained from the average of three determinations. 
 
7.  Assay of drug content in coated pellets 
Predetermined quantities (3g, 1g, and 0.8g of pellets containing 
chlorpheniramine malaete, theophylline and paracetamol respectively) of each batch 
of coated pellets were pulverized using a pestle and mortar. A specific amount of the 
resultant powder was accurately weighed and dispersed in 900 ml of pH 7.4 buffer. 
The dispersion was stirred at 50 rpm, 37 °C for 4 h. Aliquots of the dispersion were 
filtered through Pyrex- G3 filter stick (Pyrex, UK) and assayed 
spectrophotometrically (UV-1201, Shimadzu, Japan) at appropriate wavelength stated 
previously. 
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IV. RESULTS AND DISCUSSION 
Part 1. Influence of plasticizers and storage conditions on properties of films 
A.  Film morphology  
Both Eudragit L 30D and Surelease films appeared homogeneous and 
continuous. The texture of Aquacoat films varied with the type of plasticizers used. 
Aquacoat films plasticized with DBP appeared to be more flexible, smoother and 
homogeneous while those plasticized with DEP and ATEC had raised spots and 
undulating surfaces. Orange peel appearance was also observed for some of the 
Aquacoat films. SPM images showed that Eudragit L 30D and Surelease films were 
relatively smooth with small perturbations and peak heights of less than 0.5 µm. In 
contrast, Aquacoat films had rougher surfaces with prominent protrusions (Figure 8). 
The average peak heights for the plasticized Aquacoat films were greater than 0.5 µm, 
with DEP plasticized Aquacoat films having the highest mean peak height of more 
than 2 µm. 
All the freshly dried Eudragit L 30D, Surelease and Aquacoat films, except 
those plasticized with ATEC, appeared transparent initially. Upon exposure to 
ambient conditions of 22 ± 2°C and 55 ± 2 %RH for about 5 h, Eudragit L 30D and 
Surelease films showed little change in transparency but Aquacoat films became 
translucent as shown by their markedly lower transmittance values (Table 6). Similar 
findings for Aquacoat films had been reported (Hutchings et al., 1994). Surfactants 
were employed to form a fine and stable aqueous dispersion of the practically 
insoluble EC. It was suggested that the translucency of Aquacoat films might be due 
to the migration of the surfactants to the minuscule ‘islets’ of the film (Binschaedler et 
al., 1987, 1989). 
















Figure 8. SPM images of (a) MA, (b) Surelease, and Aquacoat films plasticized with (c) DEP and (d) DBP.
(b) (a) 
(c) (d) 
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Table 6. Comparison of mechanical propertiesa, film transparencyb and water vapour permeabilityb of EC and MA filmsc. 
Film transparency at  
600 nm (% 
transmittance) 
Water vapour permeability  

















0 h 5 h 50 %RH,  
30 °C 
75 %RH,  
30 °C 
Surelease 4.47 ± 0.12 11.1 ± 0.82 204 ± 21 20.9 ± 1.81 0.0219 66.0 ± 2.53 65.7 ± 2.70 1.23 ± 0.159 1.24 ± 0.169 
Aquacoat + DEP 2.55 ± 0.60 2.43 ± 0.47 162 ± 43 1.99 ± 0.69 0.0158 53.9 ± 3.89 18.8 ± 6.01 1.30 ± 0.200 1.41 ± 0.169 
Aquacoat + DBP 2.17 ± 0.22 4.15 ± 3.03 140 ± 14 3.50 ± 3.12 0.0156 43.1 ± 0.87 9.03 ± 4.43 1.66 ± 0.141 1.40 ± 0.035 
Aquacaot + TEC 1.73 ± 0.18 6.57 ± 1.08 101 ± 19 4.31 ± 1.15 0.0172 40.7 ± 9.77 7.32 ± 0.68 1.49 ± 0.130 1.41 ± 0.236 
Aquacoat + ATEC 2.76 ± 0.41 2.89 ± 0.37 157 ± 29 2.62 ± 0.68 0.0176 28.8 ± 5.77 4.20 ± 0.31 1.30 ± 0.272 1.58 ± 0.090 
Aquacoat + ATBC 3.04 ± 0.63 4.20 ± 0.18 144 ± 9.1 4.87 ± 0.31 0.0211 44.3 ± 2.21 1.93 ± 0.08 1.36 ± 0.142 1.30 ± 0.127 
Aquacoat + GTA 2.57 ± 0.71 1.17 ± 0.70 319 ± 122 0.91 ± 0.59 0.0081 57.0 ± 3.75 3.28 ± 1.59 0.127 ± 0.013 0.242 ± 0.006 
Eudragit L 30D  4.42 ± 0.35 221 ± 61.2 180 ± 30 399 ± 129 0.0235 66.8 ± 0.68 70.0 ± 1.4 0.304 ± 0.021 0.399 ± 0.077 
a Freshly dried films stored under ambient conditions for 1 h before test. 
b Freshly dried films evaluated at 0 h and 5 h. 
c Freshly dried films stored in desicator at ambient temperature for 5 days before test under different conditions.  
Ambient conditions: 55 ± 2%RH and 22 ± 2 °C72
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B.  Mechanical properties of films 
1.  Comparison between different polymeric films  
An ideal film coat should be hard and tough without being brittle. These properties 
can be defined in terms of elastic modulus, tensile strength, percentage elongation at break 
(Bilmeyer, 1984) as well as work of failure (Parikh, 1993). Elastic modulus is a key 
indicator of stiffness or rigidity of polymer films (Wu and McGinity, 2000) while 
percentage elongation at break can be used to predict the ductility of the film. Hence, a 
hard and tough polymer film has high elastic modulus, high tensile strength and high 
percentage elongation at break while a soft but tough polymer film has low elastic 
modulus, moderate tensile strength and high percentage elongation at break. Tough films 
are also characterized by high work of failure. The ratio of tensile strength to elastic 
modulus could be related to in situ performance of the film (Rowe, 1983). It is desirable to 
have films with higher ratio of tensile strength to elastic modulus as coating defects were 
observed to increase with lower values of this ratio. 
The mechanical properties of the films studied are summarized in Table 6. Eudragit 
L 30D plasticized with TEC formed a tough film as shown by the high percentage 
elongation at break and work of failure values, at least 19 times higher compared with the 
EC films. Surelease and Aquacoat films had relatively low percentage elongation at break 
and work of failure values, indicating that they were brittle. Bodmeier et al., (1994) 
suggested that the interchain hydrogen bonding and bulkiness of glucose subunits of the 
polymer might have given rise to the brittle nature of the film. Compared to Aquacoat 
films, Surelease films were tougher as they had higher work of failure, percentage 
elongation at break values, as well as higher tensile strength to elastic modulus ratio. It was 
suggested that the presence of sodium lauryl sulfate in Aquacoat might have been 
responsible for the lower tensile strength (Bodmeier et al., 1994). The higher percentage 
elongation at break also showed that Surelease films were better plasticized. Surelease is 
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stabilized by an anionic surfactant, ammonium oleate in combination with a plasticizer 
composed of medium chain triglycerides (Colorcon).  During film drying, the less stable 
ammonium oleate would be converted to oleic acid that could act as an additional 
plasticizer for EC, resulting in a better plasticized film.  
Despite varying markedly in the values of percentage elongation at break and work 
of failure, the films prepared from Surelease, Eudragit L 30D plasticized with TEC and 
Aquacoat plasticized with ATBC showed comparable ratios of tensile strength to elastic 
modulus (0.0211 to 0.0235). Compared to the rest, these 3 films had the highest ratio value 
and were expected to produce coats of the least defects. Marked variation in the ratio 
values (0.0081 to 0.0211) was observed for Aquacoat containing different types of 
plasticizers, indicating the important effects of plasticizers.  
 
2. Influence of plasticizers on properties of films 
The effects of plasticizers on mechanical properties of EC films were also 
compared. The plasticizers used were classified into 3 types: phthalic acid esters (DEP, 
DBP), citric acid esters (TEC, ATEC, ATBC) and glycerol acid ester (GTA). DBP and 
ATBC increased the percentage elongation at break and work of failure of the films to a 
greater extent than the corresponding DEP and ATEC (Table 6), suggesting that the 
plasticizers with larger alkyl substituents produced tougher EC films. This phenomenon 
was probably associated with higher hydrophobicity of the plasticizers, which was more 
compatible with water - insoluble EC. It should be recalled that DBP-plasticized films 
were smoother and homogeneous while DEP- and ATEC-plasticized films had raised spots 
and undulating surfaces. No clear trends between the effects of the citric acid esters and 
phthalic acid esters on the percentage elongation at break and work of failure of the films 
were observed. However, the citric acid esters were found to produce films with relatively 
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higher tensile strength to elastic modulus ratios than phthalate acid esters. The glycerol 
ester, GTA, produced films with the lowest ratio value. The influence of the class of 
plasticizers on the ratio value was noted. EC consists of ether and hydroxyl groups which 
are capable of interacting with plasticizer molecules via hydrogen bonds. The 3 classes of 
plasticizers have different molecular structures with a number of functional groups for 
hydrogen bonding and are expected to show different extents of interaction with EC. 
Hence, the extent of interaction between the plasticizer and the polymer has an important 
influence on the tensile strength to elastic modulus ratio of the film produced. In this 
respect, phthalic acid esters were found to be generally better plasticizers than citric acid 
esters and glycerol esters. 
 
3. Influence of storage time on properties of films 
Mechanical properties of a film are critical as they affect the intended function of 
the film on a dosage form. These properties were found to vary to different extents with 
time when the plasticized EC films were stored at 30°C, 50 %RH for over 4 weeks 
(Figures 9 - 12). The ATBC- and DBP-plasticized films were the most stable as they 
showed little change in the four mechanical properties studied while TEC- and DEP-
plasticized films were the most unstable. With the exception of Surelease films, the tensile 
strength and elastic modulus of the plasticized films were generally more affected than 
their % elongation at break and work of failure. Increase in tensile strength and decrease in 
elastic modulus were observed in most cases, indicating that the films were gradually 
becoming brittle and rigid on storage. 
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Figure 9. Effect of storage conditions on tensile strength of EC films: Surelease and 
Aquacoat films plasticized with DBP, DEP, TEC, ATEC, ATBC, GTA stored at 30 °C, 50 
%RH and 30 °C, 75 %RH. (n = 5, Mean ± SD) 
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Figure 10. Effect of storage conditions on % elongation at break of EC films: Surelease and 
Aquacoat films plasticized with DBP, DEP, TEC, ATEC, ATBC, GTA stored at 30 °C, 50 
%RH and 30 °C, 75 %RH. (n = 5, Mean ± SD) 
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Figure 11. Effect of storage conditions on elastic modulus of EC films: Surelease and 
Aquacoat films plasticized with DBP, DEP, TEC, ATEC, ATBC, GTA stored at 30 °C, 50 
%RH and 30 °C, 75 %RH. (n = 5, Mean ± SD) 




Figure 12. Effect of storage conditions on work of failure of EC films: Surelease and 
Aquacoat films plasticized with DBP, DEP, TEC, ATEC, ATBC, GTA stored at 30 °C, 50 
%RH and 30 °C, 75 %RH. (n = 5, Mean ± SD) 
 
Assays of DEP, DBP, GTA, TEC, ATEC and ATBC remaining in Aquacoat films 
at different time intervals were carried out. The amounts of DEP and GTA were found to 
decrease significantly after a week of storage at 50 %RH (Table 7). The amount of GTA 
was not detectable after 3 weeks of storage. More than 30 % of ATEC was also lost during 
storage at 50 %RH though it was not statistically significant. The loss of plasticizers could 
be attributed to volatization or degradation of the plasticizers during storage. The percent 
weight changes of films stored at 50 %RH and 75 %RH were also determined (Table 8). 
All Aquacoat films, except for those plasticized with ATBC, generally showed decline in 
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Table 7. Comparison of plasticizer content in Aquacoat films exposed to storage conditions 
of 50 %RH, 30 °C and 75 %RH, 30 °C. 
Percentage of plasticizer content remaining in the film 
0 day 3 days 1 week 2 weeks 3 weeks 4 weeks 
Plasticizers 
Storage condition: 50 %RH, 30 °C 
DEP 100 81.83 57.41* 49.59* 51.26* 41.34* 
DBP 100 94.81 84.20 84.20 84.05 82.01 
TEC 100 83.73 75.64 75.00 73.74 72.64 
ATEC 100 95.90 90.74 74.26 66.47 66.51 
ATBC 100 91.25 89.55 86.96 86.18 84.96 
GTA 100 99.30 60.31* 22.13* - - 
 Storage condition: 75 %RH, 30 °C 
DEP 100 69.73* 49.93* 32.68* 27.84* 27.21* 
DBP 100 83.03 93.99 90.07 89.07 86.53 
TEC 100 80.10 79.68 80.54 79.46 79.13 
ATEC 100 92.07 92.48 88.75 78.41* 76.52* 
ATBC 100 85.73 85.26 84.90 82.97 82.21 
GTA 100 97.35 33.63* 18.34* - - 
*values significant at p< 0.05 compared to initial content in film  
 
weight during storage. The percent weight loss was greatest for Aquacoat plasticized with 
GTA, ATEC, TEC and DEP. A two tailed correlation analysis was conducted for percent 
weight change, plasticizer content, moisture content and mechanical parameters of 
Aquacoat films stored at 50 %RH. Only Pearson correlations for percent weight change 
and content of Aquacoat films plasticized with DEP, GTA or ATEC were found to be 
statistically significant at 0.05 level (Table 9). This suggested that the decline in percent 
weight change of Aquacoat films plasticized with DEP or GTA stored for more than 3 days 
was primary due to loss of plasticizers. Other researchers have also reported loss of 
plasticizer, such as propylene glycol, during storage (Pickard, 1979; Skultety and Sims, 
1987). Statistical analysis also showed significant correlations between tensile strength or 
elastic modulus and DEP content of films stored at 50 %RH. Pearson correlation between 
tensile strength and GTA content of films was also found to be significant at 0.05 level. 
This showed that the changes in mechanical properties observed were largely due
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Table 8. Comparison of percent weight change of films exposed to storage conditions of 50 
%RH, 30 °C and 75 %RH, 30°C. 




3 days 1 week 2 weeks 3 weeks 4 weeks 
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Table 9. Pearson correlation for films exposed to storage conditions of 50 %RH, 30 °C and 75 
%RH, 30 °C. 
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to loss of DEP or GTA from films. Similar findings were reported in the study of Eudrgait L 
30D films plasticized with triacetin (Gutierrez-Rocca and McGinity, 1994). 
Changes in mechanical properties of Aquacoat films plasticized with TEC and ATEC 
also indicated a hardening of film resulting in increased brittleness. The determination of TEC 
content by gas chromatography in Aquacoat films showed a loss of approximately 25 percent 
after a week of storage at 50 %RH. However, no further loss in TEC content was observed on 
prolonged storage. In contrast, the elastic modulus and % elongation at break values continued 
to show changes beyond a week of storage. Statistical analysis showed a significant correlation 
(p < 0.05, Table 9) between TEC content and percentage elongation at break or elastic modulus 
of films. This suggests that the initial changes of Aquacoat films were due to TEC loss. After 
prolonged storage, other factors also contributed to the continual hardening of the films. 
Generally, the film forming process depends on the manufacturing method, coating 
conditions and formulation variables (Onions, 1986; Keshikawa and Nakagami, 1994; Sun, et 
al., 1999). It was also reported that the degree of coalescence of latex particles increased with 
storage time (Guo et al., 1993). In most of the studies, the degree of coalescence was found to 
be greatly affected by storage temperature (Hutchings et al., 1994; Guo et al., 1991, 1993). It 
was likely that the changes in mechanical properties and loss of weight of Aquacoat films 
plasticized with TEC and ATEC on prolonged storage was mainly due to the phenomenon of 
coalescence. On the other hand, changes in mechanical properties of Aquacoat films plasticized 
with DEP and GTA were probably influenced by two factors, loss of plasticizers and increasing 
coalescence of polymer particles during storage. This explained the greater magnitude of 
change in tensile strength and elastic modulus, as well as percent weight change observed for 
Aquacoat films plasticized with DEP and GTA. 
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4. Influence of storage humidity on properties of films 
The mechanical properties of EC films stored at medium and high humidity levels of 50 
%RH and 75 %RH respectively were compared Figures 9 - 12. A humidity of 75 % represents 
a high humidity associated with outdoor conditions whilst 50 %RH is medium level, reflecting 
indoor controlled environment conditions commonly seen in local pharmaceutical 
manufacturing facilities. Changes in the mechanical properties were not always greater for 
films stored under higher RH of 75 %. For example, the tensile strength of DBP-plasticized 
films stored at 50 %RH increased significantly with time while those stored at 75 %RH had 
relatively constant tensile strength. The magnitudes of change in tensile strength and elastic 
modulus of Aquacoat plasticized with DEP after 3 days of storage at 50 %RH were also greater 
compared to those stored at 75 %RH for the same number of days. On the other hand, 
Aquacoat films plasticized with citrate esters, TEC and ATEC, showed similar differences in 
magnitude of change in tensile strength, elastic modulus, as well as, percentage elongation at 
break when stored at different humidity levels. Nevertheless, storage at high or medium 
humidity levels affected the mechanical properties of the plasticized Aquacoat films to a 
significant extent.  
The moisture content of the films stored at 50 %RH and 75 %RH were determined 
(Table 10). Most of the plasticized Aquacoat films stored at both humidities showed an initial 
increase in moisture content, ranging from 5 to 124 percent after 3 days of storage. On 
prolonged storage, the moisture content of Aquacoat films plasticized with phthalates (DEP and 
DBP) and citrate esters (TEC and ATEC) decreased to lower than or almost similar to initial 
values. However, there was no significant correlation between the moisture content and 
mechanical parameters of the Aquacoat films, except those plasticized with TEC (Table 9). The 
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influence of moisture on Aquacoat films was temporal and on prolonged storage, other 
prominent factors such as loss of plasticizers and further coalescence resulted in a greater  
Table 10. Comparison of percent change in moisture content of films exposed to storage 
conditions of 50 %RH, 30 °C and 75 %RH, 30 °C. 
Percent change in moisture content of films (n = 4) Films Storage 
conditions 3 days 1 week 2 weeks 3 weeks 4 weeks 
50 %RH, 30°C 181 ± 34 
 
54.3 ± 6.9 202 ± 23 207 ± 49 193 ± 25 Surelease 
75 %RH, 30°C 90 ± 18 
 
17 ± 25 219 ± 49 105 ± 46 103 ± 32 
50 %RH, 30°C 14.8 ± 57 
 
-52.0 ± 6.3 -46.5 ± 2.5 -10.2 ± 14 -38.1 ± 4.6 Aquacoat 
+ DEP 
75 %RH, 30°C 59.0 ± 57 
 
-28.4 ± 3.4 22.3 ± 5.2 -1.1 ± 3.7 -16.3 ± 8.9 
50 %RH, 30°C 95.0 ± 100 -22.5 ± 2.5 -21.1 ± 2.4 19.9 ± 3.8 -12.4 ± 2.8 Aquacoat 
+ DBP 
75 %RH, 30°C 6.81 ± 71 -46.0 ± 3.6 -44.8 ± 7.0 -7.96 ± 13 -40.6 ± 4.6 
50 %RH, 30°C -33.5 ± 2.1 
 
-16.2 ± 6.7 -4.88 ± 11 42.1 ± 24 122 ± 29 Aquacaot 
+ TEC 
75 %RH, 30°C 4.57 ± 4.6 
 
23.5 ± 6.2 21.9 ± 6.5 23.2 ± 13 160 ± 64 
50 %RH, 30°C 119 ± 61 
 
45.4 ± 19 -4.89 ± 5.2 7.61 ± 5.2 13.3 ± 3.2 Aquacoat 
+ ATEC 
75 %RH, 30°C 124 ± 120 
 
4.89 ± 6.0 -37.5 ± 13 -12 ± 22 16.8 ± 29 
50 %RH, 30°C 50.4 ± 9.4 277 ± 47 50.4 ± 36 37.3 ± 6.7 39.7 ± 10 Aquacoat 
+ ATBC 
75 %RH, 30°C -7.54 ± 10 145 ± 110 7.54 ± 5.1 21.8 ± 24 11.5 ± 13 
50 %RH, 30°C 70.1 ± 15 
 
41.8 ± 2.6 53.1 ± 33 41.2 ± 6.4 46 ± 12 Aquacoat 
+ GTA 
75 %RH, 30°C 91 ± 130 
 
1.61 ± 13 -6.43 ± 6.9 -8.36 ± 4.9 0.96 ± 3.9 
50 %RH, 30°C 34.2 ± 17 
 
52.7 ± 16 91.1 ± 16 14.5 ± 18 33.2 ± 6.4 Eudragit L 
30D 
75 %RH, 30°C -36.3 ± 8.5 
 
-34.6 ± 6.4 -22.8 ± 7.3 -35.2 ± 14 -42.6 ± 6.6 
 
change in film structure. 
For example, Aquacoat films plasticized with ATBC did not show significant change in 
mechanical properties except for a small rise in elastic modulus value. This slight increase 
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might be due to the small amount of ATBC lost from Aquacoat films during storage. It is 
interesting to note that the moisture content of Aquacoat plasticized with ATBC showed the 
greatest increase after 1 week, but decreased markedly to near initial value after 2 weeks of 
storage at both humidities (Table 10). The percent weight of these films reflected a small but 
sustained increase in weight of the film though this increase was found to be insignificant 
(Table 8). The variation in moisture content however did not affect the mechanical properties 
of Aquacoat films plasticized with ATBC stored at a high humidity. This suggested that 
Aquacoat plasticized with ATBC was less influenced by moisture in the environment than 
those plasticized by other citrate esters. 
Films containing GTA which is soluble in water, showed a marked increase in moisture 
content when stored at both 50 %RH and 75 %RH (Table 10). While the moisture content of 
the films stored at 50 %RH remained almost constant after 1 week of storage, those stored at 75 
%RH showed a significant decline to near initial value. This latter corresponded to a lower 
GTA content in the films stored at 75 %RH (Table 7), indicating affinity for GTA for moisture. 
Neverthess, the high loss in GTA content of the films stored at both humidities caused 
modifications in film structure, resulting in similar change in mechanical properties of the 
films.  
Compared to Aquacoat films, the differences in mechanical properties of Surelease 
films stored at both 50 %RH and 75 %RH were less marked. A small but significant (p < 0.05) 
increase in tensile strength was observed for Surelease films stored at both 50 %RH and 75 
%RH. Independent sample T-tests were conducted and the differences between the tensile 
strength values for Surelease stored at 50 %RH and 75 %RH for 1, 2 and 4 weeks, were found 
to be statistically significant at 95 % confidence interval. The percent weight change of 
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Surelease films showed a small decline over 4 weeks of storage at both 50 %RH and 75 %RH 
(Table 8). On the contrary, the moisture content showed a significant increase after 3 days of 
storage. This indicated that other more prominent factors, such as greater coalescence, were 
responsible for the weight loss of Surelease films. Unlike EC films, there was no prominent 
change in mechanical properties of MA films stored at high humidity for up to 4 weeks. A 
small but significant decrease in film weight was observed after 4 weeks of storage (Table 8). 
This could be attributed to loss of moisture from films to atmosphere at 75 %RH and 30 °C 
(Table 10).  
 
5. Water vapour permeability 
The water vapour permeabilities of EC and MA films are shown in Table 6. With the 
exception of Aquacoat film plasticized with GTA, the rest of the EC films were at least thrice 
more permeable to water vapor than the plasticized Eudragit film and only slightly more 
permeable than Surelease films. This implies that the plasticized MA films were denser in 
structure compared to the plasticized EC films. There was no significant difference in the 
permeabilities of EC films plasticized with DBP, DEP, TEC, ATEC and ATBC. However, 
when EC films were plasticized with GTA, the permeability decreased by at least 5 folds, to 
1.27 x 10-5 g h-1 cm-3 mmHg-1at 50 %RH and to 2.42 x 10-5g h-1 cm-3 mmHg-1 at 75 %RH. 
Among the plasticizers used, GTA showed the greatest loss from films (Table 7). It was 
therefore likely that during the conditioning of EC films for permeability study, a large amount 
of GTA was lost by degradation or through volatization. This would result in a re-alignment of 
the polymer chains and formation of a more compact structure which became less permeable to 
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water vapour. Both plasticized Eudragit L 30D and EC films did not show any significant 
difference (p < 0.05) in the permeability measured at 30°C, 75 %RH and 30°C, 50 %RH. 
 
C. Drug release 
It was clearly seen in this study above that properties of plasticized Aquacoat films 
could be substantially affected by the humdity and temperature of the environment. Further 
study was conducted to examine the consequential effects that these changes in film properties 
might have on drug release. Chlorpherniramine pellets were coated with Aquacoat plasticized 
with DEP, TEC, ATEC and GTA representively. The coated pellets were exposed to 
environmental conditions of 30 °C and 10, 40 or 75 %RH for over a period of 4 weeks. At 
predetermined time intervals of 3, 7, 14, 21 and 28 days, samples of pellets were removed for 
dissolution test. In addition, the effect of storage temperature was also studied by storing the 
pellets in the oven at 30 °C or 70 °C for 4 weeks.  
 
1. Influence of plasticizer on dissolution profiles of pellets coated with Aquacoat 
The release profiles of pellets coated with Aquacoat plasticized with DEP, ATEC and 
GTA were similar and closely resembled that of a rapid release formulation with 90 percent of 
chlorpheniramine released within 30 min (Figure 13). In contrast, pellets coated with Aquacoat 
plasticized with TEC showed greater retarding effect on the release of chlorpheniramine, as 
only 80 percent of the drug was released after 10 h. The dissolution data were fitted into zero- 
order, first-order, Hixson-Crowell, Higuchi equations and analyzed 


























Aquacoat + TEC Aquacoat + DEP
Aquacoat + GTA Aquacoat + ATEC
 
Figure 13. Dissolution profiles of Aquacoat coated chlorpheniramine pellets dried at 22 °C, 70 
%RH for 24 h. 
 
using linear regression. The fit factors, represented by r2 and AIC values, showed that 
chlorpheniramine release from the coated pellets was best described by Higuchi or zero-order 
equations (Table 11). The Higuchi release rate constant of pellets coated with Aquacoat + TEC 
was at least 3 folds lower and their MDT50% and T50% at least 6 folds higher, compared to other 
coated pellets (p < 0.05, Table 12). The release of chlorpheniramine from Aquacoat + TEC 
coated pellets was also characterized by a significantly longer lag time of 48 min in constrast 
with 3 – 9 min for the rest. 
The above findings indicate a wide variation in the effect of plasticizers on drug release 
through Aquacoat films. Plasticizers are indispensable for aiding coalescence of EC polymer to  
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Table 11. Fit factors of drug release models for pellets coated with Aquacoat containing 30 








Aquacoat + TEC 0.919 0.763 0.823 0.955 
Aquacoat + DEP 0.998 0.959 0.979 0.994 
Aquacoat + GTA 0.953 0.807 0.868 0.987 
Aquacoat + ATEC 0.985 0.879 0.934 0.983 
 AIC 
Aquacoat + TEC -21.9 -1.79 -21.6 -24.9 
Aquacoat + DEP -47.1 -16.0 -38.0 -42.6 
Aquacoat + GTA -24.1 -0.730 -21.7 -32.1 
Aquacoat + ATEC -30.6 -1.70 -24.6 -29.4 
 
Table 12. Lag time, MDT50%, T50% and release rate constants of pellets coated with Aquacoat 
plasticized with 30 %w/w TEC, DEP, GTA and ATEC. 











Aquacoat + TEC 47.7 115.5 202.2 0.0026 0.069 
Aquacoat + DEP 6.3 14.2 22.5 0.0264 0.225 
Aquacoat + GTA 3.1 10.6 18.9 0.0244 0.193 
Aquacoat + ATEC 9.1 19.1 29.7 0.0214 0.206 
 
form a homogeneous film. Incomplete coalescence will result in film coat with flaws, cracks or 
pores through which drug and water can diffuse through easily. The plasticizing effect depends 
partly on the interaction between the polymer and plasticizer. Greater interaction between the 
polymer and plasticizer will lead to more uniform and complete films. Hence, TEC was the 
most effective plasticizer for Aquacoat, as it resulted in the longest lag time and lowest release 
rate constant. The dissolution profiles showed that drug was released from Aquacoat + TEC 
RESULTS AND DISCUSSION 
 91
coated pellets in 3 phases: an initial lag period, which was then followed by a phase of constant 
release and a slower release in the final phase. The initial lag period was attributed to a 
combination of factors, such as the time required for wetting of the EC coat, dissolution of TEC 
and other water-soluble components, as well as diffusion of water molecules through the coat 
to wet the pellet matrix. Once the film coat and outer matrix were wetted, the water - soluble 
components began to dissolve and leach out. This created a more permeable coat to drug 
diffusion. At the final stage, the drug particles in the outer layers were depleted and longer time 
was needed for the remaining drug to diffuse from the inner core, thus resulting in a slower 
release.   
Conversely, the rapid drug release and short lag time obtained for pellets coated with 
Aquacoat + ATEC, DEP and GTA implied that these plasticizers were relatively less efficient 
in aiding EC film coalescence. The poor plasticizing efficiency of ATEC, DEP and GTA for 
Aquacoat was further illustrated by the formation of hard and brittle films in contrast with the 
comparatively more flexible TEC - plasticized film (Table 6). The brittle films were less able to 
withstand the physical stress encountered during dissolution and hence ruptured easily, causing 
mass exodus of drug within 30 min. The release parameters obtained from both model-
dependent and model-independent analysis showed a unanimous pattern of increasing release 
rate for EC coated pellets plasticizied with ATEC, DEP and GTA. This trend correlates with 
the mechanical properties of the respective films (Tables 6 and 12). As indicated by the 
percentage elongation at break, elastic modulus and work of failure values, EC films plasticized 
with GTA were most brittle while those plasticized with ATEC possessed greater flexibility.  
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2. Influence of storage conditions on dissolution profiles of pellets coated with plasticized 
Aquacoat 
a. Citric acid esters (TEC and ATEC) 
  
Generally, a notable right shift trend was observed for release profiles of pellets stored 
at all level of humidity. In particular, pellets kept at high RH of 75 % showed a distinct right 
shift in correspondence to the storage time, except at 3 days and 1 week (Figure 14a). On the 
other hand, dissolution profiles of pelltes stored at medium RH of 40 % rebound toward the left 
after 2 weeks (Figure 14b). Similar left shift was observed for pellets exposed to 10 %RH for 
more than 2 weeks (Figure 14c). Pellets kept in low RH of 10 % showed the greatest change in 
release profile, reducing the total amount of chlorpheniramine released to only 50 percent after 
10 h.  
The release profiles of the coated pellets were best described by Higuchi equation. The 
release rate constants, lag time, MDT50% and T50% values of the pellets exposed to different 
storage conditions for varying period of time were compared (Figures 15a - d). A significant 
drop (p < 0.05) in Higuchi release rate constant was noted for all pellets after 3 days, 
irregardless of the storage conditions they were exposed to. The storage humidity however 
played a role in dictating the degree of change in the release rate. For instance, the release rate 
constant for 10 %RH decreased by 4 folds compared to 1 fold for 40 %RH.  
In general, there was no further decline in release rate for pellets exposed to 10 and 40 
%RH after 2 weeks, whereas pellets kept at 75 %RH showed further retardation of drug release 
even at 4 weeks. Interestingly, the T50% curve of pellets kept at 10 %RH indicated a drop from 
900 min at 2 weeks to about 720 min at 3 and 4 weeks, while MDT50%, curve showed only 
small fluctuation after 1 week (Figures 15c and d). The small dip in T50% was attributed to the
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Figure 14. Dissolution profiles of chlorpheniramine pellets coated with Aquacoat containing 30 %w/w TEC stored at (a) 75 %RH, 30 ºC, (b) 40 




















































































































Figure 15. Effect of storage humidity and temperature on (a) Higuchi rate constant (b) 
lag time (c) MDT50% and (d) T50% of pellets coated with Aquacoat containing 30 
%w/w TEC.      75 %RH, 30 °C;      40 %RH, 30 °C;       10 %RH, 30 °C ;     0 %RH, 
70 °C. 
 
declining lag time even after 2 weeks of storage (Figure 15b). In order to determine if 
dissolution profiles obtained after 1 week of storage at 10 %RH were significantly 
different from those kept at 2 weeks or more, the release data were compared using 
the pairwise analysis with pellets stored for 1 week as the reference batch. In all cases, 
(a) (b) 
(d) (c) 
Storage time (days) 
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the f2 values were greater than 50 and f1 values were smaller than 15, except for 
pellets stored for 2 weeks. Hence, it may be concluded from the pairwise analysis that 
there was generally not much difference in the dissolution profiles of pellets stored at 
10 %RH after 2 weeks.  
The f1 and f2 values for dissolution profiles of pellets stored at different 
humidity levels were also obtained using control pellets (not subject to storage) as the 
reference (Table 13). As shown in Table 14, the f1 and f2 values of pellets stored at 10 
%RH were greater than 15 and smaller than 50 respectively, indicating less than 10 
percent dissimilarity in the dissolution profiles upon storage for 3 days and more. This 
result supports the trend observed from model - dependent and model - independent 
analysis. Overall, both the model - dependent and model - independent analysis 
showed the storage of Aquacoat + TEC pellets at high humidity (75 %RH) or low 
humdity (10 %RH) resulted in significant changes to the release profiles. The pellets 
stored at 40 %RH were stable and showed little change in release profile. 
As discussed previously, Aquacoat + TEC films showed a gradual weight loss 
throughout the storage period of 4 weeks at 75 %RH (Table 8). Plasticizer loss and 
and polymer coalescence were believed to be responsible for the weight loss. Loss of 
TEC only affected the changes in the film properties during the initial 3 days since its 
content remained relatively constant after 3 days (Table 7). Exposure to RH of 75 % 
caused the film to absorb moisture from the environment which modulated the effect 
of TEC loss on mechanical properties of the film (Table 9 and Figures 9 - 12). Similar 
trend was observed for films kept at 50 %RH despite more rapid change in weight. 
The percent weight change reached equilibrium faster (within 3 weeks) for films 
stored at lower RH (Table 8). 
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3 days *15.3 *15.8 6.6 *39.9 
1 week 14.3 12.2 4.9 *48.4 
2 weeks *24.0 11.7 4.8 *50.1 
3 weeks *28.7 *16.6 3.1 *51.1 
75 %RH, 30°C 
4 weeks *33.0 *15.7 7.6 *29.9 
3 days 8.1 9.6 3.3 7.2 
1 week 7.0 6.5 3.0 13.3 
2 weeks *24.3 11.4 2.4 10.1 
3 weeks 8.4 15.2 7.5 13.9 
40 %RH, 30°C 
4 weeks 7.0 *16.7 6.9 12.4 
3 days *48.7 *35.0 6.5 7.5 
1 week *61.8 *28.4 8.7 9.8 
2 weeks *68.9 *24.8 8.8 5.2 
3 weeks *62.5 *24.9 7.4 6.3 
10 %RH, 30°C 
4 weeks *59.4 *24.4 7.1 8.8 
3 days *34.4 *16.5 *22.0 *63.1 
1 week *43.1 11.4 *20.1 *55.9 
2 weeks *42.1 7.4 *15.8 *30.4 
3 weeks *21.4 12.0 *16.3 *60.1 
0 %RH, 70°C 
4 weeks *27.2 11.5 14.8 *79.9 
 f2 
3 days 53.3 *49.2 63.5 *27.7 
1 week 53.9 53.9 73.9 *24.2 
2 weeks *42.1 53.7 71.2 *21.0 
3 weeks *38.3 *46.4 74.3 *23.2 
75 %RH, 30°C 
4 weeks *34.7 *47.1 63.0 *35.1 
3 days 66.5 59.5 76.2 60.9 
1 week 68.4 67.3 80.9 49.5 
2 weeks *41.9 56.1 82.2 51.6 
3 weeks 63.0 49.9 51.5 *48.1 
40 %RH, 30°C 
4 weeks 65.2 *48.1 55.7 51.2 
3 days *26.5 *31.4 65.9 59.0 
1 week *21.3 *36.3 61.2 54.5 
2 weeks *18.9 *39.1 60.2 67.1 
3 weeks *28.0 *39.1 64.7 64.4 
10 %RH, 30°C 
4 weeks *22.2 *38.9 64.4 58.1 
3 days *34.2 *48.1 *43.6 *12.5 
1 week *28.8 54.3 *46.1 *14.8 
2 weeks *29.6 63.2 *49.2 *28.2 
3 weeks *44.9 52.1 *48.7 *17.4 
0 %RH, 70°C 
4 weeks *40.0 53.0 50.3 *11.2 
* f1 > 15 or f2 > 50 indicates significant difference  
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The decline in release rate of Aquacoat + TEC coated pellets kept at medium 
to high RH for 3 days was due to an overall increase in moisture content. The 
plasticizing effect of absorbed moisture caused the film to be more flexible and less 
vulnerable to impact encountered during dissolution. At the same time, the polymer 
film underwent further coalescence, which greatly reduced the number of pores or 
cracks through which the drug escaped. The dissolution profiles of the pellets kept at 
75 %RH continued to change throughout the study period of 4 weeks. In contrast, 
pellets stored at 40 %RH showed only slight fluctuation after 2 weeks, indicating that 
the coalescence of polymer had reached equilibrium. The greater retardation in drug 
release achieved for pellets stored at 10 %RH showed that the Aquacoat films had 
undergone greater extent of coalescence, forming harder films. Consequently, much 
longer time was necessary for wetting of the coating and outer pellet core before 
diffusion of the drug could occur. This explained the longer lag time and slower 
release rate observed (Figures 15a and b). The above results suggested that lower 
humidity facilitated coalescence of Aquacoat to form less permeable films.  
Compared with Aquacoat + TEC coated pellets, those coated with Aquacoat + 
ATEC showed less changes in dissolution profile when stored at 10 and 40 %RH. As 
seen from Figures 16a and b, the dissolution profiles of pellets stored at 10 and 40 
%RH were similar to those of pellets before storage. In contrast, a right shift in the 
dissolution profiles of pellets was observed after 3 days of storage at high relative 
humidity of 75 %RH (Figure 16c). Drug release rate decreased further for storage up 
to 2 weeks, after which no further change was observed. However, the dissolution 
profile of the pellets stored for more than 4 weeks shifted back to the left, suggesting 
faster release. The shift in dissolution profiles of Aquacoat + ATEC coated pellets 
may partly be due to the increase in lag time as seen in Figure 17b. The greatest 
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Figure 16. Dissolution profiles of chlorpheniramine pellets coated with Aquacoat containing 30 %w/w ATEC stored at (a) 10 %RH, 30 ºC, (b) 40 
















































































































Figure 17. Effect of storage humidity and temperature on (a) Higuchi rate constant (b) lag 
time (c) MDT50% and (d) T50% of pellets coated with Aquacoat containing 30 %w/w ATEC.  
    75 %RH, 30 °C;       40 %RH, 30 °C;       10 %RH, 30 °C;      0 %RH, 70 °C. 
 
increase in lag time was observed for pellets after 3 days of storage. Beyond this, the lag time 
of pellets stored at 10 and 40 %RH remained almost constant while that of pellets stored at 75 
%RH decreased slightly.  
Unlike Aquacoat + TEC coated pellets, those coated with Aquacoat + ATEC showed 
an increase in Huguchi rate constant after 3 days of storage, irrespective of the humidity level 
(a) (b) 
(c) (d) 
Storage time (days) 
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(Figure 17a and b). The rate constant of pellets stored at 40 %RH remained fairly constant on 
prolonged storage while that for stored at 10 %RH decreased after 1 week, increased again 
after 2 weeks and remained constant thereafter. Interestingly, pellets stored at 75 %RH also 
showed a gradual and more pronounced decrease after the initial rise at day 3.  
According to model-independent analysis, Aquacoat + ATEC coated pellets stored at 
75 %RH showed the greatest changes in both T50% and MDT50% values (Figures 17c and d). 
In both cases, there was a significant increase after 3 days of storage, which then leveled off 
for MDT50%. Though independent t-test analysis showed significant increase in T50% and 
MDT50% values of Aquacoat + ATEC pellets stored at 10 and 40 %RH, the magnitude of 
increase was considerably small compared to those stored at 75 %RH. Moreover, pairwise 
analysis also demonstrated that the dissolution profiles of pellets stored at 75 %RH were 
more than 10 % dissimilar to those prior to storage. Though the f1 and f2 values for all the 
batches stored throughout 4 weeks were greater than 15 and smaller than 50 respectively, 
greater difference and dissimilarity factors were observed for those stored for 2 to 3 weeks 
(Table 13). In contrast, no difference or dissimilarity was observed for all the batches of 
pellets stored at 10 and 40 %RH, except for one batch of pellets stored at 40 %RH for 3 
weeks. Taken together, it was clear that storage of Aquacoat + ATEC pellets at high humidity 
had significant effect on the release of chlorpheniramine while storage in an environment of 
low or medium humidity did not affect the release profiles.  
Aquacoat films plasticized with ATEC or TEC responded similarly to storage 
humidity. Particularly, Aquacoat films plasticized with ATEC showed an increase in 
moisture content when exposed to 75 %RH for 3 days (Table 10). The absorbed moisture 
exerted a plasticizing effect on the film and brought about a decrease in chain stiffness (Wu 
and Mcginity, 2000; Bicerano, 1996). The combinational influence of film strengthening as a 
result of coalescence and increased flexibility due plasticizing action of absorbed moisture, 
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gives rise to a tougher film that is able to withstand the physical stress of dissolution. The 
weight of Aquacoat films plasticized with ATEC declined gradually over 4 weeks of storage 
at both 50 and 75 %RH. This decrease in weight was attributed to ATEC loss and further 
coalescence of polymer which occurred at a slower rate at higher humidity. Hence pellets 
kept at 75 %RH had lower release rate than those stored at lower humidity (Figure 17c). 
 
b. Phthalic acid esters (DEP) 
The influence of storage humidity on Aquacoat + DEP coated pellets is shown in 
Figures 18a - c. For the initial 30 min of dissolution study, drug release profiles of the pellets 
exposed to 40 and 75 %RH closely resembled that of pellets before storage. More prominent 
differentiation between dissolution curves for pellets subject to different storage time was 
observed for 75 %RH and 10 %RH. For those pellets, the rate and amount of drug release 
generally decreased with increasing storage time.  
Analysis of the dissolution data confirmed that Aquacoat + DEP coated pellets were 
relatively stable to storage at 40 %RH as the release parameters remained fairly constant 
throughout the test period (Figures 18a - d). Keeping the pellets at low (10 %RH) and high 
(75 %RH) humidity, however brought about an overall reduction in both the release rate and 
lag time (Figures 19a and c). Although the lag time profile portrayed a general declining 
trend, an initial increase was seen on day 3 (Figure 19b). All the release parameters affirmed 
that greater changes in chlorpheniramine release were obtained for Aquacoat + DEP coated 
pellets when stored at low humidity (Figure 19a – d). This trend was further attested to be 
significant at p < 0.01 from pairwise analysis (Table 13). Pellets exposed to higher RH of 75 
% had small variation in MDT50% and T50% and declining lag time and release rate. The
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Figure 18. Dissolution profiles of pellets coated with Aquacoat containing 30 %w/w DEP stored at (a) 75 %RH, 30 ºC, (b) 40 %RH, 30 ºC, (c) 











































































































Figure 19. Effect of storage humidity and temperature on (a) Higuchi rate constant (b) 
lag time (c) MDT50% and (d) T50% of pellets coated with Aquacoat containing 30 
%w/w DEP.     75 %RH, 30 °C;       40 %RH, 30 °C;      10 %RH, 30 °C;       0 %RH, 
70 °C. 
 
opposing effect of reduced lag time substantially negated the effect of decreasing 
release rate.  
DEP was found to be a relatively unstable plasticizer for EC films. When 
Aquacoat films plasticized with DEP were exposed to high humidity of 75 %, a great 
(a) (b) 
(c) (d) 
Storage time (days) 
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amount of DEP was lost over the test (Table 7). DEP loss eventually caused an 
increase in film hardness characterized by higher elastic modulus and tensile strength 
(Figures 9 and 11). The hardened films, having a lower permeability to drug and 
dissolution media, contributed to decreased release rate. At the same time, the lag 
time for chlorpheniramine release also decreased, especially after 2 weeks, as a 
consequence of increased film brittleness arising due to DEP depletion. Nevetheless, 
once wetted by the dissolution media, the release rate remain fairly constant and 
similar. DEP loss was significantly less and slower when the films were kept at 
medium RH of 50 % (Table 7), thus explaining the reduction in lag time of pellets 
stored for 4 weeks at 75 %RH and the accelerated release during the initial period 
observed. Storage at low RH of 10 % had a great impact on chlorpheniramine release 
which closely resembled the trend seen for pellets stored at 75 %RH. Further 
coalescence of the film was likely the major attributing factor to the changes. 
Although coalescence, manifested by increased lag time and decreased release rate, 
was clearly occurring for coated pellets kept at all humidty levels, pellets stored at 10 
%RH experienced a greater degree of coalescence. Low moisture content at 10 %RH 
was more conducive for coalescence and hence brought about significantly higher 
magnitude of changes in lag time and release rate. 
 
c. Glycerol acid ester  
Unlike other plasticizers, the dissolution profiles of pellets coated with 
Aquacoat + GTA were very similar to one another irrespective of the storage 
conditions and time. Pairwise analysis revealed that there was no significant 
dissimilarity between the release profiles. Likewise, the realease parameters derived 
from model-dependent and model - independent analysis showed little variation with  
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Figure 20. Dissolution profiles of pellets coated with Aquacoat plasticized with 30 %w/w GTA stored at (a) 75 %RH, 30 ºC, (b) 40 %RH, 30 









































































































Figure 21. Effect of storage humidity and temperature on (a) Higuchi rate constant (b) 
lag time (c) MDT50% and (d) T50% of pellets coated with Aquacoat plasticized with 30 
%w/w GTA.     75 %RH, 30 °C;       40 %RH, 30 °C;      10 %RH, 30 °C;       0 %RH, 
70 °C. 
 
time (Figures 20 a – d). 
In the earlier discussion, GTA was shown to have poor plasticizing ability for 
aqueous EC films. Due to its low stability on storage, virtually no GTA remained in 
the films even for those kept at less humid environment of 50 %RH (Table 7). 
Consequently, Aquacoat films plasticized with GTA were mechanically weakest and 
(a) (b) 
(c) (d) 
Storage time (days) 
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most brittle compared to other plasticizers (Table 6). Hence, it was not unexpected to 
see poorly sustained chlorpheniramine release for pellets coated with Aquacoat + 
GTA. Nevetheless, the release study proved that Aquacoat membrane plasticized with 
GTA were so weak that neither storage at low or high humidity could exert any 
substantial effect on the film and release properties. 
 
3.  Effect of storage temperature on drug release 
 Storage of EC films at high temperature is known to be capable of either 
strengthening or weakening the film, as a result of aging or plasticizer loss (Hutchings 
et al., 1994). The performance and stability of various plasticizers, and the effect on 
drug release for Aquacoat coated pellets kept at high temperature of 70 ºC was 
assessed in this study. The greatest change in release profiles was obtained for 
Aquacoat coated pellets plasticized with citric acid esters (TEC and ATEC) (Figures 
14d and 16d). The initial phase of the dissolution profiles of Aquacoat + DEP pellets 
appeared to be quite similar to that prior to storage at 70 ºC (Figure 18d). Slight 
deviation in the dissolution profiles was seen after 30 min and the total amounts of 
drug released at the end of the dissolution runs were comparatively lower. Pairwise 
analysis demonstrated that only batches stored for 3 days were found to be dissimilar 
to coated pellets prior to storage. Unlike other plasticized formula, Aquacoat + GTA 
coated pellets showed faster drug release when stored at 70 ºC for 3 days (Figure 
20d). No further change was observed after 3 days, indicating that whatever major 
changes had already occurred during the initial 3 days. Exposing the pellets to high 
temperature, led to accelerated loss of GTA through volatization or degradation 
causing the plasticized Aquacoat films to become more brittle.  
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Pellets with Aquacoat plasticized with either TEC or ATEC showed drastic 
changes in their dissolution profiles when stored at 70 ºC (Figures 14d and 16d). After 
3 days of storage at 70 ºC the dissolution profiles of these pellets shifted considerably 
to the right with prolonged lag time. The lag time of Aqucoat + TEC coated pellets 
increased to a maximum at 2 weeks and decreased on extended storage. In contrast, 
Aquacoat + ATEC coated pellets had shorter lag time on storage for more than 3 days 
(Figure 17b), which also resulted in a left shift in release profile. Consequently, faster 
release of chlorpheniramine was obtained after storing Aquacoat + ATEC coated 
pellets at 70 ºC for 1 week or more. The Hugichi rate constants of these coated pellets 
were found to decrease significantly after 3 days and no further change was observed 
on prolonged storage.  
The big decline in release rate constant and longer lag time at day 3 revealed a 
major structural change in Aquacoat films plasticized with ATEC and TEC. It was 
likely that these changes were driven by further coalescence of polymer, resulting in 
strengthening of the film structure and improved film integrity. Hence, there were less 
direct pathways for drug diffusion as the number of pores and cracks was greatly 
reduced. Moreover, the release rate decreased significantly as it became more difficult 
for the dissolution media and drug to penetrate through the hardened films. 
Subsequent decrease in lag time for Aquacoat + ATEC (3 days) and Aquacoat + TEC 
(1 week) indicated signs of film weakening on extended exposure to high 
temperature. This could be attributed to plasticizer loss, either through degradation or 
volatization. ATEC has comparatively lower permeance for Aquacoat films than TEC 
(Table 7). This contributes to the earlier decrease in lag time (after 3 days) for 
Aquacoat + ATEC coated pellets as constrast to 1 week for pellets coated with 
Aquacoat + TEC (Figure 15b and 17b).  
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Part 2. Influence of polymeric additives 
A.  Thermal and dynamic mechanical properties 
Many methods have been employed to study interactions in polymeric blends. 
They include thermoanalytical techniques, microscopy, light scattering, small-angle 
neutron scattering, inverse gas chromatography, rheological and spectroscopic 
techniques (Olabisi et al., 1979). Measurement of glass transition temperature is one 
of the more common approaches in studying the behaviour of polymer blends 
(Sakellariou and Rowe, 1995; Song et al., 1996; Nyamweya and Hoag, 2000). Glass 
transition temperature is the temperature at which the molecular chains of a polymer 
obtain sufficient energy to surmount the energy barrier for bond rotation (Wetton et 
al., 1991). Consequently, the polymer changes from a frozen glass-like condition with 
very limited mobility to a mobile state and achieves thermodynamic equilibrium 
instantaneously. Glass transition is a fundamental property of an amorphous material 
that can determine its end-use properties such as mechanical properties, thermal 
properties and permeability. Depending on the nature of the interaction between 
individual components, polymeric blends may be miscible (single phase), partially 
miscible or immiscible (phase separation). Miscible blends will exhibit a single glass 
transition temperature at an intermediate value, between the glass transition 
temperatures of the individual components. For immiscible blends, glass transition 
temperatures of individual components will remain unchanged. When the solubility 
limit of one of the polymers in a miscible blend is exceeded, phase separation will 
occur and an additional glass transition temperature corresponding to the excess 
polymer will be observed. The final properties of the blend will be determined by its 
miscibility and phase behaviour. 
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Determination of the miscibility of PVP, PV/VA or MCPVP with EC was 
carried out by preparing cast films aided by organic solutions. Pure EC, PVP, PV/VA 
and MCPVP films were also prepared and their thermal properties determined using 
DSC. In the first heating cycle, thermograms were erratic in the range of 30 - 110°C 
for EC and 30 – 150 °C for PVP, PV/VA and MCPVP film samples, possibly due to 
presence of water or other volatile substances as well as other effects such as sintering 
of samples (Nishio and Manley, 1988). While the glass transition temperatures of EC 
and MCPVP film samples were easily detectable from the thermograms of first 
heating cycle, the thermograms of PVP and PV/VA samples did not show any 
characteristic drop in the heat flow to suggest glass transition temperature inflections. 
However, glass transition temperatures of PVP and PV/VA film samples became 
visible on second heating cycle at 157.1°C and 100.6 °C respectively. The glass 
transition temperatures of EC and MCPVP films determined from the second heating 
cycles were 178.4 °C and 178.3 °C respectively.  
DSC scans of film blends of EC with PVP were also determined and shown in 
Figure 22. When PVP was mixed with EC, a single endothermic transition recurred in 
the temperature range of 178 – 180 °C, which was close to the glass transition 
temperature of EC. As the content of PVP increased, the endothermic inflection of EC 
became broader and shallower. However, the glass transition temperature remained 
relatively constant for EC-PVP blends up to a ratio of 4:6. An additional endothermic 
transition around 150 °C, representing the glass transition temperature of PVP, was 
observed for EC-PVP (4:6) film. At PVP concentration of 70 percent and above EC 
endothermic transition disappeared and only PVP glass transition endotherm was 
exhibited. The presence of a single endothermic transition, representing the composite 
glass transition temperature value, was used as a criterion for establishing polymer- 
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Figure 22. DSC thermograms of (a) EC (b) EC-PVP K29 (9:1) (c) EC-PVP K29 (8:2) 
(d) EC-PVP K29 (7:3) (e) EC-PVP K29 (6:4) (f) EC-PVP K29 (5:5) (g) EC-PVP K29 
(4:6) (h) EC-PVP K29 (3:7) (i) EC-PVP K29 (2:8) (j) EC-PVP K29 (1:9) (k) PVP 
K29 
 
polymer miscibility. In contrast, the presence of two glass transition temperature 
values corresponding to the glass transition temperatures of the individual 
components was an indication of immiscible blends. PVP was completely miscible 
with EC up to a concentration of 50 percent, as indicated by the presence of a single 
endothermic transition. Phase separation was evident in the EC-PVP (4:6) blend and 
complete miscibility observed again when the concentration of PVP increased to 70 
percent or more. 
The DSC thermograms of all the EC-MCPVP blends exhibited a single glass 
transition endotherm (Figure 23). However, as the glass transition endotherms of EC 
and MCPVP occurred in a similar temperature range of ~ 178 - 180 °C, it was hard to 
distinguish if the single endothermic transition was due to the glass transition 
endotherm of EC, MCPVP or fusion of both polymers. Hence, it could not be  
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Figure 23. DSC thermograms of (a) EC (b) EC-MCPVP (9:1) (c) EC MCPVP (8:2) 
(d) EC-MCPVP (7:3) (e) EC-MCPVP (6:4) (f) EC-MCPVP (5:5) (g) EC-MCPVP 
(4:6) (h) EC-MCPVP (3:7) (i) EC-MCPVP (2:8) (j) EC-MCPVP (1:9) (k) MCPVP 
 





















Figure 24. DSC thermograms of (a) EC (b) EC-PV/VA (9:1) (c) EC-PV/VA (8:2) (d) 
EC-PV/VA (7:3) (e) EC-PV/VA (6:4) (f) EC-PV/VA (5:5) (g) EC-PV/VA (4:6) (h) 
EC-PV/VA (3:7) (i) EC-PV/VA (2:8) (j) EC-PV/VA (1:9) (k) PV/VA.
Temperature (°C) 
Temperature (°C) 
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concluded from the DSC results if MCPVP was miscible with EC. A broad endotherm 
(30 – 120 °C) was observed in the DSC thermogram from MCPVP. This was 
attributed to the presence of water absorbed from the environment as MCPVP is 
relatively hygroscopic. Addition of EC at concentration as low as 10 %w/w seemed to 
be able to effectively reduce the amount of water absorbed by MCPVP.  
The DSC thermograms of EC-PV/VA blends were similar to those of EC-PVP 
blends (Figure 24). A single endothermic transition occurring in the range of 170 -180 
°C was observed for EC-PV/VA blends with PV/VA content up to 90 percent. The 
endothermic peak gradually diminished as the PV/VA concentration increased and 
disappeared at PVP/VA content of 80 percent and above. EC-PV/VA blends in the 
ratio of 1:9 and 2:8 also presented a single endothermic transition at 98 – 100 °C 
region, close to the glass transition temperature of PV/VA. On the otherhand, two 
endothermic transitions in the regions of 175 - 178 °C and 98 – 99 °C were obtained 
for EC-PV/VA blends with the ratios of 4:6 and 3:7. This indicated that PV/VA might 
be partially miscible with EC for concentration of up to 50 percent. Compared to 
PVP, PV/VA showed lesser interaction with EC as the polymer blend was immiscible 
at a lower ratio of 3:7. 
Based on the above results, Surelease films consisting of 10 - 30 %w/w PVP, 
PV/VA and MCPVP respectively were prepared for study. Further attempts were 
made to determine any interactions between the polymeric additives and EC. 
However, the DSC thermogram of the plain Surelease film did not show any glass 
transition temperature value, probably due to the presence of other components in 
Surelease formulation. In order to study the thermal and mechanical profiles of those 
composite EC films, dynamic mechanical analysis (DMA) was employed. DMA has 
been reported to be more sensitive to macroscopic, as well as molecular relaxation 
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processes compared to other thermal analysis techniques which depend solely on 
temperature probe (Wetton et al., 1991). It is widely used to determine glass transition 
temperature and compatibility between polymers (Lafferty et al., 2002; Park et al., 
2001; Honary and Orafai, 2002). A dynamic thermal analysis profile generally shows 
3 forms of transition relaxation. The α transition relaxation, which occurs at the 
highest temperature is characterized by a large decrease in E’ and a maximum in both 
the E” and tan δ curves near the inflection point of the E’ curve.  The α transition 
occurs in the amorphous regions of the polymer with the initiation of cooperative 
micro-Brownian motion of the molecular chains (Kararli et al., 1990). Hence, α 
transition relaxation corresponds to the glass transition temperature of the polymer. β 
transition, which occurs at the second highest temperature, is thought to arise due to 
motion of side groups or smaller unit backbone chains. The γ transition is another 
transition which occurs below the β transition temperature. In this region, the main 
chain segments are frozen in and side group motion is made possible by defects in 
packing in the glassy or crystalline state. It is related to end group rotation, crystalline 
defects, backbone-chain motions of short segments or groups, and phase separation of 
impurities or diluents (Kararli et al., 1990; Murayama, 1978; Nielson, 1974; Boyer, 
1974). 
Figure 25 shows typical DMA thermograms of plain and composite EC films 
prepared from Surelease. The Surelease films without polymeric additives (EC films) 
produced only a single peak in the tan δ curve at 77.5°C (Figure 25a). This peak was 
taken to be the α transition or glass transition temperature of the film. This glass 
transition temperature was much lower than that of pure EC film (without plasticizer) 
probably due to the plasticizing effect of medium chain triglycerides in Surelease. 
Composite Surelease films with 10 - 30%w/w additives, except for PVP K90, also 
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produced a single peak in the tan δ curve, however at higher temperature (Table 14). 
Composite EC-PVP K90 film showed another smaller peak at 33 – 54 °C. Control 
using pure PVP or PV/VA films were not possible as these films were too brittle for 
DMA test. Hence it was not certain whether the smaller peak observed was due to the 
α transition of PVP polymer or β transition of EC films. As the DSC profile of pure 
PVP film sample showed that its glass transition temperature is 157°C, the small peak 
could not be attributed to α transition of PVP. Presence of any additional peak due to 
incompatibility of PVP with Surelease should appear between the glass transition 
temperatures of Surelease (77°C) and PVP (157 °C). Since all the composite 
Surelease films showed a single glass transition temperature peak in the DMA profile, 
it might be concluded that PVP, PV/VA and MCPVP were miscible with EC formed 
from Surelease at concentration of 30 %w/w or below.  
Generally, addition of PVP and MCPVP caused a 5 to 22°C increase in glass 
transition of Surelease films. The increase in glass transition temperature of composite 
Surelease films seemed to be dependent on the proportion of additives present except 
for PVP K29. Unlike the other film samples, unique sharp peaks were observed for 
loss modulus of EC-PVP K17 (9:1) and (8:2) films. The peaks occurred at much 
lower temperatures of 70.4 and 78.7 °C in comparison with those of tan δ. On the 
other hand, EC-PVP K17 (7:3) did not show such peaks in its loss modulus profile 
(Figure 25b). Both changes in loss modulus and tan δ could indicate occurrence of 
transition of polymer blend from glass to rubbery state.  It is not certain if the lower 
peak temperature peaks in loss modulus of EC-PVP K17 (9:1) and (8:2) films indicate 
a possible lower glass transition temperature than that suggested by the tan δ profiles. 
 












































Figure 25. DMA thermograms: (a) tan δ (b) loss modulus profiles of Surelease (EC) 
and EC-PVP K17 films. 
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Table 14. Glass transition temperature (Tg), film transparency and mechanical properties of Surelease (EC) and composite Surelease films. 
(mean ± S.D, n = 6, unless otherwise indicated) 
Films Tg a Estimated
T g  
Film transparency 



















EC 77.5 - 69.3 ± 2.6 3.17 ± 0.1 8.34 ± 0.8 123 ± 10 11000 ± 1100 2.58  
EC-PV/VA (9:1) 78.2 79.1 75.2 ± 0.8 3.59 ± 0.1* 6.30 ± 0.6* 179 ± 7* 8950 ± 1100 2.09* 
EC-PV/VA (8:2) 82.9 80.7 57.8 ± 1.0 3.86 ± 0.2* 7.32 ± 0.5 208 ± 7* 11700 ± 1400 1.86* 
EC-PV/VA (7:3) 92.5 82.5 45.6 ± 1.7 2.93 ± 0.1 9.53 ± 0.9 155 ± 9* 11800 ± 1100 1.81* 
EC-PVP K17 (9:1) 84.4/70.4#  81.1 51.7 ± 1.8 2.56 ± 0.1* 18.70 ± 5.5 75 ± 4* 20300 ± 6800 
3.42 
EC-PVP K17 (8:2) 91.5/78.7# 85.2 58.2 ± 0.5 1.77 ± 0.1* 15.50 ± 1.5* 85 ± 9* 12000 ± 1500 
2.11 
EC-PVP K17 (7:3) 96.3 89.9 54.4 ± 1.5 3.10 ± 0.5 4.54 ± 0.9* 171 ± 27 5380 ± 1900* 
1.81 
EC-PVP K29 (9:1) 99.7 81.1 55.2 ± 2.8 3.83 ± 0.1* 6.70 ± 1.4 198 ± 7* 10300 ± 2700 2.00* 
EC-PVP K29 (8:2) 95.7 85.2 40.9 ± 2.0 3.29 ± 0.1 13.80 ± 1.6* 155 ± 8* 20300 ± 2600* 1.85* 
EC-PVP K29 (7:3) 98.7 89.9 33.9 ± 1.5 3.87 ± 0.1* 9.44 ± 0.4 199 ± 1* 13700 ± 760* 1.94* 117
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Table 14. Glass transition temperature (Tg), film transparency and mechanical properties of Surelease (EC) and composite Surelease films. 




Tg (°C)  
Film transparency 


















EC-PVP K60 (9:1) 102.0 81.1 17.8 ± 0.5 2.22 ± 0.2* 5.04 ± 1.1* 121 ± 17 4100 ± 950* 
1.86 
EC-PVP K60 (8:2) 99.1 85.2 9.55 ± 0.1 2.37 ± 0.1* 8.27 ± 0.6 123 ± 5 7920 ± 570* 
1.92 
EC-PVP K60 (7:3) 102.2 89.9 8.17 ± 0.7 2.28 ± 0.2* 10.40 ± 2.2 119 ± 16 9910 ± 2700 
1.93 
EC-PVP K90 (9:1) 96.6 81.1 28.8 ± 4.6 3.22 ± 0.2 9.70 ± 1.6 155 ± 12* 13200 ± 2700 1.93* 
EC-PVP K90 (8:2) 97.6 85.2 8.01 ± 1.9 3.95 ± 0.1* 10.60 ± 3.0 212 ± 10* 18300 ± 5500 2.11* 
EC-PVP K90 (7:3) 99.4 89.9 2.14 ± 1.5 4.03 ± 0.1* 4.93 ± 0.9* 222 ± 12* 7510 ± 780* 1.88* 
EC-MCPVP (9:1) 82.7 82.1 7.33 ± 1.1 2.29 ± 0.2* 5.73 ± 2.3 111 ± 6 4530 ± 3000 2.07* 
EC-MCPVP (8:2) 94.6 87.4 7.50 ± 2.1 3.21 ± 0.2 5.31 ± 1.3* 178 ± 6* 6730 ± 2200 1.80* 
EC-MCPVP (7:3) 98.6 93.3 3.91 ± 0.1 3.27 ± 0.6 6.03 ± 3.9 188 ± 11* 8690 ± 6900 1.73* 
a n = 1, value obtained from maxima of tan δ unless otherwise stated, bn = 3, *significant at p < 0.05 compared to EC film, # values obtained 
from loss modulus
118
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The glass transition temperature values of polymer blends may be predicted by 
the Gordon Taylor equation if they are dependent on the polymer composition (Nair 
et al., 2001). This equation is based on the additivity of free volumes of the individual 
components characteristic of ideal mixing (Gordon and Taylor, 1952). It can be 
expressed as: 
Tg12 = (w1Tg1 + Kw2Tg2)/ (w1 + Kw2)      (47) 
 
where Tg12 is the glass transition temperature of the polymer blend. w1, w2, Tg1 and  
Tg2 are the weight fractions and glass transition temperatures of the polymers. The 
constant, K, is a measure of interaction between the components and can be estimated 
using the following equation (Simha and Boyer, 1962): 
K = ρ1Tg1/ ρ2 Tg2        (48) 
 
where ρ1 and ρ2 refer to the true densities of the components. 
The glass transition temperature values of the composite Surelease films were 
calculated using the Gordon Taylor equation (Table 13). The difference between the 
actual and estimated glass transition temperature values suggested deviation from 
ideal behaviour, which was often attributed to differences in strength of 
intermolecular interactions between individual components and those of the blend. 
The glass transition temperature will be higher than expected if the two polymers bind 
more strongly to each other than to themselves. This is because stronger binding 
lowers chain mobility. In contrast, if the polymers bind less strongly to each other 
than to themselves, the glass transition temperatures of the blends are usually lower 
than expected. All the experimentally determined glass transition temperature values 
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of composite Surelease films were higher than the calculated values, suggesting than 
Surelease interacted strongly with the additives.  
Among the additives, PV/VA generally resulted in the least increase in glass 
transition temperature of Surelease films, followed by MCPVP and PVP. In order for 
the polymers to form compatible blends, favorable intermolecular interactions must 
occur between the different polymer chains (Hale and Blair, 1997). These interactions 
should result in a negative free energy of mixing which can be expressed by equation 
8. As the entropy of mixing in polymeric blends is small, the enthalpy of mixing is the 
primary factor determining the miscibilities of components. A negative enthalpy of 
mixing can be produced by specific interactions between the constituent polymers, 
such as hydrogen bonding. Taylor and Zografi (1998) had reported that interaction by 
hydrogen bonding could occur in a mixture of amorphous oligosaccharides and PVP 
via the sugar hydroxyl groups and the proton-accepting carbonyl moieties in the 
pyrrolidone rings of PVP polymer chains. Since EC is a partially substituted 
polysaccharide with unsubstituted hydroxyl groups on the cellulose chains, it is likely 
that EC interacts with PVP in a similar manner (Nishio et al., 1990). 
Glass transition temperature may also be a useful parameter for determining 
the efficiency of plasticizers. Dechesne et al., (1984) reported that addition of 
plasticizers to acrylic resin copolymers lowered glass transition temperature. The 
magnitude of change was found to be dependent on the quantity and type of 
plasticizer used. In this study, the increase in glass transition temperature values by 
the addition of PVP (except PVP K17), MCPVP and PV/VA showed that these 
additives had no typical plasticizing effect on Surelease films. In contrast, when 
present in small amounts (10 – 20 percent), PVP K17 resulted in slight depression of 
glass transition temperature values of the composite Surelease films. This indicated 
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that PVP K17 might be capable of acting as a plasticizer when added in small amount 
to Surelease. 
 
B.  Film morphology 
Figure 26 shows the light microscope images of Surelease and composite 
Surelease films. The control Surelease films appeared smooth and relatively 
transparent with transmittance of 69.3 percent. A 25 percent drop in transmittance of 
Surelease film was observed with the addition of PVP K17 (Figure 27). The reduction 
in transmittance was independent of the concentration of PVP K17 (10 to 30 %w/w) 




(a)               (b) 
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Figure 26. Light microscope images of Surelease (EC) and composite Surelease films 
(40x magnification): (a) EC, (b) EC-PVP K17 (9:1), (c) EC-PVP K29 (9:1), (d) EC-















































































Figure 27. Effect of type and concentration of polymeric additives on the film 
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Addition of PVP K29 resulted in 20 to 51 percent reduction in film 
transparency. Unlike, PVP K17, greater reduction in transmittance was obtained with 
higher concentrations of PVP K29. Films containing PVP K60 and K90 were much 
less transparent. Addition of 10 %w/w PVP K90 reduced the film transparency by 58 
percent and almost opaque films, with a transmittance of only 2.14 percent, were 
obtained with 30 %w/w K90. Similarly, MCPVP drastically reduced the transparency 
of Surelease films. As the above additives vary in molecular weights, the results 
suggested that molecular size of PVP might play an important role affecting the 
clarity of the films. 
In composite polymer films, the major constituent generally forms the 
continuous phase while the minor component if insoluble, is dispersed as discrete 
individual entities, often spherical. For example, blends of EC and 
hydroxypropylmethyl cellulose exhibit single layer morphology with the minor 
polymer dispersed in the major one (Sakellariou et al., 1993). Incompatibility between 
two polymers could be manifested as the separation of film layers. In one study, 
composite EC-cellulose acetate phthalate (1:1) films were found to separate into two 
distinct layers, with EC rich layer on top and cellulose acetate phthalate rich layer 
below (Sakellariou et al., 1991). Light microscope image of Surelease film showed a 
continuous, homogeneous layer with predominantly circular inclusions (Figure 26a). 
With the addition of low molecular weight PVPs (K17 and K29), small circular 
randomly dispersed crevices were found throughout the film layer (Figures 26b and 
c). Increasing the concentration of PVP K17 or K29 resulted in greater number of 
crevices, as well as slight increase in size of the crevices. Hence, it was thought that 
the crevices could be attributed to the presence of PVP K17 or K29 randomly 
dispersed throughout the Surelease matrix. Similar observation was seen for films 
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Figure 28. Models of interaction between PVP, MCPVP or PV/VA with Surelease 
(EC): (a) continuous phase of EC film without polymeric additives (b) minor 
component existing as random spheres/crevices in the continuous phase of EC (c) 
minor component existing as random spheres/crevices of larger size in the continuous 
phase of EC (d) minor component forming a separate continuous phase (e) overcoat 
of one continuous phase over another. 
 
with a low amount (10 %) of higher molecular weight PVPs (K60 and K90) (Figure 
26d). However, with greater amount of PVP K60 (30 %w/w) or PVP K90 (20 %w/w), 
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a separate irregular network-like layer was prominently exhibited above a less 
obvious layer. At even higher concentration of PVP K60 or K90, the composite 
Surelease films appeared as a dense layer with several small holes. This suggested 
that at concentration of 20 %w/w or more, higher molecular weight PVPs aggregated 
together to form a separate phase during film drying. A similar irregular network-like 
layer was seen for composite EC-MCPVP films with MCPVP concentration as low as 
10%. At higher concentrations of MCPVP, the composite EC films became denser 
and similar findings were obtained for EC-PVP K90 films.  
Results based on visual appearance and transparency of the film suggested that 
high concentration of large molecular weight polymers, such as PVP and MCPVP, 
were not fully miscible with Surelease. At a high concentration, the large molecular 
weight polymer had a tendency to separate out during the drying process, forming the 
upper layer of the film. In contrast, the polymer in low concentrations formed a 
homogeneous layer with the polymer interspersed in the EC matrix. Higher molecular 
weight PVP at low concentrations produced a greater observable effect than lower 
molecular weight PVP at high concentrations. EC-PV/VA (9:1) films were smooth. 
Similarly, as the amount of PV/VA increased, a separate irregular network-like layer 
was observed, particularly at 30 %w/w. This suggested that PV/VA at low 
concentration was miscible with EC, forming homogeneous and smooth films. 
However, beyond a threshold concentration, PV/VA aggregated to form a separate 
layer. 
Based on the above observation, models for interaction between Surelease and 
PVP, MCPVP or PV/VA were postulated (Figure 28). The interaction between 
Surelease and PVP polymeric additives was found to be dependent on the molecular 
weight, concentration and chemical nature of the additives. When added to Surelease, 
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low molecular weight PVP was randomly distributed in the Surelease matrix as shown 
in Figure 28b. As the concentration of polymeric additives increased, low molecular 
weight PVP remained as a disperse phase in the form of a large number of vescicles in 
the continuous Surelease phase (Figure 28c). The vescicles increased in size by the 
fusion of adjacent vesicicles. On the otherhand, interaction between Surelease and 
higher molecular weights PVP was more pronounced. At a low concentration, higher 
molecular weight PVP existed as a disperse phase in Surelease matrix (Figure 28c). 
However, as the concentration increased, the higher molecular weight additive tended 
to aggregate to form a continuous separate phase (Figure 28d). Formation of a 
continuous separate layer became more prominent with increasing concentration as 
indicated by huge patches or coat above the main film layer (Figure 28e). Increased 
molecular weight of additives accelerated the phase separation. When the molecular 
weight is high, a continuous separate phase may be formed even at low concentration 
of 10 %w/w, as in the case of MCPVP. 
 
C.  Mechanical properties - tensile test 
The stability of a film coat and its ability to withstand physical stress is of 
major concern to the formulator. Film hardness, toughness and extendability are 
desired mechanical characteristics of a polymer (Mauger, 1999; Aulton et al., 1984). 
Many studies have shown that the occurrence of adhesion and cohesion related film 
coating defects are mainly due to the building up of internal stresses within the film 
coat (Rowe, 1981, 1992). These internal stresses have been shown to be due to  
i. shrinkage of film after its solidification point as solvent continues to 
evaporate from the system (Croll et al., 1979);  
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ii. difference between thermal expansion coefficients of film coat and 
substrate, and difference between glass transition temperature of film coat 
and actual temperature of film at any time (Sato et al., 1980); and 
iii. any volumetric changes in tablet core during coating and subsequent 
storage (Rowe, 1983; Okutgen et al., 1991). 
When the total internal stress exceeds the tensile strength of the film, defects such as 
cracking, edge splitting and peeling can occur. Hence, polymeric films with high 
tensile strength may be able to withstand the internal stresses better and are less likely 
to result in film defects. Commercial EC pseudolatexes were found to produce rigid 
and brittle films, thus impairing the stress resistance of EC coating (Bodmeier and 
Paeratakul, 1994). This property is undesirable in applications where coating of high 
flexibility and toughness is required, for example in tablets compressed from coated 
beads or cores with deep logos and break lines. Therefore, it is important to 
investigate if the addition of polymeric additives has any effect on the mechanical 
property of EC films. 
Table 14 shows the mechanical properties of Surelease and composite 
Surelease films. EC films formed from aqueous dispersions were found to be weaker 
and more brittle than those prepared using organic solvents, probably due to different 
mechanisms of film formation (Tarvainen et al., 2003). Except for PVP K17 and K60, 
the addition of PVP increased the tensile strength of composite Surelease films 
slightly. Tensile strength of composite Surelease films increased slightly with 
increasing content of PVP K90. In contrast, the increase in tensile strength of EC-PVP 
K29 films did not appear to be dependent on the concentration of PVP K29. 
Composite EC films containing PVP K17 and K60 showed significantly lower tensile 
strength compared to Surelesae films. In fact, the tensile strength of composite 
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Surelease film containing 10 %w/w PVP K17 was almost 50 percent lower than that 
of Surelease film. Addition of PVP K17 also affected that percentage elongation at 
break of Surelease film significantly. Presence of PVP K17 up to 20 %w/w made 
Surelease film more flexible with a higher percentage elongation at break. However, 
with 30 %w/w PVP K17, the Surelease film become much less flexible as the 
percentage elongation at break value dropped to 4.54. Similar trend was also observed 
for the hardness of composite EC-PVP K17 films, with significant drop in elastic 
modulus when 10 to 20 %w/w PVP K17 was added to Surelease films. These 
observations suggested that PVP K17 at low concentration (≤ 20 %w/w) has a 
plasticizing effect on Surelease film. 
The addition of PVP of higher molecular weight than PVP K17 did not affect 
the percentage elongation at break of Surelease films, except for films containing 20 
%w/w PVP K29 and 30 %w/w PVP K90. EC-PVP K90 (7:3) film was comparatively 
more brittle than EC film, as shown by its significantly lower percentage elongation 
value. Unlike EC-PVP K17 films, all the rest of EC-PVP films showed significantly 
higher elastic modulus values than the EC film. Addition of 10 – 20 %w/w PVP K90 
caused the elastic modulus of EC films to increase by 26 - 72 percent. However, 
further increase in PVP K90 content to 30 %w/w did not result in further significant 
rise in elastic modulus. 
The increase in elastic modulus and tensile strength indicated that the addition 
of PVP increased the hardness of Surelease film. EC film is rigid by nature, due to the 
bulky glucose subunits of the polymer, as well as the alkyl substituents serving as 
sites for potential inter- and intramolecular interactions (Sakellariou and Rowe, 1995; 
Bodmeier and Paeratakul, 1994). PVP is also a large molecule consisting of polar 
imide group, four non-polar methylene groups and a methane group.  Hence, these 
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molecules can interact through dipole-dipole attraction and form hard and clear films 
(Barabas, 1989). Moreover, the ether and hydroxyl groups of EC could also interact 
with the imide and carbonyl groups of PVP via hydrogen bonding. These interactions 
may also enhance the strength of the composite films.  
Interestingly, when MCPVP was added to Surelease, the tensile strength 
decreased or remained unchanged while the percentage elongation at break dropped to 
5.3. Addition of 10 %w/w MCPVP did not result in significant change in elastic 
modulus. However, the elastic modulus increased significantly when the amount of 
MCPVP was increased to 20 %w/w or higher. The increase in elastic modulus of EC-
MCPVP was comparatively smaller than that of EC-PVP K90 films. Although 
MCPVP has a higher molecular weight than PVP K90, it has less sites available for 
inter-molecular interaction due to internal cross-linking. This probably explained the 
above observations. The EC-MCPVP films, at all concentrations of MCPVP, were 
also less flexible and more brittle than Surelease films. This suggested that some 
MCPVP molecules had interposed among the EC rich region. Being large in size, the 
interposed MCPVP would weaken the intermolecular bonding between the EC chains, 
causing the film to be more brittle. However, larger amounts of MCPVP enabled the 
formation of MCPVP rich region above the EC layer, thereby forming a dense film. 
The intermolecular bonding between MCPVP molecules was probably greater than 
those between EC and MCPVP, resulting in slightly harder and tougher films. 
Addition of PV/VA increased the tensile strength and elastic modulus of the 
film. Beyond 20 %w/w of PV/VA, the films showed lower tensile strength, elastic 
modulus and work of failure. PV/VA which has similar molecular weight as PVP 
K29, is less hygroscopic than PVP, due to its vinyl acetate co-polymer. In addition to 
the polar imide and carbonyl groups of its N-vinyl-2-pyrrolidone component, PV/VA 
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also has a carbonyl group from its vinyl acetate co-polymer, which can participate in 
intermolecular hydrogen bonding. Therefore, PV/VA would likely interact to a greater 
extent with EC, forming stronger films than PVP K29. However, this was not 
reflected in the tensile strength and elastic modulus values of EC-PV/VA films, which 
were comparable to those of EC-PVP K29 films.  
The incidence of cracking or edge splitting was employed as a measure of 
mechanical properties of film coatings applied to tablets (Row, 1981; Okhamafe and 
York, 1987). The occurrence of film coating defects has been associated with the 
magnitude of internal stress in the film. Rowe (1983) suggested that the overall 
internal stress, P, in a film coat can be represented as follows: 
P = EM/3(1-v)[(φs - φr)/(1- φr) + ∆αcubic ∆T]     (49) 
 
where EM is the Young’s modulus of the film, v its Poisson’s ratio, φs the volume 
fraction of solvent at the solidification point of the coating formulation, φr the volume 
fraction of solvent remaining in the dry film at ambient conditions, ∆αcubic the 
difference between the thermal cubical expansion coefficients of the coating and the 
tablet core and ∆T the difference between the glass transition temperature of the 
coating and the ambient temperature. Cracking will occur if P is greater than or equal 
to the tensile strength, τ, of the film (Sato, 1980) 
P ≥ τ          (50) 
 
Combining and rearranging both equations, cracking will occur if: 
τ /EM ≤ 1/3(1-v)[(φs - φr)/(1- φr) + ∆αcubic ∆T]    (51) 
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Hence, τ/EM may be used to predict the incidence of edge splitting of a film coat 
(Rowe, 1981). The larger its value, the higher the stress crack resistance of a film. In 
this study, the Surelease films without additives showed the highest value of 0.0258. 
Addition of PVP, MCPVP and PV/VA caused a significant drop in the ratio to 
varying extent. Hence, there was a limit to the concentration of additives that could be 
added to Surelease in order not to compromise the stress crack resistance of the 
resultant film. The lowest τ/EM value was obtained for EC-MCPVP (7:3) films, 
suggesting that MCPVP might cause greater impairment to flexibility of Surelease 
films particularly at concentrations greater than 10 %w/w.  
 
D.  Mechanical properties - puncture test  
Film coatings may be applied to particles that will be compressed into tablets. 
Hence, they should have the required resistance to damage caused by compression. 
Radebaugh et al., (1988) has reported a new device which can determine the process 
of puncture on polymeric films directly. It measures the resistance of a film sample, 
which is mounted on a fixed holder, to deformation with a puncturing probe attached 
to a force transducer. Due to its design, this device also enables the study of wet film 
samples, which is difficult to evaluate using the tensile tester. The mechanical 
properties of wet films under puncture stress are useful for predicting how polymeric 
films would behave during dissolution studies or under in vivo conditions (Remunan-
Lopez et al., 1997). 
Two parameters, puncture strength and percentage elongation, were derived 
from the load - displacement profiles (Table 15). When the Surelease films were 
soaked in water for 24 h at 37 °C, the puncture strength only decreased slightly from 
0.378 to 0.332, while a big increase in the percentage elongation was observed from  
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Table 15. Mechanical properties of dry and wet Surelease (EC) and composite EC 
films. (mean ± S.D, n = 4) 
Puncture strength (N/mm2) % elongation Films 
Dry Wet Dry Wet 
 
EC 0.378 ± 0.00 0.332 ± 0.03 0.192 ± 0.06 0.821 ± 0.28 
EC-PV/VA (9:1) 0.182 ± 0.01 0.192 ± 0.03 0.079 ± 0.02 0.481 ± 0.20 
EC-PV/VA (8:2) 0.458 ± 0.02 0.286 ± 0.03 0.056 ± 0.00 2.170 ± 0.58* 
EC-PV/VA (7:3) 0.839 ± 0.09 0.432 ± 0.04 0.258 ± 0.07 1.380 ± 0.45* 
EC-PVP K17 (9:1) 0.265 ± 0.00* 0.135 ± 0.04 0.159 ± 0.03 0.136 ± 0.01* 
EC-PVP K17 (8:2) 0.317 ± 0.01 0.184 ± 0.03 0.297 ± 0.06 0.262 ± 0.02* 
EC-PVP K17 (7:3) 0.376 ± 0.02* 0.169 ± 0.02 0.198 ± 0.03 0.143 ± 0.04* 
EC-PVP K29 (9:1) 0.531 ± 0.02* 0.322 ± 0.03 0.184 ± 0.01* 1.470 ± 0.08 
EC-PVP K29 (8:2) 0.410 ± 0.02* 0.152 ± 0.02 0.122 ± 0.02 0.189 ± 0.02* 
EC-PVP K29 (7:3) 0.983 ± 0.20 0.231 ± 0.06 0.280 ± 0.15 0.570 ± 0.61 
EC-PVP K60 (9:1) 0.396 ± 0.05 0.145 ± 0.02 0.162 ± 0.05* 0.272 ± 0.15 
EC-PVP K60 (8:2) 0.558 ± 0.06 0.130 ± 0.01 0.272 ± 0.03* 0.195 ± 0.02* 
EC-PVP K60 (7:3) 0.607 ± 0.06 0.109 ± 0.00 0.280 ± 0.04* 0.180 ± 0.05* 
EC-PVP K90 (9:1) 0.298 ± 0.04* 0.164 ± 0.01 0.159 ± 0.01* 0.230 ± 0.02 
EC-PVP K90 (8:2) 0.434 ± 0.02* 0.156 ± 0.04 0.136 ± 0.02* 0.203 ± 0.09* 
EC-PVP K90 (7:3) 0.666 ± 0.11 0.102 ± 0.02 0.254 ± 0.03* 0.170 ± 0.06* 
EC-MCPVP (9:1) 0.267 ± 0.01* 0.201 ± 0.02 0.144 ± 0.02* 0.553 ± 0.21 
EC-MCPVP (8:2) 0.470 ± 0.07* 0.093 ± 0.01 0.172 ± 0.01* 0.245 ± 0.05* 
EC-MCPVP (7:3) 0.824 ± 0.04 0.047 ± 0.01 0.374 ± 0.09* 0.809 ± 0.12* 
*significant at p < 0.05 compared to EC film 
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0.192 to 0.821.  
This showed that water has a plasticizing effect on Surelease film, resulting in 
films with greater flexibility upon wetting. Addition of PVP, except for PVP K17 and 
10 %w/w PVP K90, increased the puncture strength of dry Surelease films. The 
increase in puncture strength appeared to be related to the amount of PVP added, with 
greater increase observed with a higher concentration of PVP. The influence of 
concentration of PVP on the percentage elongation of dry Surelease films was less 
obvious as the values fluctuated. 
Nevertheless, addition of 30 %w/w PVP generally resulted in the highest 
percentage elongation for dry Surelease films. On the contrary, opposite trend was 
observed for wet EC-PVP films. Except for PVP K17, the highest puncture strength 
and percentage elongation were obtained for wet composite EC-PVP containing the 
lowest concentration of PVP and increasing amount of PVP generally decreased the 
puncture strength and percentage elongation. 
The results from puncture test of dry Surelease films were similar to those 
obtained from tensile test. Both tests showed that the composite films became harder 
with the addition of PVP. However, Surelease films containing PVP K17 showed a 
slight drop in puncture strength and increase in percentage elongation. These 
observations suggested that PVP K17 might have some plasticizing effect on 
Surelease films as discussed earlier.  
The mechanical properties of wet EC-PVP films provided additional insight 
into the structural arrangement between EC and PVP. When soaked in water for 24 h, 
the water-soluble PVP that was interspersed within the EC matrix dissolved forming 
crevices filled with water. This largely weakened the EC matrix and resulted in 
decrease in puncture strength and percentage elongation. PVP K90 exerted a greater 
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weakening effect on EC matrix than PVP K29, as shown by the lower puncture 
strength and percentage elongation of corresponding wet EC-PVP K90 films. 
The above phenomenon was also observed for both dry and wet composite 
EC-MCPVP films. However, increasing PV/VA concentration resulted in increasing 
puncture strength and percentage elongation for both dry and wet films. Addition of 
10 %w/w PV/VA reduced the puncture strength and percentage elongation of the dry 
and wet films by 40 to 60 percent. With greater amounts of PV/VA, the puncture 
strength of composite EC-PV/VA films increased to as high as 0.839 N/mm2 when 
dry and 0.432 N/mm2 when wet. The percentage elongation of wet EC-PV/VA films 
also increased to almost two-fold suggesting that the wet EC-PV/VA films were more 
‘intact’ or compact, allowing the water molecules to be retained in the matrix where 
they exerted a plasticizing effect.  
It was also noted that with 30 %w/w of additives, puncture strength of dry 
composite EC films decrease in the following order: EC-PVP K29 >EC-PV/VA > 
EC-MCPVP > EC-PVP K90 > EC-PVP K60 > EC-PVP K17. In contrast, the 
puncture strength of wet composite EC films generally decreased in the following 
order: EC-PV/VA > EC-PVP K29 > EC-PVP K17 > EC-PVP K60 > EC-PVP K90 > 
EC-MCPVP. As discussed earlier, MCPVP in high concentration probably formed a 
separate layer above the EC matrix. When the composite film was soaked in water, 
MCPVP which was soluble in water, would dissolve, leaving behind a thin and weak 
EC matrix. All composite EC films except for those containing 30 %w/w PV/VA, had 
lower puncture strengths than EC films when soaked in water for 24 h. 
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E.  Water vapour permeability 
Ethylcellulose is barely soluble in water and its film has been shown to have 
low moisture permeability (Rekhi et al., 1995). This property of EC has made it 
useful in formulation of dosage forms consisting of moisture sensitive ingredients. In 
this connection, drug particles, pellets and tablets have been coated with EC to 
prevent moisture absorption. However, water vapour permeability of film may vary, 
depending on the film preparation method, drying temperature, type and amount of 
additives included (Sun et al., 1999) as well as the storage conditions employed (Guo 
et al., 1993). Conflicting findings were reported in some cases (Macleod, 1997) and 
hence it is of practical importance to determine if addition of PVP and its derivatives, 
which are hydrophilic, will affect the water vapour permeability of EC films.  
EC film prepared from Surelease has a low water vapour permeability 
coefficient value of 1.75 g/h/cm per mmHg. The film permeability to water vapour 
remained low in the presence of small amount (10 %w/w) of low molecular weight 
PVPs (K17 and K29). Addition of higher molecular weight PVPs (K60, K90 or 
MCPVP) to EC, however caused a 30 - 70 percent rise in permeability to water 
vapour (Figure 29). The amount of PVP affected film permeability to different extents. 
Increasing amount of low molecular weight PVPs generally increased film 
permeability proportionally while the effects of high molecular weight PVPs were 
less dependent on concentration. Except for EC-PVP K17, the water vapour 
permeabilities of composite Surelease films with higher concentrations of additives 
(20 and 30 percent) were comparable, regardless of the molecular weight of PVP. The 
above observations indicated that the effect of molecular weight of PVP was more  
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Figure 29. Water vapour permeability of Surelease (EC) and composite EC films (n = 
3) 
 
significant at low concentration. The effect was notably lessened for PVPs with 
molecular weight greater than 8, 000 when added at higher amount.   
Several explanations have been proposed for change in water vapour 
permeability observed with inclusion of an additive (Macleod et al., 1997; Molina et 
al., 2003; Kester and Fennema, 1986, Greener and Fennema, 1989 and Martin-Polo et 
al., 1992). These include water sorption of film via formation of hydrogen bonding 
between water and hydrophilic region of the polymer, and alteration of film structure 
resulting in increased porosity (Macleod et al., 1997; Molina et al., 2003). The 
inclusion of PVP, which is hygroscopic, could facilitate the water sorption by EC film 
via formation of hydrogen bonding between water and polar domains on PVP as well 
as EC matrix. Increasing molecular weight and amount of PVP provided more polar 
sites for interaction with water molecules, leading to increased film permeability to 
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comparable permeability constant as PVP K90, despite possessing higher molecular 
weight. Notably, the cross-linking of PVP homopolymer in MCPVP had reduced the 
number of sites available for interaction with water. 
Similarly, addition of PV/VA of comparable molecular weight as PVP K29, 
decreased the permeability of film to water vapour (Figure 29). The vinyl acetate 
monomer which is known to reduce the hygroscopicity of PVP, is the most likely 
reason for this observation. Though EC-PV/VA films had relatively higher 
permeability than EC-PVP K17 films, the rate of increase in permeability was slightly 
lower for EC-PV/VA. In the practical application of EC films as a protective moisture 
barrier, the type or molecular weight as well as amount of PVP added should be 
carefully selected and controlled. In general, low molecular weight PVP, such as K17 
and K29, or PV/VA at low concentration are recommended as they did not 
compromise on water vapour permeability of the EC films. 
 
F.  Drug permeability 
Diffusion processes are central to drug delivery. They are particularly 
important in the release of drugs from controlled release devices, dissolution of tablets 
and particles and transport of drugs across biological barriers within the body. Hence, 
characterization of diffusion properties of a drug delivery system will provide useful 
information for formulation of controlled drug delivery systems. Two-chamber 
diffusion cells are most commonly used to determine diffusion coefficients in the 
study of drug transport across diffusion barrier.  
Two of the most important factors that affect diffusion in water - swellable 
polymeric matrices are the physicochemical properties of the drugs and the polymer 
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membranes (Sung et al., 1995). Many theories have been proposed for solute 
diffusion through such membranes (Yasuda et al., 1971; Zentner et al., 1979). The 
‘free volume’ theory, which has a wider acceptance, postulates that the solute diffuses 
within the hydrated polymer matrix through the fluctuating pores or channels inside 
the hydrated matrix. These free volumes are not occupied by the polymer backbone 
but constitue an integral part of the bulk volume of the polymer matrix. Free volume 
theory has proven to be applicable in describing the penetration of hydrophilic solutes 
in hydrogels, but less so for hydrophobic solutes which exhibit significant polymer-
solute interaction. Free volume theory presupposes that solute diffusion in hydrated 
polymer membranes occurs in the largely aqueous free volume surrounding the 
fluctuating polymer chains. Some researchers have however, reported another 
possible diffusion pathway for hydrophobic solutes, which is through the relatively 
non-hydrated polymer segments (Zentner et al., 1979). Diffusion through this 
pathway involves the dissolution and diffusion of hydrophobic solute within the 
polymer domain. In situation where both mechanisms are possible, the non-hydrated 
polymer segment would be expected to become an important diffusion pathway if a 
greater concentration of solute dissolves in this region. 
  
1.  Effect of polymer additives on drug permeability 
Generally, a membrane can be classified as a continuous, shunt or dispersed 
type (Flynn et al., 1974). The continuous type consists of a membrane that is 
uninterrupted between its 2 surfaces, as well as in the plane perpendicular to the flux 
vector. It may provide an uninterrupted diffusional path for a diffusing species or 
constitute an impervious supporting structure, depending on its composition. The 
shunt type consists of a membrane that is laterally discontinuous due to the presence 
RESULTS AND DISCUSSION 
139 
of pores or channels. It can be impermeable to the permeant or provide parallel 
diffusional pathways, depending on its composition. The dispersed type consists of 
one polymer phase embedded in a continuous or shunt phase. It is discontinuous along 
the flux vector and does not provide an uninterrupted pathway through the membrane 
or through any of its subphases. The mechanism of drug release from membrane-
controlled drug delivery systems depends on the composition and type of membrane 
(Ozturk et al., 1990; Narisawa et al., 1994). Presence of plasticizers or/and water-
soluble additives can modify the pathway of drug diffusion by providing alternative 
routes of diffusion through the shunt rather than the continuous phase. 
Ethylcellulose films cast from Surelease, with an average thickness of 200 µm 
is practically impermeable to all the model drugs used in this study, except for 
sulphanilamide (Tables 16 and 17). The presence of plasticizer, medium chain 
triglycerides, did not increase the permeability of Surelease film. This implied that 
any primary shunts (pores) present were simply too small for effective diffusion of 
drugs. A typical permeation profile of composite Surelease films is shown in Figure 
30.  
Generally, the drug permeability profile consisted of two stages – an initial 
slow release usually up to 120 min followed by a linear trend after 180 min. The 
permeability coefficient was calculated from the diffusion profile at 300 min onwards 
(Table 16). The similar permeability constants and correlation coefficient calculated 
from both the steady state and quasi-steady model suggested that sink condition and 
constant drug concentration gradient were maintained throughout the study. The type 
and concentration of additive affected the permeability of Surelease films to 
chlorpheniramine to different extents. Low molecular weight additives PVP, such as 
PVP K17, did not cause significant increase in permeability even when presented in 
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high concentration of 30 %w/w. In contrast, high molecular weight MCPVP caused a 
significant increase in permeability at concentration as low as 10 %w/w. The varying 
Table 16. Permeability and correlation coefficients of Surelease (EC) and composite 
EC films to chlorpheniramine (n = 3).  
Films Drug permeability 
coefficient1 × 10-10  
(cm2/s) 
Drug permeability 
coefficient 2 × 10-10  
(cm2/s) 
r12 r22 
EC - - - - 
EC-PV/VA (9:1) - - - - 
EC-PV/VA (8:2) - - - - 
EC-PV/VA (7:3) 396 ± 27 387 ± 26 0.980 0.979 
EC-PVP K29 (9:1) - - - - 
EC-PVP K29 (8:2) - - - - 
EC-PVP K29 (7:3) 860 ± 58 848 ± 60 0.983 0.980 
EC-PVP K90 (9:1) 38.7 ± 5.9 37.8 ± 5.9 0.988 0.987 
EC-PVP K90 (8:2) 849 ± 93 964 ± 32 0.930 0.967 
EC-PVP K90 (7:3) 2680 ± 250 2700 ± 240 0.991 0.991 
EC-MCPVP (9:1) 186 ± 16 181 ± 16 0.995 0.994 
EC-MCPVP (8:2) 1380 ± 150 944 ± 150 0.994 0.993 
EC-MCPVP (7:3) 3660 ± 220 3720 ± 240 0.995 0.994 
EC-PVP K60 (7:3) 1560 ± 90 1368 ± 141 0.980 0.979 
1 calculated from equation 42 
2 calculated from equation 44 
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Table 17. Drug permeability coefficients of Surelease (EC) and composite EC films 
(n=3) 
Drug permeability coefficient × 10-10 (cm2/s) Drugs 







Propranolol - 0.796 ± 0.015 66.4 ± 2.9 86.2 ± 6.4 1030 ± 150 
Sulphanilamide 19.0 ± 0.55 221 ± 23 202 ± 22 1240 ± 480 4270 ± 280 
Sulphaguanidine - 35.0 ± 3.6 51.4 ± 4.2 474 ± 140 4210 ± 220 
Theophylline - 29.6 ± 2.5 33.1 ± 2.2 433 ± 110 570 ± 48 
Metformin - 68.5 ± 1.5 74.4 ± 6.6 3570 ± 670 5350 ± 110 
Verapamil - 220 ± 8.1 237 ± 14 303 ± 32 1040 ± 6.2 

































) EC-PV/VA (7:3) EC-PVP K29 (7:3) EC-PVP K90 (7:3)
EC-MCPVP (7:3) EC-PVP K60 (7:3)
 
Figure 30. Permeation profiles of composite Surelease (EC) films to 
chlorpheniramine. 
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chlorpheniramine permeability of composite EC films containing PVP K29, K60 and 
K90 implied that the molecular weight of PVP played an important role in diffusion 
of drug through the composite EC films (Table 16). At 30 %w/w level, a linear 
relationship between the permeability of composite EC films containing PVP or 
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Figure 31. Relationship between permeability coefficient and molecular weight of 
PVP. 
 
analysis showed that this relationship is significant at p < 0.01, with a Pearson 
correlation coefficient of 0.988. 
At 30 %w/w of additives, the lowest permeability coefficient was obtained for 
PV/VA, followed by PVP K29, PVP K60, PVP K90 and MCPVP. Interestingly, the 
drug permeability of EC-PV/VA film is less than half the EC-PVP K29 film, even 
though their molecular weights are similar. In their study, Donbrow and Friedman 
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(1975) proposed that hydrophilic polymers could increase the permeability of 
hydrophobic films by the following mechanisms: 
• by altering the polymer configuration, proportion of crystalline to amorphous 
regions and hydrophilicity of the film; 
• by increasing film porosity; 
• by forming capillaries or a hydrated network giving direct connection between 
the two sides of the film; and 
• by interactions with penetrants to form complexes that have increased 
membrane solubility or diffusion coefficient. 
Based on the findings of other researchers, swelling of PVP and formation of water-
filled pores in insoluble EC matrix would probably enhance drug release (Donbrow 
and Friedman 1975; Rowe et al., 1986). It was not certain if all PVP present in EC 
film would completely dissolve in aqueous medium, thereby creating channels or 
pores for more rapid drug diffusion. Alternatively, some of PVP might be partly 
retained in the film matrix, resulting in greater water uptake by the film. Swelling test 
was carried out to investigate the extent and effect of swelling of different composite 
EC films on drug permeability. The extractable amounts (EXC) from composite EC 
films over time were calculated to give an indication of any change in porosity as the 
films came into contact with the dissolution medium.  The ability of film matrix in  
absorbing water was demonstrated by its average swelling index. 
A sharp rise in EXC values was observed for EC and composite EC films 
within 5 min (Figure 32a). The EXC values leveled off at around 9.0 percent after 5 
min for EC film. The extractable amount for EC film formed from Surelease was 
swelling profile of EC-PV/VA films closely resembled that of EC film with a slightly 
higher rate of swelling in the first hour. This implies that addition of PV/VA to EC 
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film did not result in significant change in the amount water it could absorb. Addition 
of PV/VA however resulted in increased permeability of EC film to all the model 
drugs studied (Table 17). This increase in drug permeability was attributed to the 
more porous film arising from dissolution of PV/VA. Light microscope images of 
wetted composite EC-PV/VA film showed irregular small pore-like structures (Figure 
33a). Increase in porosity, which is equivalent to decrease in effective thickness was 
found to be the mechanism behind the increased in the permeability of EC films 
containing polyethylene glycol (Donbrow et al., 1975). 
The EXC value for EC-PVP K29 films increased to a maximum of 15.6 
percent after 20 min while those of EC-PVP K60 and EC-PVP K90 rose more 
gradually to a maximum of 24.6 percent and 26.2 percent respectively at 60 min. On 
the other hand, EC-PVP films, in particular those containing higher molecular weight 
PVP had much greater swelling than EC or EC-PV/VA films (Figure 32b). The high 
EXC and swelling index values indicated that the permeability property of composite 
EC-PVP film were affected by both the dissolution of PVP, creating channels or pores 
in the EC matrix where the drug could diffuse through, as well as, swelling of film 
matrix which was observed. Increase in porosity, which is equivalent to a decrease in 
show large patches enhanced by the presence of PVP remaining in the film. When 
viewed under light microscope, irregular pore - like structures were also observed for 
EC-PVP K29 films, as in the case for EC-PV/VA films (Figure 33a and b). However, 
unlike EC-PV/VA films, EC-PVP K60 and EC-PVPK90 films showed large patches 
of irregular raised whitish layer (Figures 33c and d). The undefined large whitish 
patches seemed to be suggestive of swollen film matrix.  
In a study of permeation of drug through untreated poly (methylvinylether)-
maleic anhydride (PVM-MA) film, Fites et al. (1970) reported rapid increase in  
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Figure 32. (a) Amount of extracted component and (b) swelling index of EC and 
composite EC films containing 30 %w/w of additives. 
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(c)       (d) 
       
  
Figure 33. Light microscope images of wetted composite EC films: (a) EC-PV/VA 
(7:3), (b) EC-PVP K29 (7:3), (c) EC-PVP K60 (7:3), (d) EC-PVP K90 (7:3) 
 
permeability after 2 h. This rise in permeability was attributed to hydration of acid 
anhydride groups resulting in swelling of the film. In this study, the swelling index at 
300 min for EC films containing 30 %w/w of EC-PVP K29, PVP K60 and PVP K90 
films were 63.8, 90.3 and 117.8 percent respectively. This suggests that increased 
molecular weight of PVP resulted in greater uptake of water. This could be explained 
by the larger hydrophilic sites available for hydrogen bonding with water molecules. 
While EC-PVP films showed proportional increase in the swelling index with 
increasing molecular weight of PVP added, the EXC value of EC-PVP films failed to 
show the same trend. It is expected that the solubility of PVP would be similar 
regardless of molecular weight and the difference between EXC values of EC-PVP 
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K60 or K90 and EC-PVP K29 might be due to the greater effect which the molecular 
weight of PVP K60 or K 90 had exerted on the proportion of EC films. The pore size 
created by dissolution of PVP present in the film probably varied depending on the 
molecular weight. It might be expected that the channels created by dissolution of 
PVP in the EC film matrix would be larger for higher molecular weight PVP. This 
possibility, coupled with the greater water uptake by PVP of higher molecular weight, 
might explain the greater drug permeability coefficients obtained for composite EC 
film consisting of high molecular weight PVP.  
 
2. Effect of drug properties on drug permeability 
The molecular weight, aqueous solubility and basicity of the drugs are given 
in Table 4. Chlorpheniramine maelate, propranolol HCl, sulphanilamide and 
sulphaguanidine constitute a series of basic drugs with comparable molecular weights 
but different solubilities in water whereas metformin, propranolol HCl, 
chlorpheniramine maelate and verapamil HCl have comparable solubilities in water (≤ 
0.05) but different molecular weights. Using these drugs, the influence of solubility 
and molecular weight of drugs on the drug permeability of the films was investigated.  
With the exception of EC-PVP K29 and EC-PVP K90, all the composite EC 
films showed decreasing permeability to the following drugs: chlorpheniramine > 
sulphanilamide > sulphaguanidine > propranolol (Table 17). The swelling test results 
suggested that addition of PVP and derivatives might enhance the permeability of EC 
films through formation of water-filled channels and swelling of matrix. 
Consequently, greater release was obtained for water-soluble drugs as they could 
dissolve or diffuse through the aqueous swollen layer better than drugs of lower 
solubility (Jenquin et al., 1990). It was noted that the relative solubility of 
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chlorpheniramine, sulphanilamide and sulphaguanidine and the corresponding drug 
permeability of films followed the same trend. However, despite being more soluble 
than sulphanilamide and sulphaguanidine, propanalol had a lower permeability 
constant. In their studies, Donbrow and Friedman (1975) found that EC-PEG film was 
more permeable to caffeine than benzoic acid or salicylic acid. The lower 
permeability was attributed to greater affinity of these organic acids with the EC-PEG 
matrix. In this study, the lower permeability constant for propranolol was probably 
due to interaction between propranolol and EC film matrix, thereby impeding drug 
diffusion.  
Both sulphanilamide and sulphaguanidine showed higher permeability 
constants than chlorpheniramine and propranolol for EC-PVP K90 films. No 
significant difference between film permeability to propranolol and sulphaguanidine 
was observed for EC-PVP K29, but both EC-PVP K60 and K90 films were at least 
four to five times more permeable to sulphaguanidine than propranolol. Among the 
four model drugs studied, chlorpheniramine is known to have the highest aqueous 
solubility, followed by propranolol, sulphanilamide and sulphaguanidine.  
On the other hand, sulphanilamide and sulphaguanidine are of the same 
chemical series (i.e. sulphonyl drugs) and whatever drug-polymer interaction present 
would be similar. The difference in permeability of composite EC films to these 2 
drugs would most probably be affected by their solubility. It should also be noted that 
sulphaguanidine has a higher molecular weight (232.3) than sulphanilamide (172.2). 
The higher molecular weight of sulphaguanidine might have also contributed to its 
lower permeability through composite EC films. This effect was more obvious for 
EC-PV/VA film where the main mechanism of drug permeation is diffusion through 
pores. It was be easier for sulphanilamide which is smaller in molecular size to diffuse 
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through the pores than sulphaguanidine. Similarly, permeability of EC-PV/VA film to 
propranolol was markedly lower compared to EC-PVP films. This implied that the 
diameters of the pores or capillaries present in EC-PV/VA films were relatively small 
and impeded the passage of propranolol.  
The effect of molecular weight of drug on permeability of composite EC films 
was also studied using metformin, propranolol, chlorpheniramine and verapamil. With 
the exception of propranolol, the drug permeability constants decreased for all 
composite films as the molecular weight of the drug increased. A linear relationship 
between molecular weights of metformin, chlorpheniramine and verapamil and their 
respective permeability constants was observed for EC-PVP K60 and EC-PVP K90 
films. In contrast, the permeability of EC-PVP K29 and EC-PV/VA films to 
metformin was much lower than those for chlorpheniramine and verapamil. The lower 
than expected permeability could be attributed to interaction between EC and 
metformin. PVP K60 and K90 appeared to be able to reduce this interaction. Hence, 
in the presence of high molecular weight PVP, drug permeability of composite EC 
films could be related to the molecular weight of drugs. Drugs of higher molecular 
weights and therefore larger hydrodynamic size will likely diffuse more slowly 
through the swollen composite EC film matrix. In this respect, metformin, with the 
smallest molecular weight took the least amount of time to diffuse through the 
swollen composite EC films.  
 
G.  Correlation between physicomechanical properties and permeability of 
composite EC films  
Several studies have reported a correlation between the changes in 
physicomechanical properties of film and their permeability (Aulton et al., 1981; 
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Benita et al., 1986; Van Bommet et al., 1989; Jenquin et al., 1992). However, the 
findings were not always consistent. For instance, Jenquin et al. (1992) found that 
incorporation of PVP K15 and PVP K90 into acrylic resin films only resulted in a 
small change in the water vapour permeability, tensile strength and glass transition 
temperature of the matrix. In contrast, Eudragit RS PM films containing 
chlorpheniramine showed a reduction in drug release with addition of PVP. This 
decrease in drug release corresponded to increased glass transition temperature and 
tensile strength but not change in water vapour permeability. On the other hand, films 
composing of chlorpheniramine and Eudragit RL PM experienced slightly decreased 
water vapour permeability, a small upward shift in glass transition temperature and 
significantly increased tensile strength with the addition of PVP K15 or PVP K90. 
However, these changes in physicomechanical and physicochemical properties had 
decreased release rates and correlated with the changes in water vapour or drug 
permeabilities. 
This study has shown that addition of PVP increased the glass transition 
temperature, tensile properties, puncture strength, as well as water vapour and drug 
permeabilities of composite Surelease films. The magnitude of change in these 
properties was not consistent in all cases. For instance, the percent increases in glass 
transition temperature and tensile strength were relatively small (~ 27 percent), while 
greater increments (76 – 80 percent) were observed for the elastic modulus and 
puncture strength. Presence of PVP further accentuated the permeability of film to 
water vapor (80 - 177 percent) and increased drug peremeability by 1000 times or 
more in some cases. Moreover, while a linear relationship was found between the 
molecular weight of PVPs and permeability to chlorpheniramine, the thermal and 
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mechanical properties of composite Surelease films did not show similar response to 
increasing molecular weight of PVPs. 
Generally, it was thought that increase in glass transition temperature and 
tensile strength of polymer films corresponded to hardening of the films and therefore 
reduction in drug release rate (Benita et al., 1986; Van Bommet et al., 1989; Jenquin 
et al., 1992). Though addition of PVP to Surelease resulted in increase in glass 
transition temperature, tensile strength, elastic modulus and puncture strength of 
Surelease films, these changes did not correlate with a reduction in permeabilities as 
suggested by other studies. This anomaly could be due to properties of additives 
present. PVP is a highly water-soluble and hygroscopic polymer which may increase 
the drug permeability through formation of pores for rapid diffusion. Similar trends 
were observed for changes in physicomechanical and properties and release rates of 
composite ethylcellulose films, regardless of the properties of drugs used. This 
suggested that the permeability of composite Surelease films was predominantly 
affected by the properties of the adjuvants (Dittgen et al., 1997).  
 
H.  Release kinetics of pellets coated with EC and polymeric additives 
In this study, the influences of coating level, drug properties as well as film 
curing on the release kinetic of Surelease coated pellets were investigated. The effects 
of molecular weight and chemical nature of PVP and its derivatives on in vitro release 
properties of Surelease coated pellets were also then determined.  
 
1.  Effect of coating levels on drug release from Surelease - coated pellets 
As seen from Figure 34, drug release decreased as the level of coating increased. In 
particular, the release profiles appeared to be more linear at 10 - 12 percents coating 
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levels. The dissolution data for 5 – 70 percents drug release were also fitted into 
various mathematical models (Table 18). The highest r2 values were obtained for the 
Higuchi or Baker-Lonsdale models. The AIC values however distinguished Baker-
Lonsdale model as the best fit model for all coating levels. The relationship between 
the Baker-Lonsdale release rate constant of Surelease coated pellets and the level of 
Surelease was illustrated in Figure 35a. As the coating level increased from 4 to 8 
%w/w, the release rate constant decreased linearly from ~0.008 to ~0.001. While it 
not clearly shown in the graph, another significant rate of change in the release rate 
constant was seen for pellets coated with 8 and 10 %w/w EC. Thereafter, the rate of 
decrease became less marked despite further increase in coating thickness. Thus a 
minimum of 10 %w/w coating level is necessary to achieve stable and uniform 
controlled release of chlorpheniramine. Unlike, the change observed for release rate 
constant, the T50% and MDT50% profiles showed greater increase at higher coating 
levels of 8 – 12 %w/w (Figures 35b and c).  
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Figure 34. Dissolution profiles of pellets coated with different levels of Surelease. 
 
Table 18. Fit factors of drug release models for chlorpheniramine pellets coated with 
different level of EC. 
Coating levels 
4 % 6 % 8 % 10 % 12 % 
Release models 
r2 
Zero order 0.951 0.935 0.898 0.971 0.977 
First order 0.775 0.774 0.712 0.838 0.864 
Hixson-Crowell 0.851 0.841 0.788 0.897 0.915 
Higuchi 0.984 0.970 0.979 0.994 0.994 
Baker-Lonsdale 0.987 0.981 0.984 0.984 0.981 
 AIC 
Zero order -41.5 -39.5 -35.3 -45.3 -42.8 
First order 5.6 6.4 1.9 -1.0 2.1 
Hixson-Crowell -35.6 -34.6 -34.8 -39.4 -36.6 
Higuchi -54.3 -50.3 -52.0 -62.7 -60.5 
Baker-Lonsdale -81.9 -91.8 -107.1 -86.5 -90.3 
 
 



































































Figure 35. Effect of coating level of Surelease on (a) Baker-Lonsdale release rate 
constant (b) T50% (c) MDT50% of chlorpheniramine, theophylline and paracetamol 
pellets.       CPM – cured;     CPM – uncured;       THE - cured;      THE - uncured;       
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Figure 36. Dissolution profiles of theophylline pellets coated with different levels of 
EC cured at 60 °C for 24 h or at 22 °C for 48 h. 
(c) 
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Figure 37. Dissolution profiles of paracetamol pellets coated with different levels of 
Surelease cured at 60 °C for 24 h or at 22 °C for 48 h. 
 
The effect of Surelease coating levels on two other drugs with low solubility 
(theophylline and paracetamol) was also studied. As in the case for chlorpherinamine 
pellets, the dissolution profiles became increasingly linear as the coating thickness 
increased (Figures 36 – 37). Comparison of r2 values showed that theophylline pellets 
coated with 4 %w/w EC was best described by Baker Lonsdale model while those 
coated with 6 - 12 %w/w followed zero-order release (Table 19). Similarly, the r2 
values indicated that paracetamol pellets coated with 4 - 6 %w/w EC was best 
described by Baker – Lonsdale or Higuchi square root time models while those coated 
with 8 - 12 %w/w followed zero-order release model (Table 20). On the other hand, 
based on the AIC values, release of theophllyine and paracetamols from EC coated 
pellets showed best fitting with Baker-Lonsdale model.  
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Four possible mechanisms have been proposed to explain drug release from 
coated pellets (Zhuang et al., 1991):  
a. transport of drug through cracks and other imperfections within the 
matrix or uncoated system;  
b. transport of drug through a network of capillaries (or pores) in the 
coating applicable if the water-soluble components of the film leach 
out; 
c. transport of drug through a hydrated swollen film – applicable if the 
water-soluble components are retained within the coating; and/or 
d. transport of drug through the non-porous coating, which is determined 
by the permeability of the drug in the film. 
During film coating, the pellets were continuously layered with coating 
materials. Consequently, the film formed was composed of overlapping segments. 
Any holes from the overlapping layers were gradually covered as more layers of film  
Table 19. Fit factors of drug release models for theophylline pellets coated with 
different levels of Surelease. 
Coating levels 
4 % 6 % 8 % 10 % 12 % 
Release models 
r2 
Zero order 0.888 0.995 0.999 0.997 0.995 
First order 0.660 0.880 0.947 0.953 0.959 
Hixson-Crowell 0.748 0.937 0.977 0.982 0.981 
Higuchi 0.974 0.988 0.983 0.973 0.989 
Baker-Lonsdale 0.995 0.944 0.946 0.929 0.949 
 AIC 
Zero order -25.0 -79.4 -90.9 -78.6 -83.5 
First order 2.4 -0.5 -16.8 -16.3 -22.4 
Hixson-Crowell -22.9 -50.9 -58.4 -59.8 -66.4 
Higuchi -36.1 -68.1 -60.5 -58.1 -74.6 
Baker-Lonsdale -73.7 -96.3 -94.6 -98.6 -114.0 
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Table 20. Fit factors of drug release models for paracetamol pellets coated with 
different levels of EC. 
Coating levels 
4 % 6 % 8 % 10 % 12 % 
Release models 
r2 
Zero order 0.894 0.988 0.997 0.989 0.989 
First order 0.712 0.848 0.897 0.858 0.855 
Hixson-Crowell 0.786 0.915 0.949 0.925 0.924 
Higuchi 0.960 0.998 0.986 0.988 0.986 
Baker-Lonsdale 0.980 0.966 0.938 0.954 0.953 
 AIC 
Zero order -21.2 -47.1 -62.2 -55.8 -59.6 
First order 0.4 1.8 0.5 0.4 1.8 
Hixson-Crowell -23.0 -33.5 -38.8 -41.1 -43.8 
Higuchi -28.6 -64.0 -47.6 -54.4 -57.4 
Baker-Lonsdale -59.6 -69.7 -66.5 -74.2 -80.8 
 
were deposited. At low coating level of 4 %w/w, the drug was probably released 
through the pores or channels in the coating. As the coating thickness increased, the 
membrane became more complete and had less pores. Thus, the rate of release was 
drastically reduced. At higher coating level, the drug had to take the pathway 
involving diffusion through the barrier, which could be related to drug permeability in 
the coating and coating thickness. Hence, release of theophylline and paracetamol 
from pellets with high level of coating follow zero-order model (Tables 19 - 20). 
However, release of chlorpheniramine pellets from the coated pellets followed Baker-
Lonsdale model despite changes in coating level. The change in release mechanism 
was also reflected in the drastic drop in release rate constants for theophylline and 
paracetamol pellets coated with 6 %w/w EC compared to 4 %w/w EC. Release 
constants of theophylline and paracetamol pellets coated with 6 - 12 %w/w EC 
showed relatively smaller change.  
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 The MDT50% of theophylline pellets increased as the coating levels increased 
from 4 - 8 %w/w and plateau at higher coating levels (Figure 35c). On the other hand, 
the MDT50% values of paracetamol pellets continued to increase as the coating level 
increased from 8 – 10 %w/w before it plateaued at 10 - 12 %w/w. The markedly 
lower MDT50% values for paracetamol pellets indicated that a thicker coat was 
required to control the release of paracetamol compared to theophylline. Unlike 
MDT50%, the T50% values for both theophylline and paracetamol pellets showed almost 
linear increase with coating level (Figure 35b). 
Analysis of the release rate constants, T50% and MDT50% demonstrated that 
drugs with greater solubility have faster release rate. Chlorpheniramine had the fastest 
release, followed by paracetamol and theophylline. When release rates were plotted 
against the solubilities of chlorpheniramine (50 mg/ml), paracetamol (1.43 mg/ml) 
and theophylline (0.833 mg/ml), notable effect was seen at low coating levels of 4 - 6 
%w/w (Figure 38a). At higher coating levels, the differences in release rate constant 
became less significant. Plots of T50% and MDT50% against solubility showed sharp 
decrease as the solubility increased from 0.833 to 1.43 mg/ml at all coating levels 
except for 4 %w/w (Figures 38b and c). This observation could be explained by 
considering the mechanism of release at various coating levels. As discussed earlier, 
drug release occurred primarily through the pores or cracks that were present 
 


































































Figure 38. Relationship between (a) Baker-Lonsadale release rate constant (b) 
MDT50% (c) T50% and drug solubility.     4%       6%       8%      10%        12%w/w 
coating level 
 
in the incomplete membrane at low coating levels. Since drugs with higher solubility 
would have greater driving power through the medium filled pores than drugs with 
lower solubility, effect of drug solubility on release rate is heightened at low coating 
levels. At higher coating levels, the film coat was better formed and release rate was 
limited by the partitioning of drugs through the EC coat rather than their aqueous 
solubilities. In addition, it was noted that the increase in T50% and MDT50% was more 
significant at lower drug solubility range of 0.833 to 1.43 mg/ml. 
 
2.  Effect of curing on EC - coated pellets 
The dissolution profiles of EC coated chlorpheniramine pellets that were cured 
at 60 °C for 24 h were compared to those that were stored at ambient temperature of 
22 °C, 48 h (Figure 34). Curing of chlorpheniramine pellets at 60 °C resulted in 
(c) 
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slower release at all levels. However, the difference was not significantly displayed by 
the release rate constants, T50% and MDT50% values (Figures 35b and c). Independent 
t-test analysis showed that only chlorpheniramine pellets coated with 8 %w/w EC 
showed significant difference in release rate constant and MDT50% value when cured 
compared to uncured. In contrast, the effect of curing was more significant on 
theophylline and paracetamol pellets, especially those coated with low levels of EC. 
The effect appeared to be most marked on the MDT50% of theophylline pellets coated 
with 4 - 8 %w/w EC. Paracetamol pellets coated with 4 - 6 %w/w EC have significant 
difference in their MDT50% values. However, it was noted that the effect of curing on 
MDT50% diminished as the coating level increased to 10 %w/w. The f1 and f2 values 
computed from the dissolution profiles of chlorpheniramine, paracetamol and 
theophylline pellets further supported the above observations (Table 21). More than 
10 % differences were obtained for the dissolution profiles of chlorpheniramine 
pellets with coating levels of 8 - 12 %w/w, cured at 60 °C for 24 h compared to those 
uncured. In contrast, only the dissolution profiles of paracetamol and theophylline 
pellets coated with low level of EC, 4 - 6 and 4 – 8 %w/w respectively were found to 
be dissimilar. 
Table 21. Difference factors, f1, and similarity factors, f2, for chlorpheniramine (CPM), 
paracetamol (PA) and theophylline (THE) pellets coated with different levels of EC. 
Average f1 Average f2 Coating levels 
(%w/w) CPM PA THE CPM PA THE 
4 15.3 *39.1 *58.5 50.4 *34.5 *21.2 
6 8.6 *27.7 *83.9 64.5 *40.6 *31.9 
8 *29.1 6.5 *58.0 *39.4 75.7 50.5 
10 *38.3 3.7 8.0 *45.0 88.2 90.6 
12 *18.5 4.0 10.9 62.9 88.9 87.5 
*significant at p < 0.01 
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It has been reported that during curing, the pseudolatex particles would 
coalescence and fuse further to form a more complete film. The effect of curing 
would be more marked at low coating level since the polymer coats were incomplete. 
This explained the reduced drug release, especially for pellets coated with low level of 
coating. At higher coating levels, the polymer coat would be more complete with less 
pores or flaws. Further coalescence during curing would not have much influence on 
drug release since the polymer coat was already well - formed. The effect of curing 
was found to vary with the type of drugs used. This could be due to the solubility of 
the drugs in the dissolution medium. Since chlorpheniramine has very high solubility 
in aqueous medium, curing pellets coated with low level of EC might not contribute 
significant effect on retarding its release. This was because at low coating level, drug 
release mainly occurred through the pores or channels which were more abundant in 
the coating. Curing of pellets coated with low coating level of EC aided in the fusion 
of some of pores or cracks present, thereby retarding release of less water - soluble 
drugs, such as paracetamol and theophylline, significantly. As the coating thickness 
increased, the effect of curing became less retarding for the less water - soluble drugs. 
This suggested that at high coating levels, the film coat was thick enough such that the 
drug release was controlled by diffusion of the drug through the membrane coat. 
Hence, curing which promoted further coalscenece and strengthened the film but not 
its thickness did not exert significant influence in such cases. On the other hand, 
curing of chlorpheniramine pellets coated with higher levels of EC showed significant 
reduction in drug release (Table 21). This indicated that thicker film coat was required 
to retard diffusion of chlorpheniramine. If the film coat was not sufficiently thick, 
curing alone would be insufficient in retarding the release of chlorpheniramine. 
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3. Influence of PVP on EC - coated pellets 
PVP, a water-soluble additive, was also added to Surelease dispersion at 
concentrations ranging from 10 - 30 %w/w of total solid content. The resultant 
dispersions were used to coat chlorpheniramine and theophylline pellets. The 
influence of additives on the dissolution profiles of chlorpheniramine and 
theophylline pellets are shown in Figures 39 - 40. Addition of PVPs at a relatively low 
concentration of 10 %w/w resulted in great increase in rate of release and total 
amount release. Figure 39 shows that the maximum release was achieved in about 120 
min for all composite Sureleasecoated chlorpheniramine pellets coated with 10 %w/w 
The dissolution data was also fitted into zero-order, first-order, Hixson-Crowell, 
PVPs, except for PVP K17. Chlorpheniramine pellets coated with EC-PVP K17 (9:1) 
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Figure 39. Dissolution profiles of chlorpheniramine pellets with Surelease (EC) and 
composite EC coats containing (a) 10 %w/w (b) 20 %w/w and (c) 30 %w/w of PVP 
K17, K29, K60, K90, MCPVP and PV/VA cured at 60 °C, 24 h. 
(b) 
(c) 
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Figure 40. Dissolution profiles of theophylline pellets with Surelease (EC) and 
composite EC coats containing (a) 10 %w/w (b) 20 %w/w and (c) 30 %w/w of PVP 
K17, K29, K60, K90, MCPVP and PV/VA cured at 60 °C, 24 h. 
 
added to Surelease coat increased, the time taken to achieve maximum release was 
reduced to about 120 min for all coating formulations (Figures 39a - c). This 
phenoneom was in great contrast to that observed for pellets coated with plasticized 
EC (no additives) which produced an average maximum of 64 percent release even 
after 12 h.  
The dissolution data was also fitted into zero-order, first-order, Hixson-
Crowell, Higuchi square root time, Hopfenberg and Baker-Lonsdale equations based 
on linear regression. The r2 and AIC values of the various models were showed in 
Tables 22 - 23. Earlier it was found that chlorpheniramine pellets coated with 
Surelease could be best described by Baker-Lonsdale model or Higuchi model 
depending on the coating levels. With the presence of PVPs, majority of the coating 
(c) 
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formula lead to a change in release model to Hopfenberg model. Similar change in 
mechanism of release was also indicated for theophylline pellets as inferred from the 
r2 and AIC values showed in Tables 24 -25. While the release of theophylline from 
pellets coated with 6 - 12 %w/w Surelease was characterized by zero-order release, 
addition of PVPs generally resulted in a shift in release model to Hopfenberg model. 
Since Hopfenberg model is used to describe erosion-controlled release, these changes 
in model indicated a change ofmechanism from coated matrix diffusion controlled to 
erosion or swelling controlled release. As discussed above, release of drug from  
Table 22. r2 values of chlorpheniramine pellets with composite Surelease (EC) coat 
cured at 60 °C, 24 h. 













10 0.989 0.834 0.909 0.994 0.997 0.950 
20 0.983 0.885 0.930 0.995 0.997 0.973 
30 0.985 0.861 0.921 0.995 0.995 0.963 
PVP K29 
10 0.984 0.863 0.919 0.996 0.998 0.971 
20 0.957 0.827 0.883 0.980 0.972 0.973 
30 0.973 0.884 0.924 0.989 0.987 0.970 
PVP K60 
10 0.997 0.946 0.977 0.989 0.989 0.927 
20 0.984 0.883 0.930 0.995 0.997 0.972 
30 0.976 0.815 0.888 0.995 0.996 0.970 
PVP K90 
10 0.997 0.900 0.953 0.983 0.994 0.927 
20 0.975 0.821 0.891 0.994 0.995 0.974 
30 0.915 0.763 0.825 0.970 0.958 0.985 
MCPVP 
10 0.981 0.853 0.912 0.992 0.996 0.959 
20 0.966 0.831 0.893 0.985 0.987 0.967 
30 0.982 0.910 0.922 0.988 0.995 0.964 
PV/VA 
10 0.990 0.885 0.935 0.998 0.886 0.980 
20 0.973 0.884 0.924 0.989 0.987 0.970 
30 0.957 0.827 0.883 0.980 0.972 0.973 
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Table 23. AIC values of chlorpheniramine pellets coated with composite Surelease 
(EC) coat cured at 60 °C, 24 h. 













10 -50.0 0.5 -35.0 -59.0 -79.1 -67.3 
20 -35.7 -6.2 -30.8 -43.8 -57.2 -53.8 
30 -42.2 -2.6 -32.3 -49.6 -52.6 -61.5 
PVP K29 
10 -35.8 -3.6 -24.6 -46.1 -61.0 -53.3 
20 -44.1 7.3 -36.7 -60.7 -77.1 -101.2 
30 -47.7 1.2 -41.0 -51.0 -72.9 -83.6 
PVP K60 
10 -36.1 -8.9 -28.7 -29.0 -37.0 -36.7 
20 -41.0 -6.5 -34.8 -51.4 -66.8 -61.2 
30 -53.6 3.2 -41.8 -73.1 -93.9 -91.4 
PVP K90 
10 -92.8 0.9 -58.8 -68.1 -108.3 -99.1 
20 -54.6 3.4 -43.6 -73.7 -94.4 -96.4 
30 -38.5 1.3 -39.4 -51.6 -64.4 -97.5 
MCPVP 
10 -57.4 3.9 -44.2 -68.4 -96.5 -91.6 
20 -45.8 0.7 -39.7 -55.4 -72.8 -82.3 
30 -45.8 -12.1 -37.6 -51.1 -71.1 -69.6 
PV/VA 
10 -61.1 -7.3 -46.8 -78.0 -78.5 -90.8 
20 -43.5 -12.1 -42.4 -51.6 -63.4 -69.9 
30 -88.5 -5.3 -72.1 -101.9 -129.4 -170.0 
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Table 24. r2 values of theophylline pellets coated with composite Surelease (EC) coat 
cured at 60 °C, 24 h. 













10 0.996 0.894 0.946 0.989 0.996 0.936 
20 0.982 0.837 0.907 0.993 0.997 0.971 
30 0.963 0.843 0.899 0.976 0.982 0.963 
PVP K29 
10 0.996 0.860 0.931 0.993 0.999 0.953 
20 0.994 0.893 0.943 0.990 0.997 0.949 
30 0.984 0.902 0.947 0.944 0.983 0.908 
PVP K60 PVP K60 
10 0.990 0.868 0.931 0.983 0.997 0.970 
20 0.990 0.910 0.952 0.967 0.990 0.921 
30 0.990 0.904 0.951 0.966 0.990 0.927 
PVP K90 
10 0.998 0.949 0.981 0.982 0.990 0.918 
20 0.987 0.880 0.938 0.965 0.986 0.926 
30 0.974 0.855 0.911 0.981 0.989 0.961 
MCPVP 
10 0.980 0.793 0.880 0.996 0.996 0.975 
20 0.990 0.895 0.945 0.975 0.992 0.930 
30 0.993 0.905 0.952 0.983 0.993 0.943 
PV/VA 
10 0.998 0.927 0.964 0.994 0.999 0.960 
20 0.979 0.857 0.914 0.989 0.993 0.967 
30 0.989 0.883 0.934 0.990 0.996 0.958 
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Table 25. AIC values of theophylline pellets coated with composite Surelese (EC) 
coat cured at 60 °C, 24 h. 














10 -46.1 -2.8 -34.4 -49.4 -67.6 -66.6 
20 -50.1 2.8 -38.2 -60.4 -87.4 -80.2 
30 -44.2 3.9 -38.1 -48.6 -70.9 -81.7 
PVP K29 
10 -40.4 -1.5 -25.1 -36.3 -55.6 -45.5 
20 -81.4 -1.2 -55.9 -74.0 -115.2 -101.5 
30 -72.3 2.1 -42.6 -53.0 -96.2 -101.8 
PVP K60 
10 -50.4 0.2 -35.4 -45.2 -75.3 -74.8 
20 -58.6 -5.0 -47.0 -46.7 -76.3 -73.8 
30 -58.8 -3.1 -46.8 -45.0 -76.1 -74.5 
PVP K90 
10 -45.4 -9.6 -31.8 -30.9 -42.3 -42.3 
20 -66.8 -0.1 -52.4 -52.6 -84.9 -86.4 
30 -46.3 0.9 -39.1 -50.1 -72.5 -78.2 
MCPVP 
10 -40.1 0.7 -29.4 -53.2 -66.3 -57.2 
20 -56.4 -2.3 -43.3 -47.5 -75.7 -71.6 
30 -46.6 -5.8 -36.2 -39.4 -58.8 -55.9 
PV/VA 
10 -81.9 -12.6 -53.8 -70.1 -108.4 -95.3 
20 -45.2 -1.4 -36.8 -51.6 -70.5 -72.8 
30 -42.4 -4.2 -33.5 -43.3 -64.0 -56.8 
 
 
pellets with 12 %w/w coating was most likely diffusion-controlled since the film 
coating was sufficiently thick and uniform with minimum number of pores or flaws. 
The release rate would therefore depend on the permeability of the drug in the 
polymer coat and solubility in dissolution fluids. As discussed in previous sections, 
addition of small amount of PVPs resulted in the formation of almost uniform film 
with PVP dispersed in the continuous EC phase. When drug-loaded pellets were 
encapsulated with these composite films, it was expected that the film coat would still 
be intact and act as a semi-permeable membrane when the water-soluble components, 
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Figure 41. Influence of molecular weight of PVP on the (a) Hopefenberg release rate 
constant (b) T50% of chlorpheniramine pellets and (c) MDT50% of theophylline pellets 
coated with Surelease, cured at 60 °C. 24 h.     10 %w/w,      20%w/w and      30 
%w/w PVP 
 
which is mainly PVP dissolved in the aqueous medium. Hence, drug release could be 
greatly enhanced by diffusion through the water-filled channels.  
Figure 41a shows the relationship between the Hopfenberg constant for 
chlorpheniramine and molecular weight of PVP added to the Surelease coat. At 10 
%w/w level, a sharp increase in rate constant was obtained as the molecular weight of 
PVP increased from 8, 000 to 58, 000 and a relatively smaller rise as the molecular 
weight of PVP increased to 400, 000. The rate constants did not show any particular 
trend of increase as the molecular weight of PVP became larger. Similar trend was 
also observed for T50% of chlorpheniramine pellets (Figure 41b). At 10 %w/w PVP, a 
steep drop in T50% was obtained as the molecular weight of PVP rise from 8, 000 to 
58, 000. This change was followed by a leveling off. It was thought that the molecular 
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and/or greater number of pores available for drug diffusion. It was noted that the 
molecular weight of PVP exerted noticeable influence in the range of 8, 000 to about 
400, 000. Beyond 400, 000, the molecular weight of PVP did not result in much 
change in T50%. In contrast, at 10 %w/w level, increase in molecular weight of PVP 
did not produce any steep increase in rate constant of theophylline concentrations of 
PVPs (20 - 30 %w/w), sharp increase in both zero-order and Higuchi rate constant 
was observed as the molecular weight increased from 8,000 to 58, 000. In addition, a 
gradual increase in rate constant was observed as the molecular weight of PVP 
increased further. Similar trend was observed for MDT50% and T50% of theophylline 
pellets coated with composite EC film coat (Figure 41c). The two phases of change in 
release rate with increasing size of PVP suggested a possible indication of change of 
mechanism of drug release. The initial phase being controlled mainly via diffusion of 
drug molecules through aqueous pores or channels formed by dissolution of PVPs 
which were randomly dispersed in the continuous EC membrane. Hence as the 
molecular weight of PVP increased from 8, 000 to 58, 000, a significant and sharp 
increase in release rate constant and drop in time taken for 50 % of the drug to be 
released was obtained. As the molecular weight of PVP increased further, another 
mechanism of release, such as swelling and/erosion-controlled release also come into 
play. 
Investigation on the effects of swelling and erosion on EC-PVP coat were 
carried out using composite EC-PVP films containing 10 - 30 %w/w of PVPs. Figures 
42 - 43 show the swelling index and extractable amount of the composite EC films 
over time. Generally both the swelling index and extractable amount increased 
gradually within the first 2 hours and levelled off thereafter. In general, PVP with 
higher molecular weight showed higher swelling index (Figure 42). The highest 
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swelling index within the first hour was determined for each additive. It was found to 
decrease in the following order: 
for 10 % level; PVP K60 > MCPVP > PVP K90 > PVP K29 > PVP K17, 
  
 
        









































































Figure 42. Extractable amount of Surelease (EC) and composite EC films containing 
(a) 10 %w/w (b) 20 %w/w and (c) 30 %w/w of additives.     EC-PVP K17;      EC-
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Figure 43. Swelling index of Surelease (EC) and composite EC films containing (a) 
10 %w/w (b) 20 %w/w and (c) 30 %w/w of additives.      EC-PVP K17;       EC-PVP 
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for 20 % level; MCPVP > PVP K90 > PVP K29 > PVP K60 > PVP K17, and 
for 30% level; MCPVP > PVP K60 > PVP K90 > PVP K29 > PVP K17. 
With the exception of PVP K60, the rate of increase of swelling index was 
directly related to the molecular weight of PVPs. However, it was also noted that for 
30 %w/w level, the swelling index profile of EC-PVP K90 started to decline after 20 
min to a similar level as EC films (Figure 43c). This phenomenon was most obvious 
for composite Surelease films containing 30 %w/w PVP K90. This result could be 
explained by the amount of PVP that was lost due to dissolution into the aqueous 
media.  
From Figures 42a-c, the highest extractable amount for each PVP was 
determined. It was found to decrease in the following order: 
for 10 % level; PVP K60 > PVP K90 > PVP K29 > MCPVP > PVP K17, 
for 20 % level; PVP K90 > PVP K60 > PVP K29 > MCPVP > PVP k17, and 
for 30% level; PVP K90 > PVP K60 > PVP K17 ≥ MCPVP > PVP K29.  
Since the extractable amounts were related to the differences between the weights of 
dried films before and after exposure to the dissolution media, they indicated the 
amounts of water-soluble components that were lost due to dissolution. Apparently, 
PVP K90 showed the greatest tendency to be dissolved or eroded in the aqueous 
media. With the dissolution of PVP K90, the resultant composite Surelease films 
consisted of numerous pores or water-filled voids. Since most of the PVP K90 
component in the composite Surelease films were not retained, the swelling index 
profile gradually declined. In contrast, MCPVP which has the highest molecular 
weight showed the second lowest extractable amount, suggesting that the MCPVP 
component was still retained in the composite Surelease film structure after exposure 
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to water. Hence, the wetted EC-MCPVP films were able to absorb high amount of 
water. 
Low molecular weight PVPs, such as PVP K17 and K29, exhibited both low 
swelling index as well as extractable amount. It was possible that a certain portion of 
PVP K17 and PVP K29 in the composite Surelease films was dissolved while the rest 
remained trapped in the film. Generally, PVP K29 also showed a higher swelling 
index and extractable amount compared to PVP K17. This indicated that a greater 
amount of PVP K29 could be lost due to dissolution compared to PVP K17 and/or the 
amount of PVP K29 retained in the polymer film had a higher water retention power. 
The above phenomeon aptly accounted for the great difference in T50% value between 
pellets coated with EC-PVP K17 and EC-PVP K29. In addition, the greater swelling 
tendency of PVP K29 also suggested that the resultant swollen composite EC films 
could also enhanced the dissolution and diffusion of drug, especially water - soluble 
drugs through the polymer coat. Moreover, the difference in T50% values between 
pellets coated with EC-PVP K17 and EC-PVP K29 were most marked at higher 
concentration of 20 - 30 %w/w for theophylline. On the other hand, release of 
chlorpheniramine was more marked at lower concentrations of 10 - 20 %w/w PVP. 
Since theophylline has a lower aqueous solubility than chlorpheniramine, this implied 
that swelling-controlled mechanism might have a greater influence on EC-PVP K17 
and K29 coated pellets at higher concentration of PVPs. At low concentrations (10 - 
20 %) of PVP, significantly greater amounts of PVP were leached out from EC-PVP 
K29 while the difference in swelling index between EC-PVP K29 and EC-PVP K17 
films was comparatively smaller. At low concentrations of PVP, composite EC-PVP 
K29 films showed similar swelling tendencies as EC-PVP K17, and greater amounts 
of PVP K29 were also dissolved resulting in more and perhaps larger pores. 
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Consequently, chlorpheniramine which has a higher aqueous solubility, showed 
greater difference in release rate, whereas the release of theophylline which has low 
aqueous solubility, was not greatly enhanced with the change in additives form PVP 
K29 to PVP K17. However, as the concentration of PVP in the composite Surelease 
coat increased, more PVP could be dissolved and leached out from the coat, thereby 
enhancing the release of both chlorpheniramine and theophylline. Moreover at high 
concentration, relatively greater amount of PVP K17 was extracted and lost, resulting 
in much lower swelling profile compared to PVP K29.  
Except for PVP K60, the PVPs showed quite comparable or small difference 
in the extractable amount and swelling index at 10 percent level. Hence, this 
explained the lack of influence of molecular weight of PVPs on the release rate of 
chlorpheniramine and theophylline pellets coated with 10 %w/w PVP. At higher 
concentrations, the higher molecular weight PVPs showed greater swelling indices 
and leachable amounts, indicating a shift in mechanism towards swelling-controlled 
and erosion-controlled release. It was possible that PVPs of medium molecular 
weights such as PVP K29 and K60 exhibited drug release that was controlled by 
swelling and diffusion mechanisms. In the earlier part of this study, it was found that 
the higher molecular weight PVPs, such as PVP K90 and MCPVP tended to form a 
separate layer when present at high concentration. Since PVP K90 also showed a high 
tendency to dissolve in aqueous media, it was likely that the PVPs present on top of 
the Surelease membrane were dissolved and eroded away when exposed to the 
aqueous media. The resultant film coat would consist of a thinner Surelease coat with 
flaws or pores created by the embedded PVP molecules. This was illustrated by the 
greater increase in release rate of theophylline at 20 %w/w compared to 30 %w/w. 
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4. Effect of curing on drug release from EC-PVP coated pellets 
In the above discussion, it was shown that curing Surelease coated pellets at 
60 °C for 24 h impeded drug release. In order to investigate whether curing had 
similar effect on composite Surelease coat, the dissolution profiles of cured and 
uncured pellets coated with composite Surelease films were compared. As seen from 
Figures 44a - c, the dissolution profiles of uncured pellets were very similar to those 
cured. The f1 and f2 values in Table 26 showed that none of the dissolution profiles of 
pellets cured at 60 °C were more than 10 percent different from those of uncured 
pellets. This finding was not unexpected since release of drugs occurred mainly 
through water-filled channels created by dissolution of water - soluble PVP. Curing of 
composite Surelease coated pellets is not likely to affect the dissolution of water - 
soluble PVP from the composite Surelease. 
Table 26. Statistical analysis on influence of curing on chlorpheniramine release from 
pellets coated with composite Surelease (EC).  
Film coat Average f1 Average f2 
EC-PVP K29 (9:1) 4.1 78.3 
EC-PVP K29 (8:2) 9.8 57.7 
EC-PVP K29 (7:3) 8.9 65.6 
EC-PVP K90 (9:1) 11.4 58.7 
EC-PVP K90 (8:2) 7.2 69.7 
EC-PVP K90 (7:3) 6.5 68.3 
EC-MCPVP (9:1)  11.5 61.3 
EC-MCPVP (8:2)  8.8 64.2 
EC-MCPVP (7:3)  11.7 57.1 
EC-PV/VA (9:1) *19.2 53.4 
EC-PV/VA (8:2) 4.6 72.9 
EC-PV/VA (7:3)  7.7 63.5 
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Figure 44. Dissolution profiles of chlorpheniramine pellets coated with Surelease 
(EC) and composite EC containing 10 - 30 %w/w (a) PVP K29, (b) PVP K90 and (c) 
MCPVP, cured at 60 °C, 24 h or uncured. 
 
 
5. Influence of PV/VA on drug release from EC - coated pellets 
The effect of PV/VA, a cross-linked PVP co-polymer, on drug release from 
Surelease coated pellets was also studied (Figures 45 - 46). As mentioned above, 
PV/VA has similar molecular weight as PVP K29, pellets coated with EC-PV/VA 
was used as comparator to determine the effect of chemical nature of additive on 
Surelease coat. Generally, the r2 and AIC values suggested that chlorpheniramine 
pellets coated with EC-PV/VA followed Higuchi or Baker-lonsdale models while 
theophylline pellets release profiles seem to suggest Hopfenberg model (Tables 27 - 
29). Comparison between the Hopfenberg release rate constants of EC-PV/VA and 
EC-PVP K29, showed that at 10 % level, EC-PV/VA seems to be able retarded 
(c) 
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release of chlorpheniramine better than EC-PVP K29 (Table 28). However as the 
concentration of PV/VA increased, the difference between rate constant of EC-
PV/VA and EC-PVP K29 diminished. In contrast, significant difference was observed 
for the both the zero-order and Higuchi rate constants of theophylline pellets coated 
with EC-PV/VA and EC-PVP K29 at all levels (Table 30).  
Unlike, chlorpheniramine pellets, the differences for theophylline pellets 
appeared to be greater at higher concentration of additives. At 30 %w/w level, PV/VA 
was found to have slower rate constant compared to EC-PVP K17. These 
observations could be explained from the swelling results of EC-PV/VA and EC-PVP 
K29 films. As seen in Figures 42 and 43, at low concentration, EC-PVP K29 showed 
slightly higher swelling index and extractable amount compared to EC-PV/VA. 
However, as the concentration of additives increased to 20-30 %w/w, the EC-PVP 
K29 showed significantly greater swelling index, though amount extracted was quite 
comparable to EC-PV/VA. This implied that swelling-controlled mechanism would 
have exerted a greater influence on drug release from EC-PVP K29 coated pellets 
compared to EC-PV/VA. Consequently, a marked increase in release rate was 
observed for theophylline pellets as composite EC-PVP K29 coat was more ‘porous’ 
and had higher water-content. This would help to enhance the release of less water-
soluble drugs, such as theophylline as there is greater volume for dissolution. On the 
otherhand, chlorpheniramine is very soluble in aqueous medium, and presence of a 
more swollen layer did not greatly affect its release rate. 
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Figure 45. Dissolution profiles of chlorpheniramine pellets coated with composite EC 





























Figure 46. Dissolution profiles of theophylline pellets coated with composite 
Surelease (EC) coating containing 30 %w/w PV/VA, cured at 60 °C for 24 h. 
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Table 27. Fit factors of drug release models for chlorpheniramine pellets coated with 
composite Surelease (EC) containing 30 %w/w of PV/VA cured at 60 °C, 24 h 
Coating levels 
4 % 6 % 8 % 10 % 12 % 
Release models 
r2 
Zero order 0.933 0.887 0.802 0.783 0.957 
First order 0.734 0.687 0.605 0.593 0.827 
Hixson-Crowell 0.815 0.769 0.680 0.664 0.883 
Higuchi 0.991 0.968 0.907 0.895 0.980 
Hopfenberg 0.975 0.939 0.867 0.849 0.972 
Baker-Lonsdale 0.994 0.983 0.943 0.933 0.973 
 AIC 
Zero order -43.3 -35.2 -31.5 -31.3 -88.5 
First order 2.7 11.6 11.1 16.3 -5.3 
Hixson-Crowell -39.5 -34.1 -35.5 -35.6 -72.1 
Higuchi -62.8 -53.2 -42.5 -43.2 -101.9 
Hopfenberg -73.2 -63.0 -57.4 -60.2 -129.4 
Baker-Lonsdale -113.6 -103.2 -93.0 -100.6 -170.0 
 
Table 28. Hopfenberg release rate constants of chlorpheniramine (CPM) and 
theophylline (THE) pellets coated with composite Surelease (EC) containing 30 
%w/w of PV/VA cured at 60 °C, 24 h 
Coating levels CPM THE 
4 % -0.0218 -0.0436 
6 % -0.0191 -0.0401 
8 % -0.0144 -0.0373 
10 % -0.0098 -0.0335 
12 % -0.0212 -0.0046 
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Table 29. Fit factors of theophylline pellets coated with composite Surelease (EC) 
containing 30 %w/w of PV/VA cured at 60 °C, 24 h 
Coating levels 
4 % 6 % 8 % 10 % 12 % 
Release models 
r2 
Zero order 0.981 0.993 0.984 0.989 0.963 
First order 0.845 0.890 0.854 0.900 0.843 
Hixson-Crowell 0.908 0.943 0.916 0.945 0.899 
Higuchi 0.995 0.985 0.988 0.984 0.976 
Hopfenberg 0.994 0.994 0.994 0.994 0.982 
Baker-Lonsdale 0.961 0.937 0.955 0.949 0.963 
 AIC 
Zero order -38.8 -47.0 -43.4 -51.5 -44.2 
First order -3.0 -4.4 -0.1 -5.0 3.9 
Hixson-Crowell -31.7 -35.0 -33.5 -41.1 -38.1 
Higuchi -50.6 -43.0 -46.5 -48.6 -48.6 
Hopfenberg -60.3 -61.9 -67.2 -71.4 -70.9 




It has been shown in this study that EC film stability is influenced by several 
factors, including type and amount of plasticizers remaining in the film, as well as the 
storage conditions. Plasticizers interact with EC and affect its film properties 
primarily in the following three ways. Firstly, plasticizers with low permanence, such 
as GTA and DEP can cause formation of brittle films as the plasticizers volatilize or 
degrade on extended storage. Secondly, the extent of coalescence or ageing on EC 
films varies with different plasticizers. In addition, the stability of EC films to storage 
conditions is also dependent of type of plasticizers.  
Efficiency of plasticizers is one factor which contributes tremendously to the 
performance of EC film coat in controlling drug release. At a commonly applied 
concentration of 30 percent, the citrate ester, particularly TEC, had been shown to 
interact well with Aquacoat, while GTA and DEP were not able to plasticize 
Aquacoat films as effectively. Storage humidities and temperature could potentially 
affect the expected performance of coated products through modulation on the ageing 
process. Exposing the film membrane to low humidity or high temperature accelerate 
loss of bound water, thus enhancing the coalescence or fusion of polymer molecules. 
Storage environments with high moisture content, on the other hand could delay and 
reduce the coalescence of films but not prevent it. With the exception of GTA, 
chlorpheniramine release from pellets coated with plasticized Aquacoat films were 
affected to varying degree by storage conditions. Higher storage temperature tends to 
effect greater changes for pellets coated with Aquacoat containing citric acid class of 
plasticizers (TEC and ATEC) compared to other plasticizers. This study demonstrated 
that the physicochemical properties of the plasticizer coupled with the storage 
conditions have an important influence on the stability and performance of the final 
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film coat. Hence it is important to select carefully the type of plasticizers for film 
coating, ensure the stability and optimal performance of the dosage forms. 
In the second part of the study, the influence of secondary polymer, PVP and 
its derivatives on the properties of EC film and coated pellets was investigated. EC 
films formed from aqueous dispersion were found to be smooth and relatively 
transparent. Addition of PVP, especially high molecular weight PVP, and MCPVP 
resulted in drastic reduction in film transparency, suggesting that molecular weight of 
PVP greatly affects the clarity of composite EC films. The interaction between EC 
and PVP polymeric additives was found to be dependent on the molecular weight, 
concentration and chemical nature of the additives. When added to EC, low molecular 
weight PVP would be randomly distributed through the EC matrix as a disperse 
phase. Increased concentration up to 30% did not alter the phase distribution. In 
contrast, greater interaction was exhibited between EC and higher molecular weight 
PVP as represented by PVP K60, K90 and MCPVP. At low concentration, higher 
molecular weight PVP may exist as a disperse phase in EC matrix. However, as the 
concentration increased, the higher molecular weight additives tend to aggregate 
together forming a separate continuous phase. Formation of separate continuous 
layers became more prominent with increasing concentration. Increase molecular 
weight of additives accelerated the progression to formation of separate layers.  
At low concentration, PVP increased the hardness of EC films probably due to 
intermolecular interaction between EC and PVP. However, addition of large amount 
of high molecular weight PVP or MCPVP would result in polymer phase separation. 
Incorporation of PVP increased the puncture strength and percentage elongation of 
dry films but lowered the puncture strength and percentage elongation of wet films. 
On the other hand, PV/VA increased the percentage elongation of wet films, while the 
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dry films remained brittle. This suggested that wet EC-PV/VA films were more 
‘intact’ or compact than EC-PVP films, allowing the water molecule to be retained in 
the matrix where they exerted their plasticizing effect. The concentration of PVP, 
MCPVP or PV/VA used had a significant influence on the flexibility of the resultant 
films. Addition of PVP, MCPVP and PV/VA resulted in increase in glass transition 
temperature, tensile strength and elastic modulus.  
Depending on its molecular weight and concentration, addition of PVP 
affected the water vapour permeability of EC films to varying extent. The water 
vapour permeability of composite EC films was significantly increased with addition 
of high molecular weight PVP, but not low molecular weight PVP (PVP K17, K29) at 
low concentration. However, with greater amount of PVP present, the effect of 
molecular weight of PVP on water vapour permeability became less significant. 
PV/VA a N-vinyl-2-pyrrolidone and vinyl acetate co-polymer which is less 
hygroscopic than PVP K29, showed a lower permeability to water vapour. In order 
not to affect the application of EC film as a protective moisture barrier, the type or 
molecular weights as well as amount of PVP added should be carefully selected and 
controlled in order not to compromise its water vapour permeability too much. Low 
molecular weight PVP, such as K17 and K29, or PV/VA at low concentration were 
found to be the more suitable for additives that does not compromise the water vapour 
permeability of EC films. 
Addition of PVP markedly increased the permeability of drug EC. The 
increase was found to be dependent on the molecular weight of PVP added. Higher 
molecular weight PVP generally increased the drug permeability of EC film to a 
greater extent. Generally, the permeability of composite EC-PV/VA films was almost 
similar to those of composite EC-PVP K29 films for all the model drugs studied 
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expect for propranolol and sulphaguanidine. The dissimilarity in chemical nature 
between PV/VA and PVP K29 might exert different effect on the structural properties 
of composite EC films thereby resulting differences in permeabilities of the respective 
composite EC films to several model drugs. The swelling test result suggested that 
increase in drug permeability for EC-PV/VA film was likely due to diffusion of drug 
mainly through pores or channels due to dissolution of PV/VA present rather than 
through formation of hydrated network. On the other hand, permeability of composite 
EC-PVP film may be affected by both the dissolution of PVP in the EC matrix 
creating channels or pores where the drug could diffuse through, as well as swelling 
of film matrix encouraged by the presence of PVP remaining in the film. The greater 
increase in drug permeability of EC-PVP films containing higher molecular weight 
PVP may be due to dual effects of greater water uptake by composite films and 
formation of larger pores. 
Drug permeability of composite EC films is also affected by the solubility of 
drugs. Permeability is enhanced for drugs of greater aqueous solubility, which can 
dissolve and permeate through the water-filled channels and swollen composite EC 
film matrix more effective than hydrophobic drugs. Exception was found for 
propranolol which might have interactions with EC film matrix, resulting in much 
slower release. A linear relationship was also found between molecular weights of 
model drugs studied and drug permeability of composite EC films containing high 
molecular weight PVP, such as PVP K60 and K90. 
Dissolution study of pellets coated with EC and composite EC films showed 
drug release was dependent on the molecular weight and concentration of polymeric 
additives, as well as the physicochemical properties of the drugs, such as their 
solubility in the dissolution media. Modification of drug release is determined by the 
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degree of influence each factors exert and the corresponding change in the release 
mechanisms. For instance, at low concentration of additives, PVPs with molecular 
ranging from 8, 000 to 58, 000 resulted in great increase in amount of 
chlorpheniramine released, while release of a less soluble drug, theophylline remained 
unchanged. Generally, as the concentration of PVPs added to EC coat increased the 
time taken to achieve maximum release was also greatly reduced. The reduction in 
release time was attributed mainly to a change in mechanism of release from 
diffusion-controlled to erosion or swelling controlled release. However, it was noted 
that while difference in release rate was observed for PVPs with low molecular 
weight (< 58,000), release profiles of chlorpheniramine pellets coated with composite 
EC containing high molecular weight PVPs show negligible difference. In contrast, 
release of theophylline from pellets coated with composite EC containing high 
molecular weight PVP increase proportionally with the molecular weight of PVP as 
the amount of PVP added increased. This phenomenon adequately illustrated the 
solubility of drugs in influencing the release profiles of composite EC coated dosage 
forms. In summary, there is a great potential in the use of PVP and its derivatives as 
polymeric additives for modification of drug release from EC coated dosage forms. 
Modification of drug release via use of polymeric additives has also proven to be 
advantageous compared to the convectional mean of varying the coating level. Unlike 
dosage forms coated with high level of polymer, composite polymers coating can 
enhance the release and allow most of the drug to be released within the 
gastrointestinal transit period. This would greatly reduce the amount of drug lost, 
which usually happened for dosage forms. Knowledge of the behaviour of EC and 
PVPs and its derivatives could be of use in formulation of appropriate new coating for 
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a0  initial radius for a sphere or cylinder or the half-thickness for a slab 
a1 a constant incorporating structural and geometric characteristics of the 
dosage form  
A area through which diffusion occurs or effective area for mass transfer 
Acs  cross-sectional area of the film  
Ai  initial cross-sectional area of the sample 
AIC  Akaike information criterion  
AUC area under the curve 
Cb, Cs concentration of drug at drug-coating interface and the bulk 
respectively 
Cd   concentration of the drug 
Cfs   drug solubility in the liquid surrounding the matrix  
Ci , Cm  interior and media drug concentrations respectively 
C0   initial concentration of the drug in the polymer matrix. 
Cr   concentration of the drug in the receptor fluid (g/cm3) 
Ce   solubility of drug in dissolution medium  
Cs   solubility of drug in the matrix 
cw   water concentration in the system 
Dp  displacement of the probe from point of contact to point of puncture 
D   diffusion coefficient or diffusivity 
De  Deborah number 
Deff   effective diffusion coefficient  
Diw   diffusion coefficient of drug through the pores 
Dm   diffusion coefficient across the membrane 
Dr   diffusivity of the drug through the membrane  
dC/dx   gradient in concentration (C) in the x direction. 
dL/dm  slope of the linear potion of the elastic deformation 
dM/dt   rate of diffusion 
E’  storage modulus 
E”  loss modulus 
EL  percent elongation at break (tensile test) 
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EM  elastic modulus 
EXC  amount of extracted components,  
f1  difference factor  
f2   similarity factor 
ft   fraction of drug released at any time t.  
F  load required for puncture  
hm   thickness of the membrane 
K   partition coefficient 
Kf   filtration coefficient  
ke   erosion rate constant 
K0   zero order release rate constant 
K1   first order release rate constant  
KH Higuchi release rate constant 
Ks  a constant incorporating the surface–volume relation for Hixson and 
Crowell model 
K′  a constant related to the surface, the shape and the density of the 
particle 
Kβ   Hixson and Crowell release constant. 
Is   swelling index  
j   flux per unit area 
J   total flux 
li  initial gauge length 
Lmax  maximum load 
M   mass change 
Md, Ma the respective amounts of diffusing substance in the donor and 
acceptor compartment when t = 0 
MDT mean dissolution time 
n  value in order to characterise different release mechanisms or  
  number of dissolution data points 
N  number of particles  
p  number of the parameters of the model  
P  permeability constant  
Peff  effective permeability coefficient 
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Pm  permeability coefficient of the polymer membrane 
Q  amount of drug released in time t per unit area,  
Q0  initial amount of drug in the solution  
Qt  amount of drug dissolved in time t,  
r  radius of a sphere 
ro    radius of the device  
r2   correlation coefficient  
R  radius of the film exposed across the open screw cap 
jR   percent dissolved of reference products at each time point j 
Rtot  total resistance 
Rm  membrane’s diffusional resistance  
Rwvp  water vapour permeation rate  
R1, R2  aqueous resistance 
T  absolute temperature 
t  time 
tL   lag time 
tx% parameter corresponds to the time necessary to the release of a 
determined percentage of drug 
Td  dissolution time  
jT   percent dissolved of test products at each time point j 
Ts  tensile strength 
W  total amount of the drug per unit volume of the matrix 
Wd  weight of the dried polymer film  
We  weight of the film that was dried to constant weight  
wi  optional weighing factor  
W0  initial amount of drug in the dosage form,  
Ws  weight of the swollen film  
Wt  amount of drug in the dosage form at time t 
WSSR  weighed sum of square of residues 
v  Poisson’s ratio 
V  volume of the receptor fluid  
V1, V2  molar volumes 
Vd, Va  volumes of the donor and receptor compartments. 
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Vm  total volume of the mixture 
ε  void fraction (porosity)  
τ  tortuosity of the membrane 
θ  one-half the angle of coalescence (contact angle) 
θ d  diffusion time 
η viscosity of the spheres 
β  chain immobilization factor 
λ relaxation time 
∂  % elongation (puncture test) 
δ  solubility parameter 
δc  coating thickness 
δd  thickness of the diffusion layer 
δs  cross-head speed 
σ  reflection coefficient of the coating 
ω work of failure 
φ  volume fraction 
∆π  osmotic pressure difference 
∆αcubic difference between the thermal cubical expansion coefficients of the 
coating and the tablet core 
∆E  energy of vaporization  
∆E/V  cohesive energy density (CED) 
∆G  Gibbs free energy of mixing 
∆H  heat of mixing 
∆lb  increase in length at break point 
∆p  vapour pressure difference  
∆S  entropy pf mixing 
∆W  amount of water vapour permeated through the film  
γ  surface tension 
γp  puncture strength
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